<?xml version="1.0" encoding="UTF-8" standalone="yes"?><trialResultsOutput hits="10" offset="1" totalResults="7854"><Filters total="48"><Filter label="Trial Technologies" name="trialTechnologies" total="100"><FilterOption id="762" count="4959" label="Small molecule therapeutic"/><FilterOption id="585" count="3986" label="Oral formulation"/><FilterOption id="595" count="2894" label="Tablet formulation"/><FilterOption id="648" count="2864" label="Intravenous formulation"/><FilterOption id="761" count="2848" label="Biological therapeutic"/><FilterOption id="740" count="2412" label="Infusion"/><FilterOption id="746" count="2048" label="Solution"/><FilterOption id="751" count="1871" label="Film coating"/><FilterOption id="586" count="1769" label="Capsule formulation"/><FilterOption id="573" count="1440" label="Immunoglobulin-G"/><FilterOption id="647" count="1317" label="Subcutaneous formulation"/><FilterOption id="85" count="1266" label="Protein recombinant"/><FilterOption id="898" count="1258" label="Formulation powder"/><FilterOption id="750" count="1012" label="Freeze drying"/><FilterOption id="169" count="917" label="Monoclonal antibody humanized"/><FilterOption id="1263" count="771" label="Immuno-oncology"/><FilterOption id="168" count="681" label="Monoclonal antibody human"/><FilterOption id="1652" count="581" label="Prodrug"/><FilterOption id="594" count="558" label="Oral suspension formulation"/><FilterOption id="1647" count="503" label="Natural product"/><FilterOption id="80" count="482" label="Peptide"/><FilterOption id="805" count="443" label="Daily dosing"/><FilterOption id="902" count="439" label="Orally disintegrating tablet"/><FilterOption id="593" count="424" label="Oral liquid formulation"/><FilterOption id="175" count="410" label="Drug combination"/><FilterOption id="589" count="406" label="Sustained release formulation"/><FilterOption id="651" count="331" label="Intramuscular formulation"/><FilterOption id="766" count="297" label="Parenteral formulation unspecified"/><FilterOption id="745" count="266" label="Suspension"/><FilterOption id="743" count="249" label="Granule"/><FilterOption id="180" count="240" label="Antibody fragment"/><FilterOption id="166" count="230" label="Chimeric monoclonal antibody"/><FilterOption id="66" count="228" label="Antibiotic"/><FilterOption id="894" count="226" label="Liquid formulation"/><FilterOption id="348" count="203" label="PEGylated formulation"/><FilterOption id="84" count="189" label="Protein fusion"/><FilterOption id="616" count="176" label="Inhalant formulation"/><FilterOption id="74" count="173" label="Glycoprotein"/><FilterOption id="128" count="153" label="Cell culture technique"/><FilterOption id="596" count="150" label="Injectable formulation"/><FilterOption id="660" count="147" label="Oral sustained release formulation"/><FilterOption id="112" count="144" label="DNA technology"/><FilterOption id="680" count="143" label="Buccal formulation systemic"/><FilterOption id="90" count="142" label="Steroid"/><FilterOption id="667" count="138" label="Peptidomimetic"/><FilterOption id="630" count="137" label="Stereochemistry"/><FilterOption id="701" count="133" label="Nucleoside synthesis"/><FilterOption id="641" count="125" label="Controlled release formulation"/><FilterOption id="603" count="121" label="Systemic formulation unspecified"/><FilterOption id="649" count="119" label="Intraperitoneal formulation"/><FilterOption id="852" count="119" label="Intravesical formulation"/><FilterOption id="127" count="109" label="Cell culture"/><FilterOption id="723" count="109" label="Drug coating"/><FilterOption id="618" count="108" label="Powder formulation inhalant"/><FilterOption id="207" count="104" label="Protein conjugated"/><FilterOption id="599" count="102" label="Nanoparticle formulation injectable"/><FilterOption id="171" count="97" label="Monoclonal antibody conjugated"/><FilterOption id="617" count="92" label="Aerosol formulation inhalant"/><FilterOption id="742" count="92" label="Pellet"/><FilterOption id="590" count="86" label="Enteric coated formulation"/><FilterOption id="611" count="84" label="Dermatological formulation"/><FilterOption id="558" count="83" label="Transdermal formulation"/><FilterOption id="620" count="81" label="Ophthalmic formulation"/><FilterOption id="208" count="78" label="Protein conjugation"/><FilterOption id="1646" count="71" label="Injectable controlled release formulation"/><FilterOption id="167" count="70" label="Monoclonal antibody murine"/><FilterOption id="159" count="70" label="Oligosaccharide"/><FilterOption id="102" count="67" label="Nucleotide and derivatives"/><FilterOption id="51" count="62" label="Monoclonal antibody"/><FilterOption id="236" count="61" label="Macrolide"/><FilterOption id="598" count="60" label="Liposome formulation injectable"/><FilterOption id="62" count="56" label="Virus recombinant"/><FilterOption id="753" count="54" label="Microparticle formulation"/><FilterOption id="559" count="54" label="Oral controlled release formulation"/><FilterOption id="661" count="53" label="Oral quick release formulation"/><FilterOption id="662" count="52" label="Quick release formulation"/><FilterOption id="1164" count="51" label="Antibody drug conjugate"/><FilterOption id="756" count="51" label="Pharmaceutical carrier"/><FilterOption id="615" count="49" label="Aerosol formulation dermatological"/><FilterOption id="347" count="46" label="Intratumoral formulation"/><FilterOption id="776" count="44" label="Oral gel formulation"/><FilterOption id="731" count="42" label="Imaging"/><FilterOption id="724" count="42" label="Radiolabeling"/><FilterOption id="103" count="41" label="Oligonucleotide"/><FilterOption id="807" count="40" label="Monthly dosing"/><FilterOption id="569" count="39" label="Oligonucleotide antisense"/><FilterOption id="652" count="38" label="Intra-articular formulation"/><FilterOption id="1" count="36" label="Antibody"/><FilterOption id="267" count="36" label="Multivalent antibody"/><FilterOption id="170" count="36" label="Multivalent monoclonal antibody"/><FilterOption id="962" count="31" label="Biosimilar product"/><FilterOption id="342" count="30" label="Receptor fusion"/><FilterOption id="806" count="30" label="Weekly dosing"/><FilterOption id="654" count="29" label="Intrathecal formulation"/><FilterOption id="901" count="29" label="Recombinant enzyme"/><FilterOption id="111" count="27" label="Cloning technology"/><FilterOption id="851" count="27" label="Intradermal formulation"/><FilterOption id="537" count="26" label="Chimeric antibody"/><FilterOption id="349" count="26" label="Lipid"/><FilterOption id="582" count="25" label="Antibody polyclonal"/></Filter><Filter label="Indications" name="indications" total="100"><FilterOption id="1767" count="434" label="Hepatocellular carcinoma"/><FilterOption id="3665" count="334" label="Metastatic non small cell lung cancer"/><FilterOption id="3657" count="321" label="Metastatic breast cancer"/><FilterOption id="3713" count="233" label="Advanced solid tumor"/><FilterOption id="1069" count="233" label="Metastasis"/><FilterOption id="837" count="230" label="Non-insulin dependent diabetes"/><FilterOption id="2399" count="210" label="Adenocarcinoma"/><FilterOption id="159" count="188" label="HIV-1 infection"/><FilterOption id="3658" count="183" label="Metastatic colorectal cancer"/><FilterOption id="307" count="151" label="Squamous cell carcinoma"/><FilterOption id="153" count="149" label="Hepatitis C virus infection"/><FilterOption id="1828" count="131" label="Multiple myeloma"/><FilterOption id="49" count="129" label="Breast tumor"/><FilterOption id="291" count="128" label="Rheumatoid arthritis"/><FilterOption id="213" count="122" label="Multiple sclerosis"/><FilterOption id="158" count="118" label="HIV infection"/><FilterOption id="1185" count="117" label="Chronic obstructive pulmonary disease"/><FilterOption id="3246" count="113" label="Hormone refractory prostate cancer"/><FilterOption id="14" count="110" label="Alzheimers disease"/><FilterOption id="3257" count="109" label="Stage IV melanoma"/><FilterOption id="3666" count="98" label="Metastatic stomach cancer"/><FilterOption id="31" count="97" label="Asthma"/><FilterOption id="3866" count="92" label="Metastatic ovary cancer"/><FilterOption id="4250" count="88" label="Metastatic renal cell carcinoma"/><FilterOption id="1771" count="88" label="Transitional cell carcinoma"/><FilterOption id="319" count="86" label="Non-Hodgkin lymphoma"/><FilterOption id="1731" count="85" label="Acute myelogenous leukemia"/><FilterOption id="3669" count="84" label="Metastatic pancreas cancer"/><FilterOption id="1262" count="82" label="Non-small-cell lung cancer"/><FilterOption id="3673" count="81" label="Metastatic head and neck cancer"/><FilterOption id="255" count="81" label="Parkinsons disease"/><FilterOption id="80" count="78" label="Coronary artery disease"/><FilterOption id="84" count="77" label="Crohns disease"/><FilterOption id="1749" count="76" label="Diffuse large B-cell lymphoma"/><FilterOption id="3083" count="76" label="Peritoneal tumor"/><FilterOption id="2243" count="72" label="Fallopian tube cancer"/><FilterOption id="1745" count="72" label="Follicle center lymphoma"/><FilterOption id="3667" count="71" label="Metastatic esophageal cancer"/><FilterOption id="20" count="71" label="Pain"/><FilterOption id="1734" count="68" label="Chronic lymphocytic leukemia"/><FilterOption id="55" count="65" label="Cardiac failure"/><FilterOption id="17" count="63" label="Anemia"/><FilterOption id="1705" count="61" label="Endometrioid carcinoma"/><FilterOption id="799" count="61" label="Ovary tumor"/><FilterOption id="281" count="60" label="Psoriasis"/><FilterOption id="337" count="60" label="Ulcerative colitis"/><FilterOption id="2454" count="57" label="Glioblastoma"/><FilterOption id="1261" count="55" label="Small-cell lung cancer"/><FilterOption id="57" count="54" label="Cardiovascular disease"/><FilterOption id="3256" count="54" label="Stage III melanoma"/><FilterOption id="1542" count="53" label="Atrial fibrillation"/><FilterOption id="224" count="53" label="Myocardial infarction"/><FilterOption id="299" count="53" label="Schizophrenia"/><FilterOption id="3466" count="52" label="Metastatic bladder cancer"/><FilterOption id="3676" count="49" label="Ischemic stroke"/><FilterOption id="3664" count="48" label="Metastatic prostate cancer"/><FilterOption id="1272" count="47" label="Myelodysplastic syndrome"/><FilterOption id="245" count="47" label="Osteoarthritis"/><FilterOption id="318" count="47" label="Systemic lupus erythematosus"/><FilterOption id="238" count="45" label="Obesity"/><FilterOption id="836" count="44" label="Insulin dependent diabetes"/><FilterOption id="552" count="41" label="Bleeding"/><FilterOption id="1765" count="41" label="Cholangiocarcinoma"/><FilterOption id="152" count="41" label="Hepatitis B virus infection"/><FilterOption id="70" count="41" label="Liver cirrhosis"/><FilterOption id="1728" count="40" label="Acute lymphoblastic leukemia"/><FilterOption id="3378" count="40" label="Soft tissue sarcoma"/><FilterOption id="427" count="39" label="Uterine cervix tumor"/><FilterOption id="203" count="38" label="Lymphoma"/><FilterOption id="1128" count="38" label="Neuroendocrine tumor"/><FilterOption id="3510" count="38" label="Pulmonary artery hypertension"/><FilterOption id="119" count="37" label="Epilepsy"/><FilterOption id="2380" count="36" label="Bladder cancer"/><FilterOption id="1080" count="36" label="Female infertility"/><FilterOption id="316" count="35" label="B-cell lymphoma"/><FilterOption id="178" count="35" label="Hypertension"/><FilterOption id="325" count="35" label="Thromboembolism"/><FilterOption id="1735" count="34" label="Chronic myelocytic leukemia"/><FilterOption id="1781" count="34" label="Psoriatic arthritis"/><FilterOption id="989" count="33" label="Colorectal tumor"/><FilterOption id="88" count="32" label="Cystic fibrosis"/><FilterOption id="623" count="32" label="Head and neck tumor"/><FilterOption id="2989" count="32" label="Kidney transplant rejection"/><FilterOption id="725" count="32" label="Solid tumor"/><FilterOption id="1744" count="31" label="Mantle cell lymphoma"/><FilterOption id="65" count="31" label="Stroke"/><FilterOption id="3258" count="30" label="Acute coronary syndrome"/><FilterOption id="1102" count="30" label="Atopic dermatitis"/><FilterOption id="760" count="30" label="Brain tumor"/><FilterOption id="3251" count="30" label="End stage renal disease"/><FilterOption id="1108" count="30" label="Glioma"/><FilterOption id="202" count="30" label="Liver tumor"/><FilterOption id="174" count="29" label="Hypercholesterolemia"/><FilterOption id="360" count="29" label="Pneumonia"/><FilterOption id="121" count="28" label="Factor VIII deficiency"/><FilterOption id="793" count="28" label="Mouth tumor"/><FilterOption id="3439" count="28" label="Partial seizure"/><FilterOption id="276" count="28" label="Prostate tumor"/><FilterOption id="4898" count="27" label="Major depressive disorder"/><FilterOption id="2659" count="26" label="Diabetic macular edema"/></Filter><Filter label="Endpoint Index" name="trialEndpointIndex" total="100"><FilterOption id="12048" count="316" label="Hepatobiliary system tumor - Assessment of Overall Survival (OS)"/><FilterOption id="8489" count="310" label="Lung tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="8481" count="273" label="Lung tumor - Assessment of Overall Survival (OS)"/><FilterOption id="8998" count="267" label="Breast tumor - Assessment of adverse events"/><FilterOption id="8719" count="257" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Overall/Objective Response Rate (ORR)"/><FilterOption id="8713" count="248" label="Breast tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="8712" count="240" label="Breast tumor - Assessment of Overall Survival (OS)"/><FilterOption id="12051" count="230" label="Hepatobiliary system tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="8663" count="221" label="Lung tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"/><FilterOption id="8639" count="213" label="Lung tumor - Assessment of Safety and Tolerability"/><FilterOption id="15312" count="213" label="Solid tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"/><FilterOption id="8505" count="209" label="Lung tumor - Assessment of Objective Response - Assessment of objective response rate(ORR)"/><FilterOption id="12118" count="207" label="Hepatobiliary system tumor - Assessment of adverse events"/><FilterOption id="12117" count="204" label="Hepatobiliary system tumor - Assessment of Safety and Tolerability"/><FilterOption id="15287" count="191" label="Solid tumor - Assessment of adverse events"/><FilterOption id="12056" count="172" label="Hepatobiliary system tumor - Assessment of Response Rates (RR) - Assessment of objective/overall response rate (ORR)"/><FilterOption id="8522" count="170" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of duration of response"/><FilterOption id="8738" count="169" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of duration of tumor response"/><FilterOption id="12115" count="168" label="Hepatobiliary system tumor - Assessment of Disease Progression - Assessment of time to disease progression (TTP)"/><FilterOption id="9247" count="165" label="HIV infection - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events"/><FilterOption id="9153" count="165" label="Lung tumor - Imaging/Radiological Assessments - Assessment by Response Evaluation Criteria in Solid Tumors (RECIST) Criteria"/><FilterOption id="8996" count="159" label="Breast tumor - Assessment of Safety and Tolerability"/><FilterOption id="8513" count="158" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"/><FilterOption id="8430" count="156" label="Colorectal tumor - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events"/><FilterOption id="9122" count="152" label="Breast tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"/><FilterOption id="8514" count="152" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="7547" count="150" label="Lymphoma - Assessment of Progression Free Survival (PFS)"/><FilterOption id="9218" count="149" label="HIV infection - Assessment of Immune Response"/><FilterOption id="8640" count="149" label="Lung tumor - Assessment of Safety and Tolerability - Adverse events as graded by CTCAE/CTC"/><FilterOption id="15212" count="147" label="Solid tumor - Assessment of Response Rates (RR) - Assessment of objective response rate (ORR)"/><FilterOption id="8163" count="143" label="Colorectal tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="8721" count="142" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="15293" count="142" label="Solid tumor - Assessment of Safety and Tolerability - Assessment of dose limiting toxicity"/><FilterOption id="8187" count="141" label="Colorectal tumor - Assessment of Response Rates (RR) - Assessment of Objective/Overall Response Rate (ORR)"/><FilterOption id="9215" count="139" label="HIV infection - Assessment of CD4 Cell Responses - Assessment of CD4 cell count/percentage"/><FilterOption id="7680" count="138" label="Lymphoma - Assessment of adverse events"/><FilterOption id="9213" count="136" label="HIV infection - Assessment of Viral Load - Assessment of HIV RNA levels"/><FilterOption id="7538" count="136" label="Lymphoma - Assessment of Overall Survival (OS)"/><FilterOption id="7569" count="133" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of Overall/Objective Response Rate (ORR)"/><FilterOption id="6863" count="132" label="Hepatitis C virus infection - Assessment of Viral Load/Viral Kinetics"/><FilterOption id="1503" count="132" label="Non-insulin dependent diabetes - Anthropometric Assessments - Assessment of body weight"/><FilterOption id="7879" count="130" label="Leukemia - Assessment of Overall Survival (OS)"/><FilterOption id="8523" count="127" label="Lung tumor - Assessment of Disease Progression"/><FilterOption id="8720" count="126" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"/><FilterOption id="15207" count="126" label="Solid tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="8078" count="125" label="Leukemia - Assessment of adverse events"/><FilterOption id="12064" count="124" label="Hepatobiliary system tumor - Assessment of Response Rates (RR) - Assessment of disease control rate"/><FilterOption id="3736" count="121" label="Hepatitis C virus infection - Assessment of Sustained Virologic Response (SVR)"/><FilterOption id="1359" count="119" label="Non-insulin dependent diabetes - Assessment of Hemoglobin A1c (HbA1c) Levels - Change in HbA1c"/><FilterOption id="8722" count="118" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Clinical Benefit Rate (CBR)"/><FilterOption id="1624" count="117" label="Non-insulin dependent diabetes - Assessment of Safety and Tolerability"/><FilterOption id="8151" count="115" label="Colorectal tumor - Assessment of Overall Survival (OS)"/><FilterOption id="1626" count="115" label="Non-insulin dependent diabetes - Assessment of Adverse Events"/><FilterOption id="1345" count="115" label="Non-insulin dependent diabetes - Glycemic Control Analysis - Assessment of fasting blood glucose"/><FilterOption id="7611" count="114" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of tumor response rate (Duration of response)"/><FilterOption id="7563" count="111" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="15285" count="111" label="Solid tumor - Assessment of Safety and Tolerability"/><FilterOption id="26033" count="106" label="Pain - Assessment of adverse events"/><FilterOption id="22595" count="100" label="End stage renal disease - Assessment of adverse events"/><FilterOption id="12127" count="100" label="Hepatobiliary system tumor - Assessment of Laboratory/Diagnostic Measures"/><FilterOption id="7908" count="99" label="Leukemia - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="8744" count="98" label="Breast tumor - Assessment of Disease Progression"/><FilterOption id="8451" count="97" label="Colorectal tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"/><FilterOption id="12058" count="95" label="Hepatobiliary system tumor - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="15218" count="95" label="Solid tumor - Assessment of Response Rates (RR) - Assessment of duration of tumor response"/><FilterOption id="12057" count="94" label="Hepatobiliary system tumor - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"/><FilterOption id="9155" count="93" label="Lung tumor - Assessment of Safety and Tolerability - Assessment of dose limiting toxicity"/><FilterOption id="10830" count="92" label="Ovary tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="2622" count="91" label="Coronary artery disease - Assessment of Mortality/Death Rates - Cardiovascular mortality"/><FilterOption id="8077" count="91" label="Leukemia - Assessment of Safety and Tolerability"/><FilterOption id="8997" count="90" label="Breast tumor - Assessment of Safety and Tolerability - Assessment of serious adverse events"/><FilterOption id="8725" count="89" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Stable Disease"/><FilterOption id="7045" count="89" label="Prostate tumor - Assessment of Overall Survival (OS)"/><FilterOption id="3900" count="89" label="Rheumatoid arthritis - DAS-28 (Disease Activity Score) Response"/><FilterOption id="12124" count="88" label="Hepatobiliary system tumor - Assessment of Mortality/Death Rates"/><FilterOption id="6940" count="88" label="Melanoma - Assessment of Response Rates (RR) - Assessment of overall/objective response rate"/><FilterOption id="8555" count="87" label="Lung tumor - Assessment of Mortality/Death Rates"/><FilterOption id="8519" count="87" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of Tumor Growth Control Rate (TGCR)"/><FilterOption id="7679" count="87" label="Lymphoma - Assessment of Safety and Tolerability"/><FilterOption id="7190" count="87" label="Prostate tumor - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events"/><FilterOption id="37159" count="86" label="Breast tumor - Assessment of Laboratory/Diagnostic Measures"/><FilterOption id="8189" count="86" label="Colorectal tumor - Assessment of Response Rates (RR) - Assessment of duration of response"/><FilterOption id="8651" count="86" label="Lung tumor - Assessment of Laboratory/Diagnostic Measures"/><FilterOption id="8508" count="86" label="Lung tumor - Assessment of Overall Response"/><FilterOption id="8516" count="86" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of Stable Disease"/><FilterOption id="6924" count="85" label="Melanoma - Assessment of Progression Free Survival (PFS)"/><FilterOption id="7027" count="85" label="Melanoma - Assessment of adverse events"/><FilterOption id="8641" count="84" label="Lung tumor - Assessment of Safety and Tolerability - Assessment of frequency and severity of adverse events"/><FilterOption id="7367" count="84" label="Multiple myeloma - Assessment of Response Rates (RR) - Assessment of Overall/Objective Response Rate (ORR)"/><FilterOption id="1358" count="84" label="Non-insulin dependent diabetes - Assessment of Hemoglobin A1c (HbA1c) Levels"/><FilterOption id="9008" count="83" label="Breast tumor - Assessment of Safety and Tolerability - Assessment of dose limiting toxicity"/><FilterOption id="12100" count="83" label="Hepatobiliary system tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"/><FilterOption id="7049" count="83" label="Prostate tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="12114" count="82" label="Hepatobiliary system tumor - Assessment of Disease Progression"/><FilterOption id="7360" count="81" label="Multiple myeloma - Assessment of Progression Free Survival (PFS)"/><FilterOption id="3809" count="80" label="Hepatitis C virus infection - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events"/><FilterOption id="6919" count="80" label="Melanoma - Assessment of Overall Survival (OS)"/><FilterOption id="7564" count="79" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"/><FilterOption id="9242" count="78" label="HIV infection - Assessment of lipid profiles"/><FilterOption id="12231" count="77" label="Hepatobiliary system tumor - Imaging/Radiological Assessments"/></Filter><Filter label="Trial Drug Phase Highest" name="trialDrugPhaseHighest" total="12"><FilterOption id="L" count="4970" label="Launched"/><FilterOption id="C3" count="704" label="Phase 3 Clinical"/><FilterOption id="C2" count="663" label="Phase 2 Clinical"/><FilterOption id="DX" count="582" label="Discontinued"/><FilterOption id="C1" count="129" label="Phase 1 Clinical"/><FilterOption id="PR" count="125" label="Pre-registration"/><FilterOption id="NDR" count="118" label="No Development Reported"/><FilterOption id="R" count="84" label="Registered"/><FilterOption id="W" count="54" label="Withdrawn"/><FilterOption id="DR" count="42" label="Discovery"/><FilterOption id="S" count="11" label="Suspended"/><FilterOption id="CU" count="5" label="Clinical"/></Filter><Filter label="Trial Company Sponsor" name="trialCompaniesSponsor" total="100"><FilterOption id="23137" count="485" label="Novartis AG"/><FilterOption id="19446" count="370" label="Roche Holding AG"/><FilterOption id="18767" count="304" label="Pfizer Inc"/><FilterOption id="28355" count="252" label="GlaxoSmithKline plc"/><FilterOption id="1009547" count="232" label="Sanofi SA"/><FilterOption id="17810" count="220" label="Eli Lilly &amp; Co"/><FilterOption id="14190" count="209" label="AstraZeneca plc"/><FilterOption id="15065" count="202" label="Bristol-Myers Squibb Co"/><FilterOption id="1039423" count="178" label="Hospital Clinic of Barcelona"/><FilterOption id="26178" count="176" label="F Hoffmann-La Roche AG"/><FilterOption id="14455" count="169" label="Bayer AG"/><FilterOption id="14881" count="146" label="Boehringer Ingelheim International GmbH"/><FilterOption id="1144568" count="139" label="Novartis Pharma Services AG"/><FilterOption id="1067538" count="131" label="Janssen Research &amp; Development LLC"/><FilterOption id="25599" count="119" label="Novartis Pharma AG"/><FilterOption id="1091809" count="109" label="Janssen-Cilag International NV (BE)"/><FilterOption id="15331" count="106" label="Celgene Corp"/><FilterOption id="14109" count="102" label="Amgen Inc"/><FilterOption id="1072507" count="101" label="AbbVie Inc"/><FilterOption id="16450" count="96" label="Gilead Sciences Inc"/><FilterOption id="30062" count="92" label="AstraZeneca AB"/><FilterOption id="1003065" count="88" label="Hospital Vall D'Hebron"/><FilterOption id="1121088" count="80" label="Novartis Farmaceutica SA"/><FilterOption id="15133" count="74" label="Bristol-Myers Squibb International Corp"/><FilterOption id="19453" count="74" label="Genentech Inc"/><FilterOption id="29218" count="70" label="AbbVie Deutschland GmbH &amp; Co KG"/><FilterOption id="1079783" count="65" label="FUNDACIÓ INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU"/><FilterOption id="1038736" count="64" label="PETHEMA Foundation"/><FilterOption id="1059823" count="60" label="Merck Sharp &amp; Dohme Corp"/><FilterOption id="1003983" count="59" label="Bayer HealthCare AG"/><FilterOption id="18614" count="57" label="Novo Nordisk A/S"/><FilterOption id="1003992" count="57" label="Universitat de Barcelona"/><FilterOption id="1119200" count="56" label="Sanofi-Aventis Research and Development"/><FilterOption id="22546" count="50" label="Boehringer Ingelheim GmbH"/><FilterOption id="1068202" count="49" label="Parc de Salut Mar"/><FilterOption id="1110770" count="46" label="Novartis Farma SpA"/><FilterOption id="1013295" count="45" label="Astellas Pharma Inc"/><FilterOption id="1040940" count="45" label="Hospital Universitari de Bellvitge"/><FilterOption id="1039086" count="44" label="Germans Trias i Pujol Hospital"/><FilterOption id="17839" count="43" label="Eli Lilly SA"/><FilterOption id="1005244" count="41" label="Biogen Inc"/><FilterOption id="22586" count="38" label="Boehringer Ingelheim Corp"/><FilterOption id="15414" count="38" label="Chugai Pharmaceutical Co Ltd"/><FilterOption id="23119" count="37" label="European Organisation for Research and Treatment of Cancer (EORTC)"/><FilterOption id="1087775" count="36" label="Novartis Oncology"/><FilterOption id="13601" count="35" label="Abbott Laboratories"/><FilterOption id="1081359" count="35" label="Corporacion Parc Tauli"/><FilterOption id="21991" count="35" label="Takeda Oncology"/><FilterOption id="20452" count="35" label="UCB SA"/><FilterOption id="23780" count="34" label="Actelion Ltd"/><FilterOption id="1050515" count="34" label="ViiV Healthcare Ltd"/><FilterOption id="1145220" count="32" label="GlaxoSmithKline Research &amp; Development Ltd"/><FilterOption id="17216" count="32" label="Incyte Corp"/><FilterOption id="18008" count="32" label="MedImmune LLC"/><FilterOption id="1095980" count="32" label="NOVARTIS FARMACEUTICA, S.A. DE C.V."/><FilterOption id="1122528" count="32" label="SCS Boehringer Ingelheim Comm.V"/><FilterOption id="24652" count="32" label="Shire plc"/><FilterOption id="18101" count="31" label="Merck KGaA"/><FilterOption id="1103352" count="29" label="Boehringer Ingelheim Espana Sa"/><FilterOption id="1020322" count="29" label="Daiichi Sankyo Inc"/><FilterOption id="19620" count="29" label="Eisai Inc"/><FilterOption id="22563" count="28" label="Boehringer Ingelheim Ltd"/><FilterOption id="27053" count="28" label="Glaxo Group Research Ltd"/><FilterOption id="1003570" count="27" label="Janssen R&amp;D (Ireland)"/><FilterOption id="1110884" count="26" label="Biogen Idec Research Ltd"/><FilterOption id="15121" count="26" label="Bristol-Myers Squibb Belgium SA"/><FilterOption id="17259" count="26" label="Ipsen"/><FilterOption id="14913" count="25" label="Eisai Ltd"/><FilterOption id="16299" count="25" label="Sanofi Genzyme"/><FilterOption id="1042061" count="25" label="Spanish Breast Cancer Research Group"/><FilterOption id="20348" count="24" label="Teva Pharmaceutical Industries Ltd"/><FilterOption id="22554" count="23" label="Boehringer Ingelheim BV"/><FilterOption id="1053612" count="23" label="Fundacion Clinic per a la Recerca Biomédica"/><FilterOption id="19461" count="22" label="Hoffmann-La Roche Inc"/><FilterOption id="1004360" count="22" label="Sun Yat-Sen University"/><FilterOption id="22598" count="22" label="Unilfarma Lda"/><FilterOption id="28611" count="21" label="Actelion Pharmaceuticals Ltd"/><FilterOption id="19214" count="21" label="Regeneron Pharmaceuticals Inc"/><FilterOption id="1037956" count="20" label="Astellas Pharma Global Development Inc"/><FilterOption id="27847" count="20" label="Boston Scientific Corp"/><FilterOption id="1035512" count="20" label="EMD Serono Inc"/><FilterOption id="27108" count="20" label="Glaxo SA"/><FilterOption id="17332" count="20" label="Johnson &amp; Johnson"/><FilterOption id="1045513" count="20" label="Spanish Lung Cancer Group"/><FilterOption id="13979" count="19" label="Alexion Pharmaceuticals Inc"/><FilterOption id="25902" count="19" label="Array BioPharma Inc"/><FilterOption id="22555" count="19" label="Boehringer Ingelheim Ellas AE"/><FilterOption id="20300" count="19" label="Takeda Pharmaceutical Co Ltd"/><FilterOption id="25611" count="19" label="Universitat Autonoma de Barcelona"/><FilterOption id="1084801" count="18" label="Medica Scientia Innovation Research"/><FilterOption id="1048099" count="18" label="Queen Mary Hospital"/><FilterOption id="1042371" count="18" label="Spanish Oncology Genito-Urinary Group"/><FilterOption id="22549" count="17" label="Boehringer Ingelheim Austria GmbH"/><FilterOption id="1122527" count="17" label="Boehringer Ingelheim Finland Ky"/><FilterOption id="22590" count="17" label="Boehringer Ingelheim SA"/><FilterOption id="24166" count="17" label="GlaxoSmithKline Biologicals"/><FilterOption id="14112" count="17" label="Wyeth"/><FilterOption id="22545" count="16" label="Boehringer Ingelheim AB"/><FilterOption id="22556" count="16" label="Boehringer Ingelheim France SARL"/><FilterOption id="1090120" count="16" label="NOVARTIS (SINGAPORE) PTE LTD"/></Filter><Filter label="Trial Recruitment Status" name="trialRecruitmentStatus" total="8"><FilterOption id="4" count="3967" label="Completed"/><FilterOption id="2" count="1714" label="Recruiting"/><FilterOption id="3" count="1054" label="No longer recruiting"/><FilterOption id="6" count="728" label="Terminated"/><FilterOption id="1" count="191" label="Not yet recruiting"/><FilterOption id="12" count="171" label="Status not specified"/><FilterOption id="5" count="28" label="Suspended"/><FilterOption id="15" count="1" label="Planned"/></Filter><Filter label="Trial Commercially Significant" name="trialIsCommerciallySignificant" total="2"><FilterOption id="YES" count="4740" label="Yes"/><FilterOption id="NO" count="3114" label="No"/></Filter><Filter label="Trial Indications Pioneer" name="trialIndicationsPioneer" total="100"><FilterOption id="3713" count="142" label="Advanced solid tumor"/><FilterOption id="3665" count="116" label="Metastatic non small cell lung cancer"/><FilterOption id="3657" count="101" label="Metastatic breast cancer"/><FilterOption id="2399" count="81" label="Adenocarcinoma"/><FilterOption id="1069" count="79" label="Metastasis"/><FilterOption id="3658" count="76" label="Metastatic colorectal cancer"/><FilterOption id="1767" count="66" label="Hepatocellular carcinoma"/><FilterOption id="307" count="61" label="Squamous cell carcinoma"/><FilterOption id="3666" count="53" label="Metastatic stomach cancer"/><FilterOption id="3669" count="52" label="Metastatic pancreas cancer"/><FilterOption id="3866" count="49" label="Metastatic ovary cancer"/><FilterOption id="3673" count="44" label="Metastatic head and neck cancer"/><FilterOption id="1771" count="40" label="Transitional cell carcinoma"/><FilterOption id="3667" count="39" label="Metastatic esophageal cancer"/><FilterOption id="3257" count="37" label="Stage IV melanoma"/><FilterOption id="1705" count="35" label="Endometrioid carcinoma"/><FilterOption id="3466" count="31" label="Metastatic bladder cancer"/><FilterOption id="4250" count="31" label="Metastatic renal cell carcinoma"/><FilterOption id="1262" count="30" label="Non-small-cell lung cancer"/><FilterOption id="319" count="29" label="Non-Hodgkin lymphoma"/><FilterOption id="427" count="28" label="Uterine cervix tumor"/><FilterOption id="1745" count="27" label="Follicle center lymphoma"/><FilterOption id="2454" count="27" label="Glioblastoma"/><FilterOption id="3246" count="27" label="Hormone refractory prostate cancer"/><FilterOption id="1261" count="27" label="Small-cell lung cancer"/><FilterOption id="1765" count="26" label="Cholangiocarcinoma"/><FilterOption id="1731" count="25" label="Acute myelogenous leukemia"/><FilterOption id="57" count="25" label="Cardiovascular disease"/><FilterOption id="49" count="24" label="Breast tumor"/><FilterOption id="1749" count="24" label="Diffuse large B-cell lymphoma"/><FilterOption id="1828" count="23" label="Multiple myeloma"/><FilterOption id="837" count="23" label="Non-insulin dependent diabetes"/><FilterOption id="159" count="22" label="HIV-1 infection"/><FilterOption id="3664" count="22" label="Metastatic prostate cancer"/><FilterOption id="2243" count="20" label="Fallopian tube cancer"/><FilterOption id="989" count="19" label="Colorectal tumor"/><FilterOption id="793" count="19" label="Mouth tumor"/><FilterOption id="3083" count="19" label="Peritoneal tumor"/><FilterOption id="799" count="18" label="Ovary tumor"/><FilterOption id="2380" count="17" label="Bladder cancer"/><FilterOption id="224" count="17" label="Myocardial infarction"/><FilterOption id="3378" count="17" label="Soft tissue sarcoma"/><FilterOption id="316" count="16" label="B-cell lymphoma"/><FilterOption id="3198" count="16" label="Larynx tumor"/><FilterOption id="203" count="16" label="Lymphoma"/><FilterOption id="1272" count="16" label="Myelodysplastic syndrome"/><FilterOption id="794" count="16" label="Pharynx tumor"/><FilterOption id="291" count="16" label="Rheumatoid arthritis"/><FilterOption id="725" count="16" label="Solid tumor"/><FilterOption id="1734" count="15" label="Chronic lymphocytic leukemia"/><FilterOption id="158" count="14" label="HIV infection"/><FilterOption id="3256" count="14" label="Stage III melanoma"/><FilterOption id="84" count="13" label="Crohns disease"/><FilterOption id="623" count="13" label="Head and neck tumor"/><FilterOption id="3676" count="13" label="Ischemic stroke"/><FilterOption id="70" count="13" label="Liver cirrhosis"/><FilterOption id="1240" count="13" label="Mesothelioma"/><FilterOption id="3467" count="13" label="Metastatic renal cancer"/><FilterOption id="3678" count="13" label="Urethral cancer"/><FilterOption id="14" count="12" label="Alzheimers disease"/><FilterOption id="1815" count="12" label="Bacterial pneumonia"/><FilterOption id="1108" count="12" label="Glioma"/><FilterOption id="2054" count="12" label="Hematological neoplasm"/><FilterOption id="153" count="12" label="Hepatitis C virus infection"/><FilterOption id="161" count="12" label="Hodgkins disease"/><FilterOption id="3462" count="12" label="Metastatic liver cancer"/><FilterOption id="213" count="12" label="Multiple sclerosis"/><FilterOption id="1128" count="12" label="Neuroendocrine tumor"/><FilterOption id="20" count="12" label="Pain"/><FilterOption id="760" count="11" label="Brain tumor"/><FilterOption id="55" count="11" label="Cardiac failure"/><FilterOption id="90" count="11" label="Dementia"/><FilterOption id="3668" count="11" label="Metastatic lung cancer"/><FilterOption id="65" count="11" label="Stroke"/><FilterOption id="337" count="11" label="Ulcerative colitis"/><FilterOption id="3258" count="10" label="Acute coronary syndrome"/><FilterOption id="651" count="10" label="Cancer"/><FilterOption id="2446" count="10" label="Leiomyosarcoma"/><FilterOption id="2447" count="10" label="Liposarcoma"/><FilterOption id="202" count="10" label="Liver tumor"/><FilterOption id="1744" count="10" label="Mantle cell lymphoma"/><FilterOption id="2726" count="10" label="Neuroblastoma"/><FilterOption id="249" count="10" label="Pancreas tumor"/><FilterOption id="1728" count="9" label="Acute lymphoblastic leukemia"/><FilterOption id="759" count="9" label="Central nervous system tumor"/><FilterOption id="3251" count="9" label="End stage renal disease"/><FilterOption id="2975" count="9" label="Ewing sarcoma"/><FilterOption id="1080" count="9" label="Female infertility"/><FilterOption id="178" count="9" label="Hypertension"/><FilterOption id="1746" count="9" label="Marginal zone B-cell lymphoma"/><FilterOption id="3235" count="9" label="Merkel cell carcinoma"/><FilterOption id="1766" count="9" label="Renal cell carcinoma"/><FilterOption id="318" count="9" label="Systemic lupus erythematosus"/><FilterOption id="1516" count="8" label="Biliary cancer"/><FilterOption id="100" count="8" label="Diabetic nephropathy"/><FilterOption id="131" count="8" label="Gastrointestinal tumor"/><FilterOption id="584" count="8" label="Lipid metabolism disorder"/><FilterOption id="2637" count="8" label="Non-alcoholic steatohepatitis"/><FilterOption id="3351" count="8" label="Papillary thyroid tumor"/><FilterOption id="255" count="8" label="Parkinsons disease"/></Filter><Filter label="Registry Id" name="trialRegistries" total="32"><FilterOption id="1000" count="7391" label="CT.gov"/><FilterOption id="1001" count="5095" label="EudraCT"/><FilterOption id="1030" count="1039" label="RSRM CTR"/><FilterOption id="1006" count="720" label="JapicCTI"/><FilterOption id="1023" count="520" label="UKCRN"/><FilterOption id="1019" count="410" label="DRKS"/><FilterOption id="1004" count="318" label="WHO ICTRP"/><FilterOption id="1012" count="302" label="CTRI"/><FilterOption id="1035" count="287" label="Singapore HSA CTR"/><FilterOption id="1021" count="227" label="NMRR"/><FilterOption id="1039" count="170" label="CDE"/><FilterOption id="1033" count="160" label="Mexico CTR"/><FilterOption id="1009" count="154" label="HKClinicalTrials.com"/><FilterOption id="1002" count="124" label="ISRCTN"/><FilterOption id="1038" count="102" label="PHRR"/><FilterOption id="1007" count="72" label="ChiCTR"/><FilterOption id="1011" count="64" label="ANZCTR"/><FilterOption id="1003" count="35" label="UMIN"/><FilterOption id="1020" count="28" label="ReBec"/><FilterOption id="1010" count="22" label="CRiS"/><FilterOption id="1008" count="13" label="Hong Kong CCTCTR"/><FilterOption id="1015" count="12" label="NTR"/><FilterOption id="1040" count="8" label="REec"/><FilterOption id="1018" count="8" label="SLCTR"/><FilterOption id="1016" count="6" label="PACTR"/><FilterOption id="1013" count="4" label="RPCEC"/><FilterOption id="1014" count="3" label="IRCT"/><FilterOption id="1031" count="2" label="Estonia CTR"/><FilterOption id="1005" count="2" label="JMACCT CTR"/><FilterOption id="1037" count="2" label="TCTR"/><FilterOption id="1026" count="1" label="SANCTR"/><FilterOption id="1024" count="1" label="TzCTR"/></Filter><Filter label="Trial Reason for Discontinuation" name="trialReasonForDiscontinuation" total="8"><FilterOption id="1" count="167" label="Lack of Efficacy"/><FilterOption id="5" count="147" label="Patient Enrollment Issues"/><FilterOption id="2" count="134" label="Not Reported"/><FilterOption id="4" count="119" label="Other"/><FilterOption id="8" count="88" label="Sponsor/Business Decision"/><FilterOption id="7" count="49" label="Safety Issues"/><FilterOption id="3" count="46" label="Operational Issues"/><FilterOption id="6" count="3" label="Planned, not Initiated"/></Filter><Filter label="Active Controls" name="trialActiveControls" total="100"><FilterOption id="3803" count="107" label="paclitaxel"/><FilterOption id="44383" count="102" label="carboplatin"/><FilterOption id="3199" count="93" label="gemcitabine"/><FilterOption id="2953" count="89" label="docetaxel"/><FilterOption id="12205" count="54" label="capecitabine"/><FilterOption id="6736" count="48" label="rituximab"/><FilterOption id="3536" count="47" label="pemetrexed disodium"/><FilterOption id="3792" count="45" label="oxaliplatin"/><FilterOption id="6050" count="44" label="metformin hydrochloride"/><FilterOption id="8047" count="39" label="bevacizumab"/><FilterOption id="29831" count="34" label="sorafenib"/><FilterOption id="6386" count="34" label="trastuzumab"/><FilterOption id="13928" count="30" label="enoxaparin sodium"/><FilterOption id="7310" count="29" label="ritonavir"/><FilterOption id="10252" count="26" label="insulin glargine"/><FilterOption id="49219" count="26" label="tenofovir disoproxil fumarate + emtricitabine (fixed dose), Gilead Sciences"/><FilterOption id="6408" count="26" label="vinorelbine"/><FilterOption id="44375" count="26" label="warfarin"/><FilterOption id="2871" count="25" label="irinotecan"/><FilterOption id="3072" count="23" label="etoposide phosphate"/><FilterOption id="3313" count="21" label="fulvestrant"/><FilterOption id="3669" count="21" label="mycophenolate mofetil"/><FilterOption id="29016" count="21" label="paclitaxel (albumin-bound nanoparticle, intravenous), Celgene"/><FilterOption id="14163" count="20" label="adalimumab"/><FilterOption id="11961" count="20" label="erlotinib"/><FilterOption id="4510" count="20" label="tacrolimus"/><FilterOption id="44401" count="20" label="vancomycin"/><FilterOption id="37370" count="19" label="azacitidine"/><FilterOption id="7413" count="19" label="darbepoetin alfa"/><FilterOption id="15954" count="18" label="bortezomib"/><FilterOption id="2784" count="18" label="letrozole"/><FilterOption id="23625" count="18" label="peginterferon alfa-2a"/><FilterOption id="70667" count="18" label="pembrolizumab"/><FilterOption id="15254" count="17" label="atazanavir"/><FilterOption id="2836" count="17" label="clopidogrel"/><FilterOption id="32981" count="17" label="darunavir"/><FilterOption id="13022" count="17" label="epirubicin"/><FilterOption id="8165" count="17" label="tiotropium bromide"/><FilterOption id="10388" count="16" label="cetuximab"/><FilterOption id="2807" count="15" label="atorvastatin"/><FilterOption id="4529" count="15" label="temozolomide"/><FilterOption id="4577" count="15" label="topotecan"/><FilterOption id="47000" count="14" label="bendamustine"/><FilterOption id="7934" count="14" label="doxorubicin (liposomal, STEALTH), Alza"/><FilterOption id="11460" count="14" label="imatinib"/><FilterOption id="3353" count="14" label="insulin lispro"/><FilterOption id="14681" count="14" label="lopinavir + ritonavir"/><FilterOption id="14493" count="14" label="tenofovir disoproxil fumarate"/><FilterOption id="3081" count="13" label="exemestane"/><FilterOption id="48181" count="13" label="lamivudine + abacavir, GlaxoSmithKline"/><FilterOption id="12973" count="13" label="sunitinib"/><FilterOption id="3321" count="12" label="anastrozole"/><FilterOption id="10172" count="12" label="efavirenz"/><FilterOption id="13340" count="12" label="everolimus"/><FilterOption id="27572" count="12" label="lenalidomide"/><FilterOption id="3616" count="12" label="meropenem"/><FilterOption id="5369" count="12" label="ribavirin"/><FilterOption id="10309" count="11" label="abiraterone"/><FilterOption id="4567" count="11" label="etanercept"/><FilterOption id="14336" count="11" label="fluticasone propionate + salmeterol (asthma and COPD), GlaxoSmithKline"/><FilterOption id="5999" count="10" label="ciclosporin, Novartis"/><FilterOption id="8832" count="10" label="glimepiride"/><FilterOption id="10411" count="10" label="insulin aspart"/><FilterOption id="54804" count="10" label="nivolumab"/><FilterOption id="13239" count="9" label="decitabine"/><FilterOption id="11367" count="9" label="ezetimibe"/><FilterOption id="6156" count="9" label="fludarabine"/><FilterOption id="3360" count="9" label="interferon beta-1a, Biogen"/><FilterOption id="3474" count="9" label="lamivudine"/><FilterOption id="33591" count="9" label="lapatinib"/><FilterOption id="22395" count="9" label="ranibizumab"/><FilterOption id="44313" count="9" label="simvastatin"/><FilterOption id="44499" count="9" label="sitagliptin"/><FilterOption id="28773" count="8" label="eribulin mesylate"/><FilterOption id="6140" count="8" label="formoterol"/><FilterOption id="12420" count="8" label="rosuvastatin"/><FilterOption id="44312" count="8" label="salmeterol"/><FilterOption id="53547" count="7" label="aflibercept (intravitreal, wet AMD, macular edema, diabetic retinopathy), Regeneron/Bayer"/><FilterOption id="72699" count="7" label="atezolizumab"/><FilterOption id="17518" count="7" label="escitalopram"/><FilterOption id="3159" count="7" label="fluticasone propionate"/><FilterOption id="36630" count="7" label="ipilimumab"/><FilterOption id="11036" count="7" label="linezolid"/><FilterOption id="5148" count="7" label="liraglutide"/><FilterOption id="3738" count="7" label="olanzapine"/><FilterOption id="27696" count="7" label="pomalidomide"/><FilterOption id="54488" count="7" label="raltegravir"/><FilterOption id="6242" count="6" label="abacavir"/><FilterOption id="11141" count="6" label="basiliximab"/><FilterOption id="44384" count="6" label="ceftriaxone"/><FilterOption id="5907" count="6" label="duloxetine"/><FilterOption id="53981" count="6" label="enzalutamide"/><FilterOption id="7286" count="6" label="goserelin acetate"/><FilterOption id="11519" count="6" label="mitoxantrone"/><FilterOption id="53227" count="6" label="obinutuzumab"/><FilterOption id="21374" count="6" label="pegfilgrastim"/><FilterOption id="4126" count="6" label="pioglitazone"/><FilterOption id="15130" count="6" label="vinflunine"/><FilterOption id="6747" count="5" label="adefovir dipivoxil"/><FilterOption id="7781" count="5" label="aripiprazole"/></Filter><Filter label="Exclusion Criteria Index" name="trialExclusionCriteriaIndex" total="100"><FilterOption id="9412" count="374" label="Hepatobiliary system tumor - Subjects with Co-morbid Conditions"/><FilterOption id="6258" count="251" label="Breast tumor - Subjects co-morbid with cardiovascular diseases/disorders"/><FilterOption id="5125" count="251" label="Lung tumor - Subjects with Evidence of Metastasis - Subjects with central nervous system metastases"/><FilterOption id="9411" count="248" label="Hepatobiliary system tumor - Subjects with History of/Active Malignancy/Cancer"/><FilterOption id="10704" count="244" label="Solid tumor - Subjects with Co-morbid Conditions"/><FilterOption id="5132" count="239" label="Lung tumor - Subjects co-morbid with cardiovascular diseases/disorders"/><FilterOption id="20282" count="231" label="Lung tumor - Subjects co-morbid with inflammatory disorders"/><FilterOption id="6247" count="229" label="Breast tumor - Subjects by disease severity - Subjects with Brain/Leptomeningeal metastases"/><FilterOption id="5193" count="228" label="Lung tumor - Subjects with History of/Active Malignancy/Cancer"/><FilterOption id="6859" count="212" label="HIV infection - Pregnant or Breast Feeding Subjects"/><FilterOption id="6294" count="211" label="Breast tumor - Subjects with History of/Active Malignancy/Cancer"/><FilterOption id="5365" count="190" label="Lung tumor - Protocol Specified Other Exclusion Criteria - Protocol specified exclusion criteria for females"/><FilterOption id="4702" count="187" label="Lymphoma - Subjects with Co-morbid Conditions"/><FilterOption id="6272" count="186" label="Breast tumor - Subjects co-morbid with inflammatory disorders"/><FilterOption id="6554" count="183" label="Leukemia - Subjects with Co-morbid Conditions"/><FilterOption id="6393" count="182" label="Breast tumor - Subjects with History of/Scheduled to Receive Therapy"/><FilterOption id="9425" count="181" label="Hepatobiliary system tumor - Subjects with Abnormal Organ Function - Subjects with abnormal/unacceptable cardiac function"/><FilterOption id="5270" count="178" label="Lung tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled for chemotherapy"/><FilterOption id="6328" count="176" label="Breast tumor - Subjects with History of/Scheduled for Anti-neoplastic Therapy"/><FilterOption id="5345" count="174" label="Lung tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled to receive an investigational drug"/><FilterOption id="9462" count="172" label="Hepatobiliary system tumor - Protocol Specified Other Exclusion Criteria - Protocol specified exclusion criteria for females"/><FilterOption id="9447" count="172" label="Hepatobiliary system tumor - Subjects with History of/Scheduled for Other Treatments"/><FilterOption id="10761" count="169" label="Solid tumor - Subjects with Evidence of Metastasis - Subjects with brain/CNS metastasis"/><FilterOption id="5291" count="168" label="Lung tumor - Subjects with History of/Scheduled for Other Treatments"/><FilterOption id="9427" count="164" label="Hepatobiliary system tumor - Subjects with Abnormal Laboratory Findings - Subjects with abnormal hematological status"/><FilterOption id="5282" count="159" label="Lung tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled for radiation therapy"/><FilterOption id="6377" count="158" label="Breast tumor - Subjects with history of/planned radiotherapy"/><FilterOption id="6331" count="155" label="Breast tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled for chemotherapy"/><FilterOption id="6845" count="152" label="HIV infection - Subjects with Co-morbid Conditions - Subjects co-morbid with hepatobiliary diseases/disorders"/><FilterOption id="5139" count="149" label="Lung tumor - Subjects co-morbid with Respiratory Diseases/Disorders - Subjects co-morbid with pulmonary diseases/disorders"/><FilterOption id="6252" count="146" label="Breast tumor - Subjects with Co-morbid Conditions"/><FilterOption id="9444" count="143" label="Hepatobiliary system tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of radiotherapy"/><FilterOption id="9414" count="132" label="Hepatobiliary system tumor - Subjects co-morbid with infections - Subjects co-morbid with HIV infection"/><FilterOption id="9440" count="132" label="Hepatobiliary system tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled for chemotherapy"/><FilterOption id="6820" count="129" label="HIV infection - Subjects with Opportunistic/Other Infections"/><FilterOption id="5826" count="127" label="Colorectal tumor - Subjects with Metastatic Colorectal Cancer - Subjects with brain metastases or leptomeningeal carcinomatosis"/><FilterOption id="20281" count="127" label="Lung tumor - Subjects with Co-morbid Conditions"/><FilterOption id="6253" count="123" label="Breast tumor - Subjects with Co-morbid Conditions - Subjects with central nervous system diseases"/><FilterOption id="6756" count="123" label="Lung tumor - Subjects with History of/Scheduled for Other Cancer Therapies"/><FilterOption id="5349" count="123" label="Lung tumor - Subjects with Protocol Specified Compliance Status - Subjects unable/unwilling to comply with protocol requirements"/><FilterOption id="4692" count="123" label="Lymphoma - Subjects with History of/Active Malignancy/Cancer"/><FilterOption id="5149" count="122" label="Lung tumor - Subjects co-morbid with gastrointestinal diseases/disorders"/><FilterOption id="20290" count="121" label="Breast tumor - Subjects with History of/Scheduled for Intervention/Surgery - Subjects with history of/scheduled for surgery"/><FilterOption id="5128" count="121" label="Lung tumor - Subjects with Co-morbid Conditions - Subjects with central nervous system diseases/disorders"/><FilterOption id="20112" count="121" label="Pain - Subjects with Co-morbid Conditions"/><FilterOption id="6260" count="120" label="Breast tumor - Subjects co-morbid with gastrointestinal diseases/disorders"/><FilterOption id="5269" count="120" label="Lung tumor - Subjects with History of/Scheduled to Receive Therapy"/><FilterOption id="5864" count="119" label="Colorectal tumor - Subjects co-morbid with cardiovascular diseases/disorders"/><FilterOption id="5163" count="118" label="Lung tumor - Subjects with Co-morbid Conditions - Subjects co-morbid with hepatobiliary diseases/disorders"/><FilterOption id="20114" count="118" label="Pain - Subjects with Co-morbid Conditions - Subjects co-morbid with CNS disorders/diseases"/><FilterOption id="5841" count="117" label="Colorectal tumor - Subjects with History of/Active Malignancy/Cancer"/><FilterOption id="6892" count="114" label="HIV infection - Subjects with history of/scheduled to receive therapy for other indication"/><FilterOption id="9445" count="113" label="Hepatobiliary system tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of surgical interventions/procedure"/><FilterOption id="12316" count="113" label="Solid tumor - Subjects with History of/Active Malignancy/Cancer"/><FilterOption id="10739" count="111" label="Solid tumor - Subjects with History of Other Non Anti-cancer Drugs/Agents"/><FilterOption id="9423" count="110" label="Hepatobiliary system tumor - Subjects with Abnormal Organ Function - Subjects with abnormal/unacceptable liver function"/><FilterOption id="9454" count="110" label="Hepatobiliary system tumor - Subjects with Protocol Specified Compliance Status - Subjects with inability/unwillingness to comply with the protocol"/><FilterOption id="5285" count="110" label="Lung tumor - Subjects with History of/Scheduled for Intervention/Surgery - Subjects with history of/scheduled for surgery"/><FilterOption id="5277" count="110" label="Lung tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled for biological therapy"/><FilterOption id="6302" count="109" label="Breast tumor - Subjects with Hypersensitivity/Contraindications to Drugs/Excipients - Subjects with hypersensitivity/contraindication to any investigational agents"/><FilterOption id="6941" count="109" label="HIV infection - Subjects with Hypersensitivity/Contraindications to Drugs/Excipients - Hypersensitivity/Contraindications to study medications or its excipients"/><FilterOption id="17519" count="106" label="End stage renal disease - Subjects co-morbid with cardiovascular diseases/disorders"/><FilterOption id="5962" count="105" label="Colorectal tumor - Subjects with history of/scheduled to receive therapy for other indication"/><FilterOption id="4909" count="105" label="Prostate tumor - Subjects with History of/Active Malignancy/Cancer"/><FilterOption id="6783" count="103" label="Lung tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled for immunotherapy"/><FilterOption id="4769" count="103" label="Lymphoma - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled for chemotherapy"/><FilterOption id="20289" count="102" label="Breast tumor - Subjects with History of/Scheduled for Disease Specific Pharmacological Therapy - Subjects with history of biologic therapy"/><FilterOption id="6534" count="102" label="Leukemia - Subjects with History of/Active Malignancy/Cancer"/><FilterOption id="9810" count="101" label="Ovary tumor - Subjects with Co-morbid Conditions"/><FilterOption id="5856" count="100" label="Colorectal tumor - Subjects co-morbid with inflammatory disorders"/><FilterOption id="9424" count="100" label="Hepatobiliary system tumor - Subjects with Abnormal Organ Function - Subjects with abnormal/unacceptable renal function"/><FilterOption id="6065" count="100" label="Multiple myeloma - Subjects with Co-morbid Conditions"/><FilterOption id="6259" count="99" label="Breast tumor - Subjects co-morbid with Respiratory Diseases/Disorders - Subjects co-morbid with pulmonary diseases/disorders"/><FilterOption id="4847" count="99" label="Prostate tumor - Subjects with Advanced/Metastatic Prostate Cancer - Subjects with brain metastasis"/><FilterOption id="3058" count="98" label="Chronic obstructive pulmonary disease - Subjects co-morbid with Respiratory Diseases/Disorders"/><FilterOption id="4967" count="97" label="Prostate tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled for chemotherapy"/><FilterOption id="5879" count="96" label="Colorectal tumor - Subjects with Co-morbid Conditions"/><FilterOption id="5347" count="95" label="Lung tumor - Protocol Specified Other Exclusion Criteria - Subjects with abnormal laboratory values"/><FilterOption id="6261" count="94" label="Breast tumor - Subjects with Co-morbid Conditions - Subjects co-morbid with hepatobiliary diseases/disorders"/><FilterOption id="9441" count="94" label="Hepatobiliary system tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of targeted therapy"/><FilterOption id="837" count="94" label="Non-insulin dependent diabetes - Subjects co-morbid with renal disease/disorder"/><FilterOption id="5848" count="93" label="Colorectal tumor - Subjects co-morbid with gastrointestinal diseases/disorders"/><FilterOption id="9446" count="93" label="Hepatobiliary system tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled to receive an investigational drug"/><FilterOption id="925" count="93" label="Non-insulin dependent diabetes - Subjects with History of/Active Malignancy/Cancer"/><FilterOption id="10717" count="93" label="Solid tumor - Subjects with Abnormal Organ Function - Subjects with abnormal/unacceptable cardiac function"/><FilterOption id="891" count="92" label="Non-insulin dependent diabetes - Subjects co-morbid with heart disorders/diseases"/><FilterOption id="10736" count="92" label="Solid tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of radiotherapy"/><FilterOption id="5744" count="91" label="Head and neck tumor - Subjects with Co-morbid Conditions"/><FilterOption id="5949" count="90" label="Colorectal tumor - Subjects with history of/scheduled to receive radiation therapy"/><FilterOption id="5344" count="90" label="Lung tumor - Protocol Specified Other Exclusion Criteria"/><FilterOption id="17531" count="89" label="End stage renal disease - Subjects co-morbid with infections"/><FilterOption id="10738" count="89" label="Solid tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled to receive an investigational drug"/><FilterOption id="9456" count="88" label="Hepatobiliary system tumor - Subjects with Protocol Specified Participation Status - Subjects not suitable to participate as per investigator's discretion"/><FilterOption id="6660" count="88" label="Leukemia - Subjects with History of Treatment with Non-chemotherapeutic Drugs"/><FilterOption id="6767" count="88" label="Lymphoma - Lymphoma Subjects with Advanced Disease - Subjects with central nervous system involvement of lymphoma"/><FilterOption id="10378" count="88" label="Pancreas tumor - Subjects with Co-morbid Conditions"/><FilterOption id="9431" count="87" label="Hepatobiliary system tumor - Subjects with Hypersensitivity/Contraindications to Drugs/Excipients"/><FilterOption id="4864" count="87" label="Prostate tumor - Subjects co-morbid with cardiovascular diseases/disorders"/><FilterOption id="9390" count="86" label="Hepatobiliary system tumor - Liver Cancer Subjects with Specific Child-Pugh Score"/><FilterOption id="26439" count="86" label="Hepatobiliary system tumor - Subjects with Evidence of Metastasis"/></Filter><Filter label="Trial Date Enrollment End By Month" name="trialDateEnrollmentEndByMonth" total="100"><FilterOption count="50" label="201607"/><FilterOption count="50" label="201905"/><FilterOption count="43" label="201506"/><FilterOption count="43" label="201510"/><FilterOption count="42" label="201705"/><FilterOption count="42" label="201802"/><FilterOption count="41" label="201906"/><FilterOption count="40" label="201509"/><FilterOption count="40" label="201708"/><FilterOption count="39" label="201603"/><FilterOption count="39" label="201608"/><FilterOption count="39" label="201806"/><FilterOption count="39" label="201901"/><FilterOption count="39" label="201904"/><FilterOption count="38" label="201504"/><FilterOption count="37" label="201512"/><FilterOption count="37" label="201809"/><FilterOption count="37" label="201812"/><FilterOption count="36" label="201612"/><FilterOption count="36" label="201803"/><FilterOption count="35" label="201210"/><FilterOption count="35" label="201601"/><FilterOption count="35" label="201710"/><FilterOption count="35" label="201902"/><FilterOption count="34" label="201604"/><FilterOption count="34" label="201605"/><FilterOption count="34" label="201709"/><FilterOption count="34" label="201801"/><FilterOption count="34" label="201807"/><FilterOption count="34" label="201810"/><FilterOption count="33" label="201609"/><FilterOption count="33" label="201903"/><FilterOption count="32" label="201402"/><FilterOption count="32" label="201503"/><FilterOption count="32" label="201507"/><FilterOption count="32" label="201701"/><FilterOption count="32" label="201706"/><FilterOption count="31" label="201711"/><FilterOption count="31" label="201712"/><FilterOption count="30" label="201301"/><FilterOption count="30" label="201410"/><FilterOption count="30" label="201606"/><FilterOption count="29" label="201107"/><FilterOption count="29" label="201302"/><FilterOption count="29" label="201305"/><FilterOption count="29" label="201404"/><FilterOption count="29" label="201811"/><FilterOption count="28" label="201103"/><FilterOption count="28" label="201207"/><FilterOption count="28" label="201306"/><FilterOption count="28" label="201310"/><FilterOption count="28" label="201311"/><FilterOption count="28" label="201406"/><FilterOption count="28" label="201703"/><FilterOption count="28" label="201707"/><FilterOption count="28" label="201805"/><FilterOption count="27" label="201308"/><FilterOption count="27" label="201401"/><FilterOption count="27" label="201409"/><FilterOption count="27" label="201808"/><FilterOption count="26" label="201109"/><FilterOption count="26" label="201110"/><FilterOption count="26" label="201112"/><FilterOption count="26" label="201203"/><FilterOption count="26" label="201309"/><FilterOption count="26" label="201408"/><FilterOption count="26" label="201502"/><FilterOption count="26" label="201505"/><FilterOption count="26" label="201702"/><FilterOption count="25" label="200810"/><FilterOption count="25" label="200909"/><FilterOption count="25" label="201105"/><FilterOption count="25" label="201209"/><FilterOption count="24" label="201001"/><FilterOption count="24" label="201102"/><FilterOption count="24" label="201106"/><FilterOption count="24" label="201201"/><FilterOption count="24" label="201405"/><FilterOption count="24" label="201501"/><FilterOption count="24" label="201610"/><FilterOption count="24" label="201611"/><FilterOption count="24" label="201804"/><FilterOption count="23" label="201202"/><FilterOption count="23" label="201307"/><FilterOption count="23" label="201403"/><FilterOption count="23" label="201411"/><FilterOption count="23" label="201511"/><FilterOption count="22" label="201002"/><FilterOption count="22" label="201312"/><FilterOption count="22" label="201602"/><FilterOption count="22" label="201704"/><FilterOption count="21" label="200903"/><FilterOption count="21" label="200905"/><FilterOption count="21" label="200906"/><FilterOption count="21" label="200911"/><FilterOption count="21" label="200912"/><FilterOption count="21" label="201003"/><FilterOption count="21" label="201004"/><FilterOption count="21" label="201206"/><FilterOption count="21" label="201412"/></Filter><Filter label="Funder Type" name="trialFunderType" total="5"><FilterOption id="CMP" count="6400" label="Company"/><FilterOption id="ACA" count="1950" label="Academic"/><FilterOption id="GOV" count="99" label="Government"/><FilterOption id="OTH" count="75" label="Others"/><FilterOption id="NGO" count="49" label="Non-Government"/></Filter><Filter label="Trial Region" name="trialRegions" total="11"><FilterOption id="NSWE" count="7181" label="Northern, Southern &amp; Western Europe"/><FilterOption id="USCA" count="4349" label="US &amp; Canada"/><FilterOption id="EEUR" count="3688" label="Eastern Europe"/><FilterOption id="EAPO" count="2572" label="East Asia &amp; Pacific Ocean"/><FilterOption id="AUNZ" count="2319" label="Australia &amp; New Zealand"/><FilterOption id="MENA" count="2038" label="Middle East &amp; North Africa"/><FilterOption id="SOAM" count="1895" label="South America"/><FilterOption id="CAAC" count="1464" label="Central America &amp; Caribbean"/><FilterOption id="CSAF" count="963" label="Central &amp; Southern Africa"/><FilterOption id="SOCA" count="640" label="Southern &amp; Central Asia"/><FilterOption id="INDO" count="7" label="Indian Ocean"/></Filter><Filter label="Patient Segment Index" name="trialPatientSegmentIndex" total="100"><FilterOption id="3634" count="323" label="Lung tumor - Subjects with Advanced Stage Lung Cancer - Subjects with metastatic/stage IV lung cancer"/><FilterOption id="3954" count="316" label="Breast tumor - Subjects with Advanced/Metastatic Breast Cancer/Stage IV Breast Cancer"/><FilterOption id="3617" count="294" label="Lung tumor - Subjects with Non Small Cell Lung Cancer (NSCLC)"/><FilterOption id="16345" count="263" label="Hepatobiliary system tumor - Subjects with specific disease - Subjects with hepatocellular carcinoma"/><FilterOption id="7126" count="262" label="HIV infection - Subjects with HIV Infection - Subjects with HIV-1 Infection"/><FilterOption id="10295" count="231" label="Lung tumor - Subjects with Advanced Stage Lung Cancer - Subjects with locally advanced/stage III lung cancer"/><FilterOption id="7961" count="229" label="Solid tumor - Subjects with Advanced/Metastatic Solid Tumors"/><FilterOption id="3824" count="189" label="Colorectal tumor - Subjects with TNM stage IV/Metastatic/Advanced Colorectal Cancer"/><FilterOption id="8062" count="180" label="Hepatobiliary system tumor - Subjects with Unresectable Hepato-biliary Cancer"/><FilterOption id="3623" count="176" label="Lung tumor - Subjects with Advanced Stage Lung Cancer"/><FilterOption id="8059" count="171" label="Hepatobiliary system tumor - Subjects with Advanced/Metastatic Primary Liver Cancer"/><FilterOption id="7967" count="171" label="Solid tumor - Subjects with Treatment Resistant Disease"/><FilterOption id="3965" count="161" label="Breast tumor - Subjects with Treatment Resistant Disease"/><FilterOption id="3952" count="160" label="Breast tumor - Subjects with Locally Advanced Breast Cancer"/><FilterOption id="3937" count="154" label="Breast tumor - Subjects with HER-2 Negative Breast Cancer"/><FilterOption id="461" count="150" label="Hepatitis C virus infection - Subjects with Chronic Hepatitis C Infection"/><FilterOption id="145" count="144" label="Non-insulin dependent diabetes - Subjects with Moderate Glycemic Control"/><FilterOption id="103" count="136" label="Non-insulin dependent diabetes - Subjects with Poor/Inadequate Glycemic Control"/><FilterOption id="3530" count="132" label="Lymphoma - Subjects with Treatment Resistant Disease"/><FilterOption id="3647" count="130" label="Lung tumor - Subjects with Treatment Resistant Disease"/><FilterOption id="3564" count="129" label="Prostate tumor - Subjects with Advanced/Metastatic Prostate Cancer"/><FilterOption id="3936" count="123" label="Breast tumor - Subjects with HER-2 Positive Breast Cancer"/><FilterOption id="3525" count="120" label="Lymphoma - Subjects with Relapse/Recurrent Lymphoma"/><FilterOption id="8067" count="111" label="Hepatobiliary system tumor - Subjects with Treatment Resistant Disease"/><FilterOption id="3966" count="103" label="Breast tumor - Subjects with Relapsed/Recurrent Breast cancer"/><FilterOption id="3931" count="102" label="Breast tumor - Subjects with Hormone Receptor Positive Breast Cancer - Estrogen receptor positive (ER+) breast cancer"/><FilterOption id="12053" count="102" label="Lung tumor - Treatment Naive Subjects"/><FilterOption id="3814" count="99" label="Colorectal tumor - Subjects with Colon Cancer"/><FilterOption id="3667" count="97" label="Melanoma - Subjects with Advanced/Metastatic Cancer"/><FilterOption id="7487" count="96" label="Hepatitis C virus infection - Subjects Infected with HCV Genotype 1"/><FilterOption id="3565" count="94" label="Prostate tumor - Subjects with Stage IV Prostate Cancer"/><FilterOption id="3813" count="93" label="Colorectal tumor - Subjects with Rectal Cancer"/><FilterOption id="102" count="93" label="Non-insulin dependent diabetes - Subjects with Good Glycemic Control"/><FilterOption id="3938" count="90" label="Breast tumor - Subjects with Triple Negative Breast Cancer"/><FilterOption id="128" count="90" label="Multiple sclerosis - Subjects with Relapsing Remitting Multiple Sclerosis (RRMS)"/><FilterOption id="502" count="90" label="Rheumatoid arthritis - Active Rheumatoid Arthritis"/><FilterOption id="3650" count="89" label="Lung tumor - Subjects with Recurrent/Relapsed Lung Cancer"/><FilterOption id="7877" count="88" label="Lung tumor - Subjects with Non Small Cell Lung Cancer (NSCLC) - Subjects with non-squamous cell lung cancer"/><FilterOption id="8073" count="88" label="Pancreas tumor - Subjects with Advanced/Metastatic Pancreatic Cancer"/><FilterOption id="3583" count="86" label="Prostate tumor - Subjects with Castrate Resistant Prostate Cancer"/><FilterOption id="3586" count="84" label="Prostate tumor - Subjects with Treatment Resistant Disease"/><FilterOption id="3977" count="83" label="Leukemia - Subjects with Acute Myeloid Leukemia (AML)"/><FilterOption id="100" count="83" label="Non-insulin dependent diabetes - Subjects on Treatment/Requiring &gt;1 Antidiabetic Agent"/><FilterOption id="108" count="82" label="Non-insulin dependent diabetes - Subjects with comorbid conditions - Subjects with obesity"/><FilterOption id="8010" count="82" label="Stomach tumor - Subjects with Advanced/Metastatic Gastric Cancer"/><FilterOption id="562" count="80" label="Chronic obstructive pulmonary disease - Subjects with GOLD Stage 3/Severe COPD"/><FilterOption id="3926" count="80" label="Multiple myeloma - Subjects with Relapsed/Recurrent Multiple Myeloma"/><FilterOption id="7108" count="78" label="HIV infection - Subjects on Prior/Concurrent Antiretroviral Therapy"/><FilterOption id="3945" count="77" label="Breast tumor - Subjects with Stage III Breast Cancer"/><FilterOption id="561" count="77" label="Chronic obstructive pulmonary disease - Subjects with GOLD Stage 2/Moderate COPD"/><FilterOption id="3774" count="77" label="Head and neck tumor - Subjects with Advanced/Metastatic Head and Neck Cancer"/><FilterOption id="3680" count="77" label="Melanoma - Subjects with Stage IV Melanoma"/><FilterOption id="3472" count="76" label="Lymphoma - Subjects with B Cell Non Hodgkin's Lymphoma - Subjects with diffuse large B cell lymphoma"/><FilterOption id="3956" count="75" label="Breast tumor - Subjects with Un-resectable/Non-operable Breast Cancer"/><FilterOption id="3860" count="74" label="Colorectal tumor - Subjects with Treatment Resistant Disease"/><FilterOption id="3473" count="74" label="Lymphoma - Subjects with B Cell Non Hodgkin's Lymphoma - Subjects with follicular lymphoma"/><FilterOption id="3923" count="74" label="Multiple myeloma - Subjects with Treatment Resistant Disease"/><FilterOption id="3778" count="73" label="Head and neck tumor - Subjects with Specific Histological Sub-type of HNC - Subjects with squamous cell carcinoma"/><FilterOption id="3502" count="71" label="Lymphoma - Subjects with Specific Grade of Lymphoma - Subjects with Aggressive (high grade) Lymphoma"/><FilterOption id="12018" count="71" label="Prostate tumor - Subjects with adenocarcinoma of prostate"/><FilterOption id="7415" count="71" label="Renal cell carcinoma - Subjects with Metastatic Renal Cell Carcinoma"/><FilterOption id="7960" count="71" label="Solid tumor - Subjects with Locally Advanced Solid Tumors"/><FilterOption id="7810" count="70" label="Bladder cancer - Subjects with Metastatic Bladder Cancer"/><FilterOption id="3736" count="70" label="Chronic obstructive pulmonary disease - Subjects at risk of developing disease - Smokers"/><FilterOption id="3489" count="70" label="Lymphoma - Subjects with B Cell Non Hodgkin's Lymphoma"/><FilterOption id="7107" count="69" label="HIV infection - Treatment Naive Subjects"/><FilterOption id="3500" count="69" label="Lymphoma - Subjects with Specific Grade of Lymphoma - Subjects with Indolent (slow-growing, low grade) Lymphoma"/><FilterOption id="489" count="65" label="Hepatitis C virus infection - Treatment Naive Subjects"/><FilterOption id="11994" count="65" label="Hepatobiliary system tumor - Treatment Naive Subjects"/><FilterOption id="513" count="65" label="Rheumatoid arthritis - Subjects with Treatment Resistant Disease"/><FilterOption id="12845" count="64" label="Breast tumor - Subjects with gene variants - ERBB2_HUMAN_Amplification"/><FilterOption id="161" count="63" label="Alzheimers disease - Subjects with Mild Alzheimer's Disease"/><FilterOption id="4003" count="62" label="Leukemia - Subjects with Relapsed/Recurrent Leukemia"/><FilterOption id="3950" count="61" label="Breast tumor - Subjects with Early Stage Breast Cancer"/><FilterOption id="7486" count="61" label="Lung tumor - Subjects with Non Small Cell Lung Cancer (NSCLC) - Subjects with squamous cell lung cancer"/><FilterOption id="3999" count="60" label="Leukemia - Subjects with Treatment Resistant Disease"/><FilterOption id="7879" count="60" label="Ovary tumor - Subjects with Ovarian Epithelial Tumor"/><FilterOption id="7700" count="57" label="End stage renal disease - Subjects with Non-Dialysis Dependant Chronic Kidney Disease(NDD-CKD) - Subjects with stage 3 chronic kidney disease"/><FilterOption id="10129" count="57" label="Lung tumor - Subjects with EGFR Positive Lung Cancer"/><FilterOption id="8387" count="57" label="Pain - Subjects with Chronic Pain"/><FilterOption id="11631" count="57" label="Stroke - Subjects with Ischemic Stroke"/><FilterOption id="11954" count="56" label="Bladder cancer - Subjects with Urothelial cell/Transitional Cell Bladder Cancer"/><FilterOption id="3932" count="56" label="Breast tumor - Subjects with Hormone Receptor Positive Breast Cancer - Progesterone receptor positive (PR+) breast cancer"/><FilterOption id="3637" count="56" label="Lung tumor - Subjects with Unresectable/In-operable Lung Cancer"/><FilterOption id="3681" count="56" label="Melanoma - Subjects with Evidence of Metastasis"/><FilterOption id="3980" count="55" label="Leukemia - Subjects with Chronic Lymphocytic Leukemia (CLL)"/><FilterOption id="8414" count="55" label="Pain - Subjects with Somatic Pain - Subjects with arthritic pain"/><FilterOption id="3944" count="54" label="Breast tumor - Subjects with Stage II Breast Cancer"/><FilterOption id="7966" count="54" label="Solid tumor - Subjects with Relapsed/Recurrent Solid Tumors"/><FilterOption id="490" count="53" label="Hepatitis C virus infection - Subjects with Prior Hepatitis C Therapy"/><FilterOption id="7111" count="53" label="HIV infection - Subjects on Prior/Concurrent Antiretroviral Therapy - Subjects on prior/concurrent protease inhibitors"/><FilterOption id="3975" count="53" label="Leukemia - Subjects with Acute Leukemia Unspecified Type"/><FilterOption id="3698" count="53" label="Melanoma - Subjects with Surgically Non-resectable Melanoma"/><FilterOption id="7414" count="53" label="Renal cell carcinoma - Advanced Stage Renal Cell Carcinoma"/><FilterOption id="7895" count="52" label="Ovary tumor - Platinum-Resistant/Refractory Ovarian Cancer Subjects"/><FilterOption id="11612" count="51" label="Menopause - Subjects with Protocol Specified Menstrual Status - Postmenopausal Subjects"/><FilterOption id="3434" count="51" label="Psoriasis - Subjects with Plaque Psoriasis/Psoriasis Vulgaris"/><FilterOption id="7402" count="50" label="Renal cell carcinoma - Subjects with Clear Cell Renal Cell Carcinoma"/><FilterOption id="7918" count="49" label="Ovary tumor - Advanced Ovarian Cancer Subjects - Stage IV or metastatic ovarian cancer subjects"/><FilterOption id="7411" count="49" label="Renal cell carcinoma - Subjects with TNM Stage IV Renal Cell Carcinoma"/></Filter><Filter label="Primary Completion Filter by Month" name="trialPrimaryCompletionDateByMonth" total="100"><FilterOption count="142" label="201912"/><FilterOption count="90" label="201906"/><FilterOption count="80" label="202012"/><FilterOption count="77" label="202006"/><FilterOption count="74" label="201909"/><FilterOption count="72" label="201812"/><FilterOption count="72" label="202003"/><FilterOption count="65" label="201712"/><FilterOption count="65" label="201907"/><FilterOption count="62" label="201910"/><FilterOption count="61" label="201612"/><FilterOption count="61" label="201707"/><FilterOption count="61" label="201905"/><FilterOption count="58" label="201512"/><FilterOption count="57" label="201803"/><FilterOption count="56" label="201911"/><FilterOption count="55" label="201706"/><FilterOption count="55" label="201809"/><FilterOption count="55" label="201810"/><FilterOption count="53" label="201705"/><FilterOption count="52" label="201606"/><FilterOption count="50" label="202011"/><FilterOption count="49" label="201806"/><FilterOption count="49" label="201808"/><FilterOption count="49" label="201904"/><FilterOption count="49" label="202001"/><FilterOption count="49" label="202007"/><FilterOption count="48" label="201507"/><FilterOption count="48" label="201609"/><FilterOption count="48" label="201805"/><FilterOption count="48" label="201901"/><FilterOption count="48" label="201908"/><FilterOption count="48" label="202004"/><FilterOption count="47" label="201807"/><FilterOption count="47" label="201903"/><FilterOption count="46" label="202005"/><FilterOption count="45" label="201404"/><FilterOption count="45" label="201407"/><FilterOption count="45" label="201604"/><FilterOption count="45" label="201611"/><FilterOption count="45" label="201710"/><FilterOption count="45" label="201801"/><FilterOption count="44" label="201310"/><FilterOption count="44" label="201701"/><FilterOption count="44" label="201704"/><FilterOption count="44" label="201811"/><FilterOption count="43" label="201511"/><FilterOption count="43" label="201602"/><FilterOption count="43" label="201605"/><FilterOption count="43" label="201607"/><FilterOption count="43" label="201709"/><FilterOption count="43" label="202009"/><FilterOption count="43" label="202112"/><FilterOption count="42" label="202104"/><FilterOption count="41" label="201402"/><FilterOption count="41" label="201503"/><FilterOption count="41" label="201506"/><FilterOption count="41" label="202106"/><FilterOption count="40" label="202002"/><FilterOption count="40" label="202010"/><FilterOption count="39" label="201603"/><FilterOption count="39" label="201703"/><FilterOption count="38" label="201305"/><FilterOption count="38" label="201406"/><FilterOption count="38" label="201410"/><FilterOption count="38" label="201505"/><FilterOption count="38" label="202103"/><FilterOption count="37" label="201106"/><FilterOption count="37" label="202101"/><FilterOption count="36" label="200912"/><FilterOption count="36" label="201205"/><FilterOption count="36" label="201206"/><FilterOption count="36" label="201409"/><FilterOption count="36" label="201804"/><FilterOption count="36" label="202008"/><FilterOption count="36" label="202109"/><FilterOption count="35" label="201112"/><FilterOption count="35" label="201212"/><FilterOption count="35" label="201312"/><FilterOption count="35" label="201403"/><FilterOption count="35" label="201504"/><FilterOption count="35" label="201708"/><FilterOption count="35" label="201711"/><FilterOption count="34" label="201301"/><FilterOption count="34" label="201502"/><FilterOption count="34" label="201510"/><FilterOption count="34" label="201610"/><FilterOption count="33" label="201405"/><FilterOption count="33" label="201601"/><FilterOption count="33" label="201802"/><FilterOption count="32" label="200906"/><FilterOption count="32" label="201304"/><FilterOption count="32" label="201702"/><FilterOption count="31" label="200810"/><FilterOption count="31" label="201011"/><FilterOption count="31" label="201303"/><FilterOption count="31" label="201307"/><FilterOption count="31" label="201411"/><FilterOption count="30" label="201111"/><FilterOption count="30" label="201204"/></Filter><Filter label="Trial Country" name="trialCountries" total="100"><FilterOption id="ES" count="7011" label="Spain"/><FilterOption id="DE" count="4034" label="Germany"/><FilterOption id="US" count="4028" label="US"/><FilterOption id="FR" count="3820" label="France"/><FilterOption id="IT" count="3653" label="Italy"/><FilterOption id="GB" count="3515" label="UK"/><FilterOption id="CA" count="2910" label="Canada"/><FilterOption id="BE" count="2834" label="Belgium"/><FilterOption id="PL" count="2537" label="Poland"/><FilterOption id="AU" count="2272" label="Australia"/><FilterOption id="NL" count="2269" label="Netherlands"/><FilterOption id="RU" count="1869" label="Russian Federation"/><FilterOption id="HU" count="1857" label="Hungary"/><FilterOption id="CZ" count="1808" label="Czech Republic"/><FilterOption id="AT" count="1717" label="Austria"/><FilterOption id="SE" count="1561" label="Sweden"/><FilterOption id="KR" count="1534" label="South Korea"/><FilterOption id="IL" count="1492" label="Israel"/><FilterOption id="DK" count="1367" label="Denmark"/><FilterOption id="BR" count="1314" label="Brazil"/><FilterOption id="CH" count="1267" label="Switzerland"/><FilterOption id="AR" count="1252" label="Argentina"/><FilterOption id="MX" count="1193" label="Mexico"/><FilterOption id="TW" count="1166" label="Taiwan"/><FilterOption id="GR" count="1098" label="Greece"/><FilterOption id="PT" count="1091" label="Portugal"/><FilterOption id="RO" count="1040" label="Romania"/><FilterOption id="JP" count="1018" label="Japan"/><FilterOption id="TR" count="970" label="Turkey"/><FilterOption id="ZA" count="941" label="South Africa"/><FilterOption id="FI" count="909" label="Finland"/><FilterOption id="BG" count="854" label="Bulgaria"/><FilterOption id="SK" count="818" label="Slovakia"/><FilterOption id="UA" count="773" label="Ukraine"/><FilterOption id="CN" count="766" label="China"/><FilterOption id="NO" count="752" label="Norway"/><FilterOption id="IE" count="684" label="Ireland"/><FilterOption id="IN" count="617" label="India"/><FilterOption id="NZ" count="615" label="New Zealand"/><FilterOption id="CL" count="609" label="Chile"/><FilterOption id="SG" count="603" label="Singapore"/><FilterOption id="HK" count="572" label="Hong Kong"/><FilterOption id="TH" count="481" label="Thailand"/><FilterOption id="CO" count="472" label="Colombia"/><FilterOption id="PR" count="465" label="Puerto Rico"/><FilterOption id="RS" count="459" label="Serbia"/><FilterOption id="LT" count="432" label="Lithuania"/><FilterOption id="EE" count="411" label="Estonia"/><FilterOption id="HR" count="410" label="Croatia"/><FilterOption id="PE" count="399" label="Peru"/><FilterOption id="LV" count="390" label="Latvia"/><FilterOption id="MY" count="375" label="Malaysia"/><FilterOption id="PH" count="299" label="Philippines"/><FilterOption id="X5" count="263" label="Europe"/><FilterOption id="SI" count="222" label="Slovenia"/><FilterOption id="EG" count="143" label="Egypt"/><FilterOption id="BY" count="115" label="Belarus"/><FilterOption id="GE" count="111" label="Georgia"/><FilterOption id="GT" count="110" label="Guatemala"/><FilterOption id="LB" count="108" label="Lebanon"/><FilterOption id="BA" count="98" label="Bosnia and Herzegovina"/><FilterOption id="SA" count="98" label="Saudi Arabia"/><FilterOption id="XD" count="94" label="North America"/><FilterOption id="VN" count="87" label="Vietnam"/><FilterOption id="PA" count="85" label="Panama"/><FilterOption id="X2" count="77" label="Asia"/><FilterOption id="CR" count="57" label="Costa Rica"/><FilterOption id="KP" count="57" label="North Korea"/><FilterOption id="IS" count="56" label="Iceland"/><FilterOption id="TN" count="52" label="Tunisia"/><FilterOption id="LU" count="50" label="Luxembourg"/><FilterOption id="EU" count="48" label="EU"/><FilterOption id="VE" count="48" label="Venezuela"/><FilterOption id="MK" count="44" label="Macedonia, The Former Yugoslav Republic of"/><FilterOption id="ID" count="41" label="Indonesia"/><FilterOption id="XE" count="39" label="South America"/><FilterOption id="MD" count="37" label="Moldova, Republic of"/><FilterOption id="EC" count="34" label="Ecuador"/><FilterOption id="AE" count="34" label="United Arab Emirates"/><FilterOption id="PK" count="33" label="Pakistan"/><FilterOption id="JO" count="32" label="Jordan"/><FilterOption id="MA" count="32" label="Morocco"/><FilterOption id="DO" count="29" label="Dominican Republic"/><FilterOption id="DZ" count="22" label="Algeria"/><FilterOption id="CY" count="19" label="Cyprus"/><FilterOption id="UY" count="19" label="Uruguay"/><FilterOption id="KW" count="17" label="Kuwait"/><FilterOption id="SV" count="16" label="El Salvador"/><FilterOption id="ME" count="15" label="Montenegro"/><FilterOption id="KZ" count="14" label="Kazakhstan"/><FilterOption id="MT" count="13" label="Malta"/><FilterOption id="MZ" count="13" label="Mozambique"/><FilterOption id="XW" count="13" label="Western Europe"/><FilterOption id="LK" count="11" label="Sri Lanka"/><FilterOption id="AL" count="9" label="Albania"/><FilterOption id="AS" count="9" label="American Samoa"/><FilterOption id="PG" count="9" label="Papua New Guinea"/><FilterOption id="X0" count="8" label="Africa"/><FilterOption id="BS" count="8" label="Bahamas"/><FilterOption id="MC" count="8" label="Monaco"/></Filter><Filter label="Trial Patient Selection" name="trialTermsPatientSelection" total="18"><FilterOption id="EAMAA" count="6960" label="Middle-aged Adults (45-64 yrs)"/><FilterOption id="EAYAD" count="6852" label="Young Adults (18-44 yrs)"/><FilterOption id="EAAAD" count="6651" label="Aged Adults (65-79 yrs)"/><FilterOption id="EAELD" count="5557" label="Elderly Adults (80 and over)"/><FilterOption id="EAADL" count="683" label="Adolescents (13-17 yrs)"/><FilterOption id="EACHI" count="618" label="Children (6-12 yrs)"/><FilterOption id="EGFEM" count="570" label="Female"/><FilterOption id="EAPRE" count="364" label="Preschool Children (2-5 yrs)"/><FilterOption id="EVHVA" count="309" label="Healthy volunteers accepted"/><FilterOption id="EGMAL" count="286" label="Male"/><FilterOption id="EAINF" count="231" label="Infants (6-23 months)"/><FilterOption id="EANEW" count="164" label="Newborn Infants (up to 5 months)"/><FilterOption id="ECASI" count="78" label="Asian Ancestry"/><FilterOption id="ECJAP" count="74" label="Japanese Ancestry"/><FilterOption id="ECEUR" count="49" label="European Ancestry"/><FilterOption id="EVHVO" count="33" label="Healthy volunteers only"/><FilterOption id="ECAFR" count="15" label="African Ancestry"/><FilterOption id="ECOCE" count="1" label="Oceanic Ancestry"/></Filter><Filter label="Trial Terms Design" name="trialTermsDesign" total="27"><FilterOption id="SSTINV" count="7178" label="Interventional"/><FilterOption id="SIPTRE" count="6688" label="Treatment"/><FilterOption id="SIARND" count="5121" label="Randomized"/><FilterOption id="SISPRL" count="5053" label="Parallel Assignment"/><FilterOption id="SIMOPN" count="3722" label="Open Label"/><FilterOption id="SIMMBD" count="3056" label="Multiple Blind"/><FilterOption id="SICPLC" count="2689" label="Placebo Control"/><FilterOption id="SICACT" count="1702" label="Active Control"/><FilterOption id="SISSNG" count="1569" label="Single Group Assignment"/><FilterOption id="SIANON" count="1425" label="Non-Randomized"/><FilterOption id="SICNOC" count="998" label="No Control"/><FilterOption id="SSTOBS" count="644" label="Observational"/><FilterOption id="SOTPRO" count="475" label="Prospective"/><FilterOption id="SIPPRE" count="415" label="Prevention"/><FilterOption id="SOSCOH" count="380" label="Cohort"/><FilterOption id="SIMSBD" count="239" label="Single Blind"/><FilterOption id="SISXOV" count="170" label="Crossover Assignment"/><FilterOption id="SOTRET" count="128" label="Retrospective"/><FilterOption id="SOSCSC" count="66" label="Case Control"/><FilterOption id="SIPDIA" count="61" label="Diagnosis"/><FilterOption id="SODXSC" count="50" label="Cross-sectional"/><FilterOption id="SICDSC" count="34" label="Dose Comparison"/><FilterOption id="SODLNG" count="26" label="Longitudinal"/><FilterOption id="SISFCT" count="24" label="Factorial Assignment"/><FilterOption id="SICHST" count="21" label="Historical Control"/><FilterOption id="SISEAA" count="6" label="Expanded Access Assignment"/><FilterOption id="SOSDEF" count="1" label="Defined Population"/></Filter><Filter label="Trial Source" name="trialSources" total="3"><FilterOption id="CTGOVOTHERS" count="4573" label="ClinicalTrials.gov and others"/><FilterOption id="CTGOV" count="2779" label="ClinicalTrials.gov only"/><FilterOption id="OTHERS" count="352" label="Others only"/></Filter><Filter label="Trial Actions Secondary Interventions Primary" name="trialActionsSecondaryInterventionsPrimary" total="100"><FilterOption id="1545" count="2717" label="Anticancer"/><FilterOption id="2953" count="1635" label="Anti-inflammatory"/><FilterOption id="62255" count="1365" label="Anticancer protein kinase inhibitor"/><FilterOption id="55685" count="1264" label="Anticancer monoclonal antibody"/><FilterOption id="991" count="957" label="Antiviral"/><FilterOption id="61" count="792" label="Angiogenesis inhibitor"/><FilterOption id="1589" count="771" label="Apoptosis stimulator"/><FilterOption id="767" count="693" label="Cell cycle inhibitor"/><FilterOption id="7293" count="599" label="Synergist"/><FilterOption id="393" count="571" label="Immunostimulant"/><FilterOption id="7761" count="531" label="T-lymphocyte stimulator"/><FilterOption id="140" count="410" label="DNA synthesis inhibitor"/><FilterOption id="50" count="377" label="Anticancer alkylating agent"/><FilterOption id="399" count="356" label="Hypoglycemic agent"/><FilterOption id="1569" count="334" label="Anticancer antimetabolite"/><FilterOption id="1596" count="318" label="Immunomodulator"/><FilterOption id="2946" count="315" label="Analgesic"/><FilterOption id="396" count="286" label="Immunosuppressant"/><FilterOption id="1615" count="269" label="Neuroprotectant"/><FilterOption id="15184" count="258" label="Systemic antipsoriatic product"/><FilterOption id="2657" count="255" label="Antihypertensive"/><FilterOption id="2575" count="238" label="Microtubule inhibitor"/><FilterOption id="2576" count="228" label="Microtubule stabilizer"/><FilterOption id="2660" count="202" label="Vasoprotectant"/><FilterOption id="70" count="194" label="Anticonvulsant agent"/><FilterOption id="1594" count="189" label="Antibacterial"/><FilterOption id="2947" count="143" label="Antiparkinsonian"/><FilterOption id="2941" count="140" label="Antidepressant"/><FilterOption id="646" count="139" label="Bronchodilator"/><FilterOption id="2943" count="138" label="Antipsychotic"/><FilterOption id="2659" count="127" label="Cardioprotectant"/><FilterOption id="284" count="123" label="Nootropic agent"/><FilterOption id="2667" count="122" label="Antiarteriosclerotic"/><FilterOption id="695" count="113" label="Metastasis inhibitor"/><FilterOption id="659" count="107" label="Coagulation inhibitor"/><FilterOption id="71" count="105" label="Antihypercholesterolemic agent"/><FilterOption id="449" count="102" label="Antiarrhythmic agent"/><FilterOption id="59620" count="102" label="Unspecified drug target"/><FilterOption id="12379" count="100" label="Therapeutic vaccine"/><FilterOption id="747" count="99" label="HIV replication inhibitor"/><FilterOption id="750" count="97" label="DNA intercalator"/><FilterOption id="12378" count="96" label="Prophylactic vaccine"/><FilterOption id="439" count="94" label="RNA synthesis inhibitor"/><FilterOption id="610" count="93" label="Hematopoietic stimulator"/><FilterOption id="72" count="89" label="Antihyperlipidemic agent"/><FilterOption id="2942" count="87" label="Anxiolytic"/><FilterOption id="38206" count="87" label="Biguanide antidiabetic product"/><FilterOption id="382" count="84" label="TNF alpha synthesis inhibitor"/><FilterOption id="15187" count="81" label="Systemic dermatological antibacterial product"/><FilterOption id="664" count="80" label="Fibrosuppressant"/><FilterOption id="388" count="78" label="Vasodilator"/><FilterOption id="62254" count="76" label="Anticancer hormone antagonist"/><FilterOption id="1470" count="74" label="Respiratory system agent"/><FilterOption id="539" count="67" label="Immunotoxin"/><FilterOption id="805" count="66" label="Folate modulator"/><FilterOption id="7760" count="66" label="T-lymphocyte inhibitor"/><FilterOption id="1332" count="65" label="Gastrointestinal system agent"/><FilterOption id="55684" count="64" label="Anticancer antibody"/><FilterOption id="312" count="64" label="Platelet aggregation inhibitor"/><FilterOption id="15128" count="60" label="Ophthalmological agent"/><FilterOption id="15319" count="58" label="Hepatitis C virus replication inhibitor"/><FilterOption id="285" count="58" label="Norepinephrine uptake inhibitor"/><FilterOption id="89" count="57" label="Bone resorption inhibitor"/><FilterOption id="3189" count="55" label="Corticosteroid agonist"/><FilterOption id="12372" count="53" label="Protein subunit vaccine"/><FilterOption id="3" count="52" label="5-HT uptake inhibitor"/><FilterOption id="2954" count="52" label="Steroidal anti-inflammatory"/><FilterOption id="104" count="50" label="Bacterial cell wall synthesis inhibitor"/><FilterOption id="1538" count="47" label="Bacterial protein synthesis inhibitor"/><FilterOption id="1532" count="46" label="Viral replication inhibitor"/><FilterOption id="15148" count="44" label="Ocular antineovascularisation agent"/><FilterOption id="7292" count="42" label="Vulnerary agent"/><FilterOption id="38439" count="41" label="DPP IV inhibitor antidiabetic product"/><FilterOption id="2970" count="39" label="Anti-emetic"/><FilterOption id="463" count="38" label="Ribosome binding agent"/><FilterOption id="1748" count="37" label="Fungicide"/><FilterOption id="7220" count="37" label="Neoplasm diagnostic agent"/><FilterOption id="2939" count="36" label="CNS modulator"/><FilterOption id="3272" count="36" label="Growth hormone release inhibitor"/><FilterOption id="7018" count="34" label="Antihypertriglyceridemic agent"/><FilterOption id="3984" count="34" label="Bacterial nucleic acid synthesis inhibitor"/><FilterOption id="12371" count="34" label="Subunit vaccine"/><FilterOption id="968" count="33" label="Coagulation stimulator"/><FilterOption id="32411" count="33" label="Hepatitis B virus replication inhibitor"/><FilterOption id="2955" count="33" label="Non-steroidal anti-inflammatory"/><FilterOption id="7294" count="32" label="Antisense oligonucleotide inhibitor"/><FilterOption id="5580" count="32" label="Chemotaxis inhibitor"/><FilterOption id="937" count="31" label="Androgen synthesis inhibitor"/><FilterOption id="1537" count="31" label="Cephalosporin"/><FilterOption id="38215" count="31" label="Human insulin long acting product"/><FilterOption id="5704" count="30" label="B-lymphocyte adhesion inhibitor"/><FilterOption id="5710" count="30" label="B-lymphocyte migration inhibitor"/><FilterOption id="137" count="30" label="Diuretic agent"/><FilterOption id="38212" count="30" label="Human insulin intermediate acting product"/><FilterOption id="12596" count="30" label="Osteoclast inhibitor"/><FilterOption id="3980" count="29" label="HIV fusion inhibitor"/><FilterOption id="2658" count="28" label="Hypertensive"/><FilterOption id="15180" count="28" label="Topical antipruritic product"/><FilterOption id="1840" count="27" label="Appetite suppressant"/><FilterOption id="74" count="26" label="Antioxidant agent"/></Filter><Filter label="Trial Endpoint Achieved" name="trialEndpointsAchieved" total="3"><FilterOption id="UNSPECIFIED" count="2174" label="Unspecified"/><FilterOption id="YES" count="1382" label="Yes"/><FilterOption id="NO" count="511" label="No"/></Filter><Filter label="Endpoint Index Secondary" name="trialEndpointIndexSecondary" total="100"><FilterOption id="8489" count="221" label="Lung tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="8712" count="215" label="Breast tumor - Assessment of Overall Survival (OS)"/><FilterOption id="12048" count="207" label="Hepatobiliary system tumor - Assessment of Overall Survival (OS)"/><FilterOption id="8719" count="202" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Overall/Objective Response Rate (ORR)"/><FilterOption id="8663" count="196" label="Lung tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"/><FilterOption id="8481" count="194" label="Lung tumor - Assessment of Overall Survival (OS)"/><FilterOption id="15312" count="186" label="Solid tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"/><FilterOption id="8998" count="176" label="Breast tumor - Assessment of adverse events"/><FilterOption id="8522" count="165" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of duration of response"/><FilterOption id="8738" count="164" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of duration of tumor response"/><FilterOption id="12051" count="161" label="Hepatobiliary system tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="8713" count="159" label="Breast tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="8505" count="146" label="Lung tumor - Assessment of Objective Response - Assessment of objective response rate(ORR)"/><FilterOption id="12056" count="137" label="Hepatobiliary system tumor - Assessment of Response Rates (RR) - Assessment of objective/overall response rate (ORR)"/><FilterOption id="12118" count="130" label="Hepatobiliary system tumor - Assessment of adverse events"/><FilterOption id="8639" count="130" label="Lung tumor - Assessment of Safety and Tolerability"/><FilterOption id="9218" count="124" label="HIV infection - Assessment of Immune Response"/><FilterOption id="9153" count="123" label="Lung tumor - Imaging/Radiological Assessments - Assessment by Response Evaluation Criteria in Solid Tumors (RECIST) Criteria"/><FilterOption id="7538" count="123" label="Lymphoma - Assessment of Overall Survival (OS)"/><FilterOption id="9122" count="121" label="Breast tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"/><FilterOption id="9215" count="121" label="HIV infection - Assessment of CD4 Cell Responses - Assessment of CD4 cell count/percentage"/><FilterOption id="1503" count="121" label="Non-insulin dependent diabetes - Anthropometric Assessments - Assessment of body weight"/><FilterOption id="12115" count="120" label="Hepatobiliary system tumor - Assessment of Disease Progression - Assessment of time to disease progression (TTP)"/><FilterOption id="8514" count="120" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="15207" count="115" label="Solid tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="9247" count="110" label="HIV infection - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events"/><FilterOption id="15212" count="110" label="Solid tumor - Assessment of Response Rates (RR) - Assessment of objective response rate (ORR)"/><FilterOption id="8513" count="109" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"/><FilterOption id="8187" count="107" label="Colorectal tumor - Assessment of Response Rates (RR) - Assessment of Objective/Overall Response Rate (ORR)"/><FilterOption id="7547" count="107" label="Lymphoma - Assessment of Progression Free Survival (PFS)"/><FilterOption id="1345" count="106" label="Non-insulin dependent diabetes - Glycemic Control Analysis - Assessment of fasting blood glucose"/><FilterOption id="8721" count="103" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="12064" count="103" label="Hepatobiliary system tumor - Assessment of Response Rates (RR) - Assessment of disease control rate"/><FilterOption id="7611" count="103" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of tumor response rate (Duration of response)"/><FilterOption id="8430" count="98" label="Colorectal tumor - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events"/><FilterOption id="12117" count="97" label="Hepatobiliary system tumor - Assessment of Safety and Tolerability"/><FilterOption id="8640" count="97" label="Lung tumor - Assessment of Safety and Tolerability - Adverse events as graded by CTCAE/CTC"/><FilterOption id="8151" count="96" label="Colorectal tumor - Assessment of Overall Survival (OS)"/><FilterOption id="7879" count="94" label="Leukemia - Assessment of Overall Survival (OS)"/><FilterOption id="8996" count="93" label="Breast tumor - Assessment of Safety and Tolerability"/><FilterOption id="8722" count="92" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Clinical Benefit Rate (CBR)"/><FilterOption id="8720" count="92" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"/><FilterOption id="8163" count="92" label="Colorectal tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="6863" count="92" label="Hepatitis C virus infection - Assessment of Viral Load/Viral Kinetics"/><FilterOption id="9213" count="92" label="HIV infection - Assessment of Viral Load - Assessment of HIV RNA levels"/><FilterOption id="7680" count="91" label="Lymphoma - Assessment of adverse events"/><FilterOption id="15218" count="91" label="Solid tumor - Assessment of Response Rates (RR) - Assessment of duration of tumor response"/><FilterOption id="8451" count="87" label="Colorectal tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"/><FilterOption id="15287" count="85" label="Solid tumor - Assessment of adverse events"/><FilterOption id="8523" count="84" label="Lung tumor - Assessment of Disease Progression"/><FilterOption id="8078" count="83" label="Leukemia - Assessment of adverse events"/><FilterOption id="22595" count="82" label="End stage renal disease - Assessment of adverse events"/><FilterOption id="7563" count="81" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="8189" count="80" label="Colorectal tumor - Assessment of Response Rates (RR) - Assessment of duration of response"/><FilterOption id="26033" count="77" label="Pain - Assessment of adverse events"/><FilterOption id="8519" count="75" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of Tumor Growth Control Rate (TGCR)"/><FilterOption id="7569" count="75" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of Overall/Objective Response Rate (ORR)"/><FilterOption id="12058" count="73" label="Hepatobiliary system tumor - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="6940" count="73" label="Melanoma - Assessment of Response Rates (RR) - Assessment of overall/objective response rate"/><FilterOption id="12057" count="72" label="Hepatobiliary system tumor - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"/><FilterOption id="3900" count="70" label="Rheumatoid arthritis - DAS-28 (Disease Activity Score) Response"/><FilterOption id="2622" count="69" label="Coronary artery disease - Assessment of Mortality/Death Rates - Cardiovascular mortality"/><FilterOption id="8516" count="69" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of Stable Disease"/><FilterOption id="7354" count="69" label="Multiple myeloma - Assessment of Overall Survival (OS)"/><FilterOption id="7908" count="68" label="Leukemia - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="6924" count="68" label="Melanoma - Assessment of Progression Free Survival (PFS)"/><FilterOption id="1626" count="68" label="Non-insulin dependent diabetes - Assessment of Adverse Events"/><FilterOption id="10828" count="68" label="Ovary tumor - Assessment of Overall Survival (OS)"/><FilterOption id="12100" count="67" label="Hepatobiliary system tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"/><FilterOption id="9242" count="64" label="HIV infection - Assessment of lipid profiles"/><FilterOption id="3736" count="63" label="Hepatitis C virus infection - Assessment of Sustained Virologic Response (SVR)"/><FilterOption id="8651" count="63" label="Lung tumor - Assessment of Laboratory/Diagnostic Measures"/><FilterOption id="8555" count="63" label="Lung tumor - Assessment of Mortality/Death Rates"/><FilterOption id="6919" count="63" label="Melanoma - Assessment of Overall Survival (OS)"/><FilterOption id="1624" count="62" label="Non-insulin dependent diabetes - Assessment of Safety and Tolerability"/><FilterOption id="10830" count="62" label="Ovary tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="37159" count="61" label="Breast tumor - Assessment of Laboratory/Diagnostic Measures"/><FilterOption id="7190" count="61" label="Prostate tumor - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events"/><FilterOption id="7393" count="60" label="Multiple myeloma - Assessment of Response Rates (RR) - Assessment of tumor response rate (Duration of response)"/><FilterOption id="12124" count="59" label="Hepatobiliary system tumor - Assessment of Mortality/Death Rates"/><FilterOption id="8725" count="58" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Stable Disease"/><FilterOption id="12127" count="58" label="Hepatobiliary system tumor - Assessment of Laboratory/Diagnostic Measures"/><FilterOption id="7564" count="58" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"/><FilterOption id="10939" count="58" label="Ovary tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"/><FilterOption id="26827" count="58" label="Solid tumor - Imaging/Radiological Assessments - Assessment by Response Evaluation Criteria in Solid Tumors (RECIST) Criteria"/><FilterOption id="11717" count="57" label="Bladder cancer - Assessment of Overall Survival (OS)"/><FilterOption id="12070" count="57" label="Hepatobiliary system tumor - Patient Reported Outcomes/Quality of Life Assessments"/><FilterOption id="8508" count="57" label="Lung tumor - Assessment of Overall Response"/><FilterOption id="13357" count="57" label="Pancreas tumor - Assessment of Response Rates (RR) - Assessment of objective response rate (ORR)"/><FilterOption id="7045" count="57" label="Prostate tumor - Assessment of Overall Survival (OS)"/><FilterOption id="8744" count="56" label="Breast tumor - Assessment of Disease Progression"/><FilterOption id="8997" count="56" label="Breast tumor - Assessment of Safety and Tolerability - Assessment of serious adverse events"/><FilterOption id="8563" count="56" label="Lung tumor - Patient Reported Outcomes/Quality of Life Assessments"/><FilterOption id="7027" count="56" label="Melanoma - Assessment of adverse events"/><FilterOption id="12231" count="55" label="Hepatobiliary system tumor - Imaging/Radiological Assessments"/><FilterOption id="7679" count="55" label="Lymphoma - Assessment of Safety and Tolerability"/><FilterOption id="15215" count="55" label="Solid tumor - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="8759" count="54" label="Breast tumor - Patient Reported Outcomes/Quality of Life Assessments"/><FilterOption id="7367" count="54" label="Multiple myeloma - Assessment of Response Rates (RR) - Assessment of Overall/Objective Response Rate (ORR)"/><FilterOption id="12156" count="54" label="Stomach tumor - Assessment of Response Rates (RR) - Assessment of objective/overall response rate (ORR)"/></Filter><Filter label="Biomarker" name="trialBiomarkerNames" total="100"><FilterOption id="1211" count="719" label="Alanine transaminase"/><FilterOption id="12058" count="640" label="Total body mass"/><FilterOption id="2527" count="613" label="Aspartate aminotransferase"/><FilterOption id="213" count="528" label="Creatinine"/><FilterOption id="1236" count="499" label="Hemoglobin"/><FilterOption id="1735" count="478" label="Glucose"/><FilterOption id="2054" count="455" label="Blood platelets"/><FilterOption id="1904" count="453" label="Heart rate"/><FilterOption id="2586" count="413" label="Blood pressure"/><FilterOption id="46" count="403" label="C-reactive protein"/><FilterOption id="2387" count="389" label="Bilirubin"/><FilterOption id="1925" count="373" label="Neutrophils"/><FilterOption id="3" count="352" label="HER2"/><FilterOption id="330" count="343" label="Systolic blood pressure"/><FilterOption id="289" count="321" label="Hemoglobin A, glycosylated"/><FilterOption id="217" count="317" label="Triglycerides"/><FilterOption id="133" count="313" label="Total cholesterol"/><FilterOption id="125" count="308" label="Leukocyte count"/><FilterOption id="152" count="305" label="Low-density lipoprotein cholesterol"/><FilterOption id="332" count="301" label="Diastolic blood pressure"/><FilterOption id="28899" count="285" label="Alkaline phosphatase"/><FilterOption id="153" count="284" label="High-density lipoprotein cholesterol"/><FilterOption id="118" count="263" label="Albumin"/><FilterOption id="4806" count="261" label="Lymphocytes"/><FilterOption id="1857" count="252" label="T-cell surface glycoprotein CD4"/><FilterOption id="7895" count="250" label="Estimated glomerular filtration rate"/><FilterOption id="113" count="226" label="Body Mass Index"/><FilterOption id="8" count="218" label="Epidermal growth factor receptor"/><FilterOption id="2713" count="210" label="Forced expiratory volume"/><FilterOption id="824" count="202" label="Programmed cell death 1 ligand 1"/><FilterOption id="1880" count="189" label="T-Helper Lymphocytes"/><FilterOption id="5" count="188" label="Estrogen receptor"/><FilterOption id="44216" count="186" label="Body temperature"/><FilterOption id="3447" count="181" label="T-cell surface glycoprotein CD8 alpha chain"/><FilterOption id="176" count="180" label="Interleukin-6"/><FilterOption id="8458" count="177" label="gamma-Glutamyltransferase"/><FilterOption id="2098" count="175" label="Potassium"/><FilterOption id="148" count="172" label="QT interval"/><FilterOption id="14767" count="169" label="Lipids"/><FilterOption id="1289" count="166" label="Tumor mass"/><FilterOption id="2417" count="163" label="Calcium"/><FilterOption id="2662" count="161" label="Sodium"/><FilterOption id="46506" count="155" label="T-Lymphocytes"/><FilterOption id="46505" count="153" label="Cytotoxic T-Lymphocytes"/><FilterOption id="8024" count="152" label="Creatine kinase"/><FilterOption id="6" count="137" label="Progesterone receptor"/><FilterOption id="147" count="136" label="Six-minute walk distance"/><FilterOption id="4522" count="133" label="Erythrocytes"/><FilterOption id="36136" count="131" label="Cytokines"/><FilterOption id="1912" count="131" label="Forced Vital Capacity"/><FilterOption id="248" count="130" label="Eosinophils"/><FilterOption id="7033" count="128" label="Lipase"/><FilterOption id="6663" count="127" label="B-lymphocytes"/><FilterOption id="1221" count="126" label="Hematocrit"/><FilterOption id="52" count="125" label="GTPase KRas"/><FilterOption id="82" count="121" label="B-Raf proto-oncogene serine/threonine-protein kinase"/><FilterOption id="808" count="121" label="Insulin"/><FilterOption id="1945" count="121" label="Left ventricular ejection fraction"/><FilterOption id="38" count="117" label="Prostate-specific antigen"/><FilterOption id="2358" count="116" label="Urea nitrogen"/><FilterOption id="44218" count="115" label="Human immunodeficiency virus RNA"/><FilterOption id="44186" count="110" label="Hepatitis C virus RNA"/><FilterOption id="17697" count="108" label="Body height"/><FilterOption id="274" count="108" label="Tumor necrosis factor"/><FilterOption id="18315" count="107" label="Visual acuity"/><FilterOption id="154" count="106" label="Lactate dehydrogenase"/><FilterOption id="252" count="98" label="Interferon gamma"/><FilterOption id="106" count="98" label="N-terminal Pro Brain Natriuretic Peptide"/><FilterOption id="8097" count="94" label="Monocytes"/><FilterOption id="10260" count="93" label="Respiratory frequency"/><FilterOption id="30214" count="92" label="Joint swelling"/><FilterOption id="288" count="87" label="Uric acid"/><FilterOption id="418" count="85" label="Waist circumference"/><FilterOption id="11857" count="84" label="Transaminases"/><FilterOption id="6993" count="83" label="Alpha-amylase 1"/><FilterOption id="3374" count="83" label="Bone mineral density"/><FilterOption id="11114" count="83" label="Brain"/><FilterOption id="30217" count="83" label="Joint tenderness"/><FilterOption id="1183" count="83" label="Urinary albumin to creatinine ratio"/><FilterOption id="5700" count="82" label="ALK receptor"/><FilterOption id="7" count="81" label="Antigen KI-67"/><FilterOption id="92" count="80" label="Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform"/><FilterOption id="215" count="78" label="Apolipoprotein B-100"/><FilterOption id="22" count="78" label="Breast cancer type 1 susceptibility protein"/><FilterOption id="12516" count="78" label="Urinary protein"/><FilterOption id="9807" count="77" label="Basophils"/><FilterOption id="10684" count="77" label="Blood cells"/><FilterOption id="1731" count="76" label="B-lymphocyte antigen CD20"/><FilterOption id="3247" count="76" label="Chlorides"/><FilterOption id="41" count="74" label="Breast cancer type 2 susceptibility protein"/><FilterOption id="3451" count="73" label="Immunoglobulin G"/><FilterOption id="19714" count="73" label="Muscle strength"/><FilterOption id="2382" count="73" label="Phosphorus"/><FilterOption id="2626" count="72" label="Total protein"/><FilterOption id="2053" count="71" label="Non-high density lipoprotein cholesterol"/><FilterOption id="3083" count="71" label="Phosphate"/><FilterOption id="67" count="70" label="Alpha-fetoprotein"/><FilterOption id="781" count="69" label="Erythrocyte sedimentation rate"/><FilterOption id="64" count="67" label="Circulating Tumor Cells"/><FilterOption id="2515" count="65" label="Magnesium"/></Filter><Filter label="Trial Terms Endpoint" name="trialTermsEndpoint" total="6"><FilterOption id="SIEEFC" count="7010" label="Efficacy"/><FilterOption id="SIESFT" count="6715" label="Safety"/><FilterOption id="SIEPCK" count="3095" label="Pharmacokinetics"/><FilterOption id="SIEPCD" count="1793" label="Pharmacodynamics"/><FilterOption id="SIEBAV" count="35" label="Bioavailability"/><FilterOption id="SIEBEQ" count="18" label="Bioequivalence"/></Filter><Filter label="Trial Interventions Primary In Regimen Name Display" name="trialInterventionsPrimaryInRegimenNameDisplay" total="100"><FilterOption id="3803" count="173" label="paclitaxel"/><FilterOption id="44383" count="150" label="carboplatin"/><FilterOption id="3199" count="127" label="gemcitabine"/><FilterOption id="3792" count="111" label="oxaliplatin"/><FilterOption id="2953" count="109" label="docetaxel"/><FilterOption id="8047" count="108" label="bevacizumab"/><FilterOption id="6736" count="85" label="rituximab"/><FilterOption id="12205" count="82" label="capecitabine"/><FilterOption id="5369" count="82" label="ribavirin"/><FilterOption id="54804" count="80" label="nivolumab"/><FilterOption id="72699" count="77" label="atezolizumab"/><FilterOption id="7310" count="75" label="ritonavir"/><FilterOption id="6050" count="74" label="metformin hydrochloride"/><FilterOption id="6386" count="72" label="trastuzumab"/><FilterOption id="70667" count="70" label="pembrolizumab"/><FilterOption id="23625" count="68" label="peginterferon alfa-2a"/><FilterOption id="3536" count="59" label="pemetrexed disodium"/><FilterOption id="2871" count="53" label="irinotecan"/><FilterOption id="36630" count="51" label="ipilimumab"/><FilterOption id="3072" count="48" label="etoposide phosphate"/><FilterOption id="13340" count="48" label="everolimus"/><FilterOption id="15954" count="47" label="bortezomib"/><FilterOption id="10388" count="44" label="cetuximab"/><FilterOption id="29831" count="43" label="sorafenib"/><FilterOption id="29016" count="41" label="paclitaxel (albumin-bound nanoparticle, intravenous), Celgene"/><FilterOption id="81193" count="37" label="durvalumab"/><FilterOption id="11961" count="37" label="erlotinib"/><FilterOption id="3313" count="37" label="fulvestrant"/><FilterOption id="27572" count="36" label="lenalidomide"/><FilterOption id="2784" count="36" label="letrozole"/><FilterOption id="13022" count="33" label="epirubicin"/><FilterOption id="4510" count="32" label="tacrolimus"/><FilterOption id="28532" count="31" label="pertuzumab"/><FilterOption id="47000" count="30" label="bendamustine"/><FilterOption id="32981" count="30" label="darunavir"/><FilterOption id="6156" count="29" label="fludarabine"/><FilterOption id="3669" count="28" label="mycophenolate mofetil"/><FilterOption id="53227" count="26" label="obinutuzumab"/><FilterOption id="71886" count="26" label="ribavirin (oral tablet, HCV), Roche"/><FilterOption id="10309" count="25" label="abiraterone"/><FilterOption id="53200" count="24" label="daratumumab"/><FilterOption id="3474" count="24" label="lamivudine"/><FilterOption id="45841" count="24" label="lenvatinib mesylate"/><FilterOption id="58741" count="23" label="daclatasvir"/><FilterOption id="7934" count="23" label="doxorubicin (liposomal, STEALTH), Alza"/><FilterOption id="3081" count="23" label="exemestane"/><FilterOption id="14681" count="23" label="lopinavir + ritonavir"/><FilterOption id="55237" count="22" label="ibrutinib"/><FilterOption id="12646" count="22" label="panitumumab"/><FilterOption id="54488" count="22" label="raltegravir"/><FilterOption id="2807" count="21" label="atorvastatin"/><FilterOption id="33591" count="21" label="lapatinib"/><FilterOption id="96193" count="21" label="spartalizumab"/><FilterOption id="6408" count="21" label="vinorelbine"/><FilterOption id="2836" count="20" label="clopidogrel"/><FilterOption id="56544" count="20" label="cobimetinib"/><FilterOption id="4529" count="20" label="temozolomide"/><FilterOption id="61901" count="19" label="buparlisib"/><FilterOption id="55288" count="19" label="trametinib"/><FilterOption id="15254" count="18" label="atazanavir"/><FilterOption id="37370" count="18" label="azacitidine"/><FilterOption id="16063" count="18" label="olaparib"/><FilterOption id="14493" count="18" label="tenofovir disoproxil fumarate"/><FilterOption id="48181" count="17" label="lamivudine + abacavir, GlaxoSmithKline"/><FilterOption id="4126" count="17" label="pioglitazone"/><FilterOption id="27696" count="17" label="pomalidomide"/><FilterOption id="65360" count="17" label="ribociclib"/><FilterOption id="49219" count="17" label="tenofovir disoproxil fumarate + emtricitabine (fixed dose), Gilead Sciences"/><FilterOption id="59062" count="16" label="dolutegravir"/><FilterOption id="10172" count="16" label="efavirenz"/><FilterOption id="10271" count="16" label="palbociclib"/><FilterOption id="12973" count="16" label="sunitinib"/><FilterOption id="45562" count="16" label="tremelimumab"/><FilterOption id="55305" count="15" label="binimetinib"/><FilterOption id="10252" count="15" label="insulin glargine"/><FilterOption id="45902" count="15" label="ramucirumab"/><FilterOption id="53133" count="14" label="dabrafenib"/><FilterOption id="12420" count="14" label="rosuvastatin"/><FilterOption id="39069" count="14" label="simeprevir"/><FilterOption id="10096" count="14" label="telaprevir"/><FilterOption id="65353" count="13" label="alpelisib"/><FilterOption id="11141" count="13" label="basiliximab"/><FilterOption id="54601" count="13" label="carfilzomib"/><FilterOption id="5999" count="13" label="ciclosporin, Novartis"/><FilterOption id="3130" count="13" label="filgrastim"/><FilterOption id="66051" count="13" label="ipatasertib dihydrochloride"/><FilterOption id="54452" count="13" label="rivoceranib mesylate"/><FilterOption id="44313" count="13" label="simvastatin"/><FilterOption id="4200" count="13" label="sirolimus"/><FilterOption id="65416" count="13" label="sofosbuvir"/><FilterOption id="12731" count="13" label="tipranavir"/><FilterOption id="70895" count="13" label="venetoclax"/><FilterOption id="65085" count="12" label="alirocumab"/><FilterOption id="3321" count="12" label="anastrozole"/><FilterOption id="83065" count="12" label="avelumab"/><FilterOption id="39209" count="12" label="axitinib"/><FilterOption id="59953" count="12" label="capmatinib"/><FilterOption id="4728" count="12" label="emtricitabine"/><FilterOption id="11603" count="12" label="gefitinib"/><FilterOption id="11519" count="12" label="mitoxantrone"/></Filter><Filter label="Trial Document Source" name="trialDocumentSource" total="5"><FilterOption id="OTHER" count="2884" label="Other Publications"/><FilterOption id="SERIAL" count="2759" label="Serial Publications"/><FilterOption id="PR" count="2749" label="Press Releases"/><FilterOption id="CONFERENCE" count="734" label="Conference Reports"/><FilterOption id="CORPORATE" count="662" label="Corporate Publications"/></Filter><Filter label="Trial Interventions Primary Alone Name Display" name="trialInterventionsPrimaryAloneNameDisplay" total="100"><FilterOption id="29831" count="69" label="sorafenib"/><FilterOption id="54804" count="52" label="nivolumab"/><FilterOption id="14163" count="35" label="adalimumab"/><FilterOption id="55275" count="33" label="secukinumab"/><FilterOption id="32677" count="27" label="rivaroxaban"/><FilterOption id="72699" count="26" label="atezolizumab"/><FilterOption id="81193" count="26" label="durvalumab"/><FilterOption id="13340" count="25" label="everolimus"/><FilterOption id="16063" count="25" label="olaparib"/><FilterOption id="70667" count="25" label="pembrolizumab"/><FilterOption id="54452" count="23" label="rivoceranib mesylate"/><FilterOption id="12973" count="22" label="sunitinib"/><FilterOption id="6259" count="21" label="tocilizumab (intravenous), Roche/Chugai"/><FilterOption id="11961" count="20" label="erlotinib"/><FilterOption id="27572" count="20" label="lenalidomide"/><FilterOption id="45499" count="20" label="tofacitinib citrate (oral, inflammation), Pfizer"/><FilterOption id="6050" count="19" label="metformin hydrochloride"/><FilterOption id="74726" count="19" label="upadacitinib"/><FilterOption id="52967" count="18" label="apixaban"/><FilterOption id="24343" count="18" label="dabigatran etexilate"/><FilterOption id="58762" count="18" label="empagliflozin"/><FilterOption id="53981" count="18" label="enzalutamide"/><FilterOption id="8047" count="17" label="bevacizumab"/><FilterOption id="35644" count="17" label="methoxy polyethylene glycol-epoetin beta"/><FilterOption id="4567" count="16" label="etanercept"/><FilterOption id="10154" count="16" label="fingolimod"/><FilterOption id="43738" count="16" label="pazopanib"/><FilterOption id="17814" count="16" label="pregabalin"/><FilterOption id="22395" count="16" label="ranibizumab"/><FilterOption id="6736" count="16" label="rituximab"/><FilterOption id="8165" count="16" label="tiotropium bromide"/><FilterOption id="2953" count="15" label="docetaxel"/><FilterOption id="14681" count="15" label="lopinavir + ritonavir"/><FilterOption id="2807" count="14" label="atorvastatin"/><FilterOption id="55237" count="14" label="ibrutinib"/><FilterOption id="36630" count="14" label="ipilimumab"/><FilterOption id="54488" count="14" label="raltegravir"/><FilterOption id="58782" count="14" label="sacubitril + valsartan trisodium hemipentahydrate"/><FilterOption id="42858" count="14" label="ustekinumab"/><FilterOption id="54449" count="13" label="afatinib"/><FilterOption id="59098" count="13" label="baricitinib"/><FilterOption id="12205" count="13" label="capecitabine"/><FilterOption id="65240" count="13" label="evolocumab"/><FilterOption id="45841" count="13" label="lenvatinib mesylate"/><FilterOption id="6692" count="13" label="natalizumab"/><FilterOption id="51388" count="13" label="nilotinib"/><FilterOption id="51160" count="13" label="nintedanib"/><FilterOption id="83873" count="13" label="osimertinib"/><FilterOption id="36669" count="13" label="trastuzumab emtansine"/><FilterOption id="2765" count="13" label="zoledronic acid"/><FilterOption id="47733" count="12" label="canakinumab"/><FilterOption id="52854" count="12" label="macitentan"/><FilterOption id="37613" count="12" label="maraviroc"/><FilterOption id="21994" count="12" label="vardenafil hydrochloride"/><FilterOption id="72538" count="11" label="abemaciclib"/><FilterOption id="49721" count="11" label="denosumab"/><FilterOption id="3700" count="11" label="nevirapine"/><FilterOption id="3803" count="11" label="paclitaxel"/><FilterOption id="77337" count="11" label="risankizumab"/><FilterOption id="8713" count="11" label="sildenafil citrate"/><FilterOption id="14493" count="11" label="tenofovir disoproxil fumarate"/><FilterOption id="53547" count="10" label="aflibercept (intravitreal, wet AMD, macular edema, diabetic retinopathy), Regeneron/Bayer"/><FilterOption id="10606" count="10" label="eltrombopag"/><FilterOption id="32355" count="10" label="indacaterol"/><FilterOption id="62451" count="10" label="ixekizumab"/><FilterOption id="53172" count="10" label="mavoglurant"/><FilterOption id="12037" count="10" label="mepolizumab"/><FilterOption id="12420" count="10" label="rosuvastatin"/><FilterOption id="4119" count="10" label="tadalafil"/><FilterOption id="50935" count="9" label="cabozantinib S-malate"/><FilterOption id="69858" count="9" label="ceritinib"/><FilterOption id="5907" count="9" label="duloxetine"/><FilterOption id="51255" count="9" label="edoxaban"/><FilterOption id="47941" count="9" label="GSK-1437173A"/><FilterOption id="55852" count="9" label="linagliptin"/><FilterOption id="3738" count="9" label="olanzapine"/><FilterOption id="54624" count="9" label="regorafenib"/><FilterOption id="25182" count="9" label="valganciclovir"/><FilterOption id="2716" count="8" label="alemtuzumab"/><FilterOption id="47205" count="8" label="ataluren"/><FilterOption id="37592" count="8" label="brivaracetam"/><FilterOption id="28035" count="8" label="cabazitaxel"/><FilterOption id="55798" count="8" label="crizotinib"/><FilterOption id="15593" count="8" label="eculizumab"/><FilterOption id="25049" count="8" label="laquinimod"/><FilterOption id="4151" count="8" label="pramipexole"/><FilterOption id="4200" count="8" label="sirolimus"/><FilterOption id="4529" count="8" label="temozolomide"/><FilterOption id="44897" count="7" label="apremilast"/><FilterOption id="28358" count="7" label="bemiparin"/><FilterOption id="5871" count="7" label="bosentan"/><FilterOption id="12135" count="7" label="celecoxib"/><FilterOption id="52192" count="7" label="dapagliflozin propanediol"/><FilterOption id="61317" count="7" label="daprodustat (oral, anemia), GlaxoSmithKline"/><FilterOption id="48946" count="7" label="dasatinib"/><FilterOption id="59062" count="7" label="dolutegravir"/><FilterOption id="9313" count="7" label="lanreotide"/><FilterOption id="12978" count="7" label="moxifloxacin"/><FilterOption id="64962" count="7" label="ozanimod"/><FilterOption id="40115" count="7" label="radium Ra 223 dichloride"/></Filter><Filter label="Trial Interventions Control In Regimen Name Display" name="trialInterventionsControlInRegimenNameDisplay" total="100"><FilterOption id="44383" count="100" label="carboplatin"/><FilterOption id="3803" count="73" label="paclitaxel"/><FilterOption id="3199" count="66" label="gemcitabine"/><FilterOption id="3792" count="45" label="oxaliplatin"/><FilterOption id="2953" count="43" label="docetaxel"/><FilterOption id="3536" count="39" label="pemetrexed disodium"/><FilterOption id="6736" count="37" label="rituximab"/><FilterOption id="8047" count="36" label="bevacizumab"/><FilterOption id="12205" count="35" label="capecitabine"/><FilterOption id="6050" count="33" label="metformin hydrochloride"/><FilterOption id="6386" count="32" label="trastuzumab"/><FilterOption id="7310" count="27" label="ritonavir"/><FilterOption id="3072" count="23" label="etoposide phosphate"/><FilterOption id="49219" count="22" label="tenofovir disoproxil fumarate + emtricitabine (fixed dose), Gilead Sciences"/><FilterOption id="2871" count="18" label="irinotecan"/><FilterOption id="29016" count="18" label="paclitaxel (albumin-bound nanoparticle, intravenous), Celgene"/><FilterOption id="3669" count="17" label="mycophenolate mofetil"/><FilterOption id="15954" count="16" label="bortezomib"/><FilterOption id="32981" count="16" label="darunavir"/><FilterOption id="13022" count="16" label="epirubicin"/><FilterOption id="15254" count="15" label="atazanavir"/><FilterOption id="10252" count="15" label="insulin glargine"/><FilterOption id="6408" count="15" label="vinorelbine"/><FilterOption id="47000" count="14" label="bendamustine"/><FilterOption id="2836" count="14" label="clopidogrel"/><FilterOption id="23625" count="13" label="peginterferon alfa-2a"/><FilterOption id="4510" count="12" label="tacrolimus"/><FilterOption id="10309" count="11" label="abiraterone"/><FilterOption id="10388" count="11" label="cetuximab"/><FilterOption id="48181" count="11" label="lamivudine + abacavir, GlaxoSmithKline"/><FilterOption id="27572" count="11" label="lenalidomide"/><FilterOption id="44375" count="11" label="warfarin"/><FilterOption id="3353" count="10" label="insulin lispro"/><FilterOption id="14681" count="10" label="lopinavir + ritonavir"/><FilterOption id="5369" count="10" label="ribavirin"/><FilterOption id="10172" count="9" label="efavirenz"/><FilterOption id="6156" count="8" label="fludarabine"/><FilterOption id="11519" count="8" label="mitoxantrone"/><FilterOption id="14163" count="7" label="adalimumab"/><FilterOption id="44384" count="7" label="ceftriaxone"/><FilterOption id="13928" count="7" label="enoxaparin sodium"/><FilterOption id="8832" count="7" label="glimepiride"/><FilterOption id="44401" count="7" label="vancomycin"/><FilterOption id="2807" count="6" label="atorvastatin"/><FilterOption id="37370" count="6" label="azacitidine"/><FilterOption id="59062" count="6" label="dolutegravir"/><FilterOption id="13340" count="6" label="everolimus"/><FilterOption id="3081" count="6" label="exemestane"/><FilterOption id="10411" count="6" label="insulin aspart"/><FilterOption id="3474" count="6" label="lamivudine"/><FilterOption id="33591" count="6" label="lapatinib"/><FilterOption id="2784" count="6" label="letrozole"/><FilterOption id="27696" count="6" label="pomalidomide"/><FilterOption id="14493" count="6" label="tenofovir disoproxil fumarate"/><FilterOption id="3321" count="5" label="anastrozole"/><FilterOption id="11141" count="5" label="basiliximab"/><FilterOption id="5999" count="5" label="ciclosporin, Novartis"/><FilterOption id="7934" count="5" label="doxorubicin (liposomal, STEALTH), Alza"/><FilterOption id="5907" count="5" label="duloxetine"/><FilterOption id="17518" count="5" label="escitalopram"/><FilterOption id="11367" count="5" label="ezetimibe"/><FilterOption id="6861" count="5" label="lobaplatin"/><FilterOption id="21374" count="5" label="pegfilgrastim"/><FilterOption id="28532" count="5" label="pertuzumab"/><FilterOption id="71886" count="5" label="ribavirin (oral tablet, HCV), Roche"/><FilterOption id="29831" count="5" label="sorafenib"/><FilterOption id="12150" count="5" label="vincristine sulfate (liposomal injection), Spectrum Pharmaceuticals"/><FilterOption id="54601" count="4" label="carfilzomib"/><FilterOption id="62275" count="4" label="cobicistat"/><FilterOption id="13239" count="4" label="decitabine"/><FilterOption id="24471" count="4" label="fosamprenavir"/><FilterOption id="7286" count="4" label="goserelin acetate"/><FilterOption id="3488" count="4" label="leflunomide"/><FilterOption id="3616" count="4" label="meropenem"/><FilterOption id="54804" count="4" label="nivolumab"/><FilterOption id="53227" count="4" label="obinutuzumab"/><FilterOption id="70667" count="4" label="pembrolizumab"/><FilterOption id="52857" count="4" label="rilpivirine hydrochloride"/><FilterOption id="4259" count="4" label="saquinavir"/><FilterOption id="44499" count="4" label="sitagliptin"/><FilterOption id="36332" count="4" label="ticagrelor"/><FilterOption id="8165" count="4" label="tiotropium bromide"/><FilterOption id="6242" count="3" label="abacavir"/><FilterOption id="72699" count="3" label="atezolizumab"/><FilterOption id="16915" count="3" label="calcium levofolinate"/><FilterOption id="44370" count="3" label="clindamycin"/><FilterOption id="72148" count="3" label="darunavir + cobicistat (fixed dose, HIV infection), Janssen R&amp;D/ Gilead"/><FilterOption id="4728" count="3" label="emtricitabine"/><FilterOption id="25880" count="3" label="enteric-coated mycophenolate sodium, Novartis"/><FilterOption id="11961" count="3" label="erlotinib"/><FilterOption id="30682" count="3" label="etravirine"/><FilterOption id="13572" count="3" label="exenatide"/><FilterOption id="3130" count="3" label="filgrastim"/><FilterOption id="14336" count="3" label="fluticasone propionate + salmeterol (asthma and COPD), GlaxoSmithKline"/><FilterOption id="59269" count="3" label="insulin degludec"/><FilterOption id="17426" count="3" label="insulin detemir"/><FilterOption id="36630" count="3" label="ipilimumab"/><FilterOption id="5148" count="3" label="liraglutide"/><FilterOption id="4126" count="3" label="pioglitazone"/><FilterOption id="54488" count="3" label="raltegravir"/></Filter><Filter label="Trial Category" name="trialCategory" total="18"><FilterOption id="4" count="5295" label="Small molecule"/><FilterOption id="3" count="2666" label="Biological"/><FilterOption id="8" count="456" label="Medical device"/><FilterOption id="9" count="395" label="Medical procedure"/><FilterOption id="16" count="209" label="Behavioral intervention"/><FilterOption id="5" count="209" label="Vaccine"/><FilterOption id="15" count="185" label="Radiation therapy"/><FilterOption id="11" count="139" label="Dietary supplement"/><FilterOption id="7" count="127" label="Gene therapy"/><FilterOption id="6" count="121" label="Cell therapy"/><FilterOption id="14" count="71" label="Diagnostic"/><FilterOption id="18" count="70" label="Pathophysiology"/><FilterOption id="17" count="58" label="Biomarker identification"/><FilterOption id="10" count="13" label="Borderline product"/><FilterOption id="19" count="10" label="Surgical procedure"/><FilterOption id="12" count="7" label="Herbal preparation"/><FilterOption id="2" count="4" label="Drug"/><FilterOption id="13" count="2" label="Hospital solutions"/></Filter><Filter label="Trial Outcome Available" name="trialOutcomesAvailable" total="2"><FilterOption id="YES" count="4091" label="Yes"/><FilterOption id="NO" count="3763" label="No"/></Filter><Filter label="Trial Actions Primary Interventions Primary" name="trialActionsPrimaryInterventionsPrimary" total="100"><FilterOption id="3848" count="377" label="VEGF-2 receptor antagonist"/><FilterOption id="3846" count="309" label="VEGF-1 receptor antagonist"/><FilterOption id="3808" count="303" label="Kit tyrosine kinase inhibitor"/><FilterOption id="3850" count="290" label="VEGF-3 receptor antagonist"/><FilterOption id="67136" count="267" label="Programmed cell death protein 1 inhibitor"/><FilterOption id="740" count="252" label="Epidermal growth factor receptor antagonist"/><FilterOption id="48492" count="232" label="PDGF receptor beta antagonist"/><FilterOption id="3806" count="215" label="Flt3 tyrosine kinase inhibitor"/><FilterOption id="1722" count="200" label="VEGF receptor antagonist"/><FilterOption id="948" count="197" label="PDGF receptor antagonist"/><FilterOption id="3816" count="187" label="RET tyrosine kinase receptor family inhibitor"/><FilterOption id="14007" count="178" label="Programmed cell death ligand 1 inhibitor"/><FilterOption id="4548" count="168" label="Raf B protein kinase inhibitor"/><FilterOption id="372" count="166" label="Thymidylate synthase inhibitor"/><FilterOption id="3756" count="159" label="Erbb2 tyrosine kinase receptor inhibitor"/><FilterOption id="5085" count="147" label="B-lymphocyte antigen CD20 inhibitor"/><FilterOption id="142" count="133" label="Topoisomerase II inhibitor"/><FilterOption id="48489" count="132" label="PDGF receptor alpha antagonist"/><FilterOption id="10240" count="129" label="mTOR inhibitor"/><FilterOption id="138" count="128" label="DNA polymerase inhibitor"/><FilterOption id="4550" count="126" label="Raf 1 protein kinase inhibitor"/><FilterOption id="3688" count="122" label="FGF3 receptor antagonist"/><FilterOption id="12521" count="122" label="VEGF ligand inhibitor"/><FilterOption id="3682" count="119" label="FGF1 receptor antagonist"/><FilterOption id="1016" count="119" label="HIV-1 reverse transcriptase inhibitor"/><FilterOption id="3754" count="115" label="EGFR family tyrosine kinase receptor inhibitor"/><FilterOption id="1832" count="113" label="Nucleoside reverse transcriptase inhibitor"/><FilterOption id="4542" count="108" label="Raf protein kinase inhibitor"/><FilterOption id="204" count="105" label="HIV protease inhibitor"/><FilterOption id="3685" count="98" label="FGF2 receptor antagonist"/><FilterOption id="768" count="97" label="HIV-1 protease inhibitor"/><FilterOption id="76090" count="97" label="mTOR complex 1 inhibitor"/><FilterOption id="3154" count="96" label="CSF-1 antagonist"/><FilterOption id="3562" count="94" label="Jak1 tyrosine kinase inhibitor"/><FilterOption id="5482" count="92" label="Cytotoxic T-lymphocyte protein-4 inhibitor"/><FilterOption id="8805" count="91" label="AMP activated protein kinase stimulator"/><FilterOption id="7424" count="86" label="Cytochrome P450 3A4 inhibitor"/><FilterOption id="120" count="86" label="Factor Xa antagonist"/><FilterOption id="214" count="85" label="Interferon alpha 2 ligand"/><FilterOption id="38283" count="81" label="Poly ADP ribose polymerase 1 inhibitor"/><FilterOption id="385" count="78" label="Protein tyrosine kinase inhibitor"/><FilterOption id="141" count="78" label="Topoisomerase I inhibitor"/><FilterOption id="7588" count="77" label="HIV-1 integrase inhibitor"/><FilterOption id="38286" count="77" label="Poly ADP ribose polymerase 2 inhibitor"/><FilterOption id="721" count="77" label="TNF binding agent"/><FilterOption id="40" count="76" label="Beta 2 adrenoceptor agonist"/><FilterOption id="12349" count="75" label="Hepatitis C virus NS3 protease inhibitor"/><FilterOption id="4010" count="71" label="Calcineurin inhibitor"/><FilterOption id="4762" count="70" label="MEK-1 protein kinase inhibitor"/><FilterOption id="1575" count="70" label="Phosphoinositide 3-kinase inhibitor"/><FilterOption id="135" count="69" label="DHFR inhibitor"/><FilterOption id="2585" count="69" label="Glucagon-like peptide 1 receptor agonist"/><FilterOption id="675" count="69" label="Hepatocyte growth factor receptor antagonist"/><FilterOption id="4764" count="69" label="MEK-2 protein kinase inhibitor"/><FilterOption id="4917" count="68" label="Proteasome inhibitor"/><FilterOption id="629" count="67" label="Inosine monophosphate dehydrogenase inhibitor"/><FilterOption id="381" count="67" label="TNF alpha ligand inhibitor"/><FilterOption id="374" count="66" label="Transferase inhibitor"/><FilterOption id="76" count="65" label="Aromatase inhibitor"/><FilterOption id="205" count="65" label="HMG CoA reductase inhibitor"/><FilterOption id="181" count="64" label="GAR transformylase inhibitor"/><FilterOption id="1833" count="64" label="Non-nucleoside reverse transcriptase inhibitor"/><FilterOption id="23014" count="63" label="Insulin ligand"/><FilterOption id="400" count="63" label="Insulin receptor agonist"/><FilterOption id="4314" count="61" label="Cyclin-dependent kinase-4 inhibitor"/><FilterOption id="168" count="61" label="FGF receptor antagonist"/><FilterOption id="471" count="61" label="IL-6 receptor antagonist"/><FilterOption id="2507" count="61" label="PARP inhibitor"/><FilterOption id="13571" count="60" label="Bcr protein inhibitor"/><FilterOption id="4318" count="60" label="Cyclin-dependent kinase-6 inhibitor"/><FilterOption id="3576" count="60" label="Src tyrosine kinase inhibitor"/><FilterOption id="4020" count="59" label="Sodium glucose transporter-2 inhibitor"/><FilterOption id="3584" count="57" label="Lck tyrosine kinase inhibitor"/><FilterOption id="150" count="56" label="Dopamine D2 receptor antagonist"/><FilterOption id="3818" count="56" label="Ret tyrosine kinase receptor inhibitor"/><FilterOption id="286" count="55" label="Estrogen receptor antagonist"/><FilterOption id="43842" count="52" label="Hepatitis C virus protein NS5A inhibitor"/><FilterOption id="38289" count="52" label="Poly ADP ribose polymerase 3 inhibitor"/><FilterOption id="1689" count="51" label="VEGF-A ligand inhibitor"/><FilterOption id="76469" count="50" label="26S proteasome complex inhibitor"/><FilterOption id="60" count="49" label="Androgen receptor antagonist"/><FilterOption id="3691" count="49" label="FGF4 receptor antagonist"/><FilterOption id="3252" count="49" label="Insulin-like growth factor 1 receptor antagonist"/><FilterOption id="3834" count="49" label="Tek tyrosine kinase receptor inhibitor"/><FilterOption id="262" count="48" label="Muscarinic M3 receptor antagonist"/><FilterOption id="498" count="48" label="Sodium channel inhibitor"/><FilterOption id="3524" count="47" label="Abl tyrosine kinase inhibitor"/><FilterOption id="3592" count="47" label="Btk tyrosine kinase inhibitor"/><FilterOption id="259" count="47" label="Muscarinic receptor antagonist"/><FilterOption id="4802" count="44" label="IL-17 antagonist"/><FilterOption id="3796" count="44" label="MET tyrosine kinase receptor family inhibitor"/><FilterOption id="3758" count="43" label="Erbb3 tyrosine kinase receptor inhibitor"/><FilterOption id="541" count="43" label="Tubulin receptor antagonist"/><FilterOption id="5537" count="42" label="Dipeptidyl peptidase IV inhibitor"/><FilterOption id="12358" count="42" label="Hepatitis C virus NS5B polymerase inhibitor"/><FilterOption id="2480" count="42" label="PPAR gamma agonist"/><FilterOption id="347" count="42" label="RNA polymerase inhibitor"/><FilterOption id="585" count="41" label="5-HT 2a receptor antagonist"/><FilterOption id="3564" count="41" label="Jak2 tyrosine kinase inhibitor"/><FilterOption id="431" count="40" label="DNA gyrase inhibitor"/></Filter><Filter label="Trial Company Collaborator" name="trialCompaniesCollaborator" total="100"><FilterOption id="18767" count="66" label="Pfizer Inc"/><FilterOption id="28355" count="59" label="GlaxoSmithKline plc"/><FilterOption id="1013295" count="56" label="Astellas Pharma Inc"/><FilterOption id="15065" count="54" label="Bristol-Myers Squibb Co"/><FilterOption id="1017818" count="52" label="Instituto de Salud Carlos III"/><FilterOption id="1059823" count="52" label="Merck Sharp &amp; Dohme Corp"/><FilterOption id="19446" count="51" label="Roche Holding AG"/><FilterOption id="1009547" count="50" label="Sanofi SA"/><FilterOption id="19214" count="45" label="Regeneron Pharmaceuticals Inc"/><FilterOption id="20300" count="45" label="Takeda Pharmaceutical Co Ltd"/><FilterOption id="14190" count="44" label="AstraZeneca plc"/><FilterOption id="17810" count="42" label="Eli Lilly &amp; Co"/><FilterOption id="1039423" count="40" label="Hospital Clinic of Barcelona"/><FilterOption id="23137" count="38" label="Novartis AG"/><FilterOption id="20519" count="36" label="National Cancer Institute"/><FilterOption id="14455" count="32" label="Bayer AG"/><FilterOption id="18681" count="32" label="Ono Pharmaceutical Co Ltd"/><FilterOption id="19453" count="31" label="Genentech Inc"/><FilterOption id="1003065" count="27" label="Hospital Vall D'Hebron"/><FilterOption id="1067538" count="27" label="Janssen Research &amp; Development LLC"/><FilterOption id="15331" count="25" label="Celgene Corp"/><FilterOption id="14109" count="21" label="Amgen Inc"/><FilterOption id="1055006" count="21" label="Ministry of Health, Spain"/><FilterOption id="1059977" count="20" label="European Commission"/><FilterOption id="1039086" count="20" label="Germans Trias i Pujol Hospital"/><FilterOption id="1101929" count="20" label="IQVIA Holdings Inc"/><FilterOption id="18101" count="19" label="Merck KGaA"/><FilterOption id="1072507" count="18" label="AbbVie Inc"/><FilterOption id="20452" count="18" label="UCB SA"/><FilterOption id="19620" count="17" label="Eisai Inc"/><FilterOption id="1039087" count="17" label="Fundacio Lluita Contra La Sida"/><FilterOption id="1065900" count="16" label="Apices Soluciones, S.L."/><FilterOption id="26178" count="16" label="F Hoffmann-La Roche AG"/><FilterOption id="1079783" count="16" label="FUNDACIÓ INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU"/><FilterOption id="1040940" count="16" label="Hospital Universitari de Bellvitge"/><FilterOption id="18440" count="16" label="Myriad Genetics Inc"/><FilterOption id="1033116" count="16" label="PAREXEL International"/><FilterOption id="18077" count="15" label="Merck &amp; Co Inc"/><FilterOption id="1068433" count="15" label="Spanish Clinical Research Network"/><FilterOption id="1067340" count="14" label="Pivotal SL"/><FilterOption id="1116693" count="14" label="Productos Roche, S.A. de C.V."/><FilterOption id="25611" count="14" label="Universitat Autonoma de Barcelona"/><FilterOption id="1042255" count="13" label="Breast International Group"/><FilterOption id="1056444" count="13" label="Foundation Medicine Inc"/><FilterOption id="25554" count="13" label="Seattle Genetics Inc"/><FilterOption id="13601" count="12" label="Abbott Laboratories"/><FilterOption id="21082" count="12" label="Walter and Eliza Hall Institute of Medical Research"/><FilterOption id="1088989" count="11" label="Barcelona Institute for Global Health"/><FilterOption id="1084506" count="11" label="European Network of Gynaecological Oncological Trial Groups"/><FilterOption id="1017771" count="11" label="Institut d'Investigacions Biomediques August Pi I Sunyer"/><FilterOption id="17332" count="11" label="Johnson &amp; Johnson"/><FilterOption id="1063946" count="11" label="Syneos Health Inc"/><FilterOption id="19864" count="10" label="Adir &amp; Co"/><FilterOption id="1005244" count="10" label="Biogen Inc"/><FilterOption id="14881" count="10" label="Boehringer Ingelheim International GmbH"/><FilterOption id="23119" count="10" label="European Organisation for Research and Treatment of Cancer (EORTC)"/><FilterOption id="1073758" count="10" label="Fondo de Investigacion Sanitaria"/><FilterOption id="16198" count="10" label="Forest Laboratories Inc"/><FilterOption id="27741" count="10" label="Galapagos NV"/><FilterOption id="1041702" count="10" label="Gynecologic Oncology Group"/><FilterOption id="1054094" count="10" label="Hospital del Mar"/><FilterOption id="17216" count="10" label="Incyte Corp"/><FilterOption id="29481" count="10" label="Johnson &amp; Johnson Pharmaceutical Research &amp; Development LLC"/><FilterOption id="20518" count="10" label="National Institutes of Health"/><FilterOption id="1144568" count="10" label="Novartis Pharma Services AG"/><FilterOption id="1033989" count="10" label="Pharmaceutical Product Development LLC"/><FilterOption id="19063" count="10" label="Pharmacyclics Inc"/><FilterOption id="1100315" count="10" label="PRA Health Sciences"/><FilterOption id="29469" count="9" label="Cancer Research UK"/><FilterOption id="15414" count="9" label="Chugai Pharmaceutical Co Ltd"/><FilterOption id="22676" count="9" label="Exelixis Inc"/><FilterOption id="16450" count="9" label="Gilead Sciences Inc"/><FilterOption id="1033112" count="9" label="Hospital Universitario 12 de Octubre"/><FilterOption id="1006639" count="9" label="Hospital Universitario Ramon y Cajal"/><FilterOption id="19863" count="9" label="Servier"/><FilterOption id="24652" count="9" label="Shire plc"/><FilterOption id="1077534" count="9" label="Sociedad Española de Neumología y Cirugía Torácica"/><FilterOption id="1061163" count="8" label="Abbott Vascular"/><FilterOption id="25902" count="8" label="Array BioPharma Inc"/><FilterOption id="1104124" count="8" label="GlaxoSmithKline LLC"/><FilterOption id="1128229" count="8" label="Kaiping Central Hospital"/><FilterOption id="1074428" count="8" label="Ministerio de Economia y Competitividad"/><FilterOption id="1036091" count="8" label="National Institute of Neurological Disorders and Stroke"/><FilterOption id="20348" count="8" label="Teva Pharmaceutical Industries Ltd"/><FilterOption id="1003992" count="8" label="Universitat de Barcelona"/><FilterOption id="1097931" count="7" label="Andalusian Initiative for Advanced Therapies"/><FilterOption id="1018807" count="7" label="Covance Inc"/><FilterOption id="1017506" count="7" label="Daiichi Sankyo Co Ltd"/><FilterOption id="1053612" count="7" label="Fundacion Clinic per a la Recerca Biomédica"/><FilterOption id="1089894" count="7" label="Guangzhou Municipal Twelfth People's Hospital"/><FilterOption id="1079458" count="7" label="Hospital de Sant Pau"/><FilterOption id="1040862" count="7" label="Hospital General Universitario Gregorio Marañon"/><FilterOption id="17416" count="7" label="Janssen LP"/><FilterOption id="1014884" count="7" label="Medivation Inc"/><FilterOption id="20520" count="7" label="National Institute of Allergy and Infectious Diseases"/><FilterOption id="1125317" count="6" label="ADIR Association"/><FilterOption id="1116195" count="6" label="Fundació Marató de TV3"/><FilterOption id="17900" count="6" label="H Lundbeck A/S"/><FilterOption id="1056709" count="6" label="ICON Clinical Research"/><FilterOption id="1068275" count="6" label="Innovative Medicines Initiative"/></Filter><Filter label="Trial Actions Secondary Interventions Control" name="trialActionsSecondaryInterventionsControl" total="100"><FilterOption id="1545" count="833" label="Anticancer"/><FilterOption id="2953" count="291" label="Anti-inflammatory"/><FilterOption id="767" count="278" label="Cell cycle inhibitor"/><FilterOption id="991" count="235" label="Antiviral"/><FilterOption id="140" count="219" label="DNA synthesis inhibitor"/><FilterOption id="55685" count="213" label="Anticancer monoclonal antibody"/><FilterOption id="1569" count="201" label="Anticancer antimetabolite"/><FilterOption id="62255" count="198" label="Anticancer protein kinase inhibitor"/><FilterOption id="50" count="188" label="Anticancer alkylating agent"/><FilterOption id="61" count="152" label="Angiogenesis inhibitor"/><FilterOption id="1589" count="127" label="Apoptosis stimulator"/><FilterOption id="2576" count="125" label="Microtubule stabilizer"/><FilterOption id="2575" count="117" label="Microtubule inhibitor"/><FilterOption id="2660" count="111" label="Vasoprotectant"/><FilterOption id="399" count="107" label="Hypoglycemic agent"/><FilterOption id="7293" count="83" label="Synergist"/><FilterOption id="396" count="73" label="Immunosuppressant"/><FilterOption id="2946" count="71" label="Analgesic"/><FilterOption id="1594" count="70" label="Antibacterial"/><FilterOption id="1596" count="60" label="Immunomodulator"/><FilterOption id="646" count="55" label="Bronchodilator"/><FilterOption id="15184" count="54" label="Systemic antipsoriatic product"/><FilterOption id="2657" count="49" label="Antihypertensive"/><FilterOption id="659" count="49" label="Coagulation inhibitor"/><FilterOption id="104" count="48" label="Bacterial cell wall synthesis inhibitor"/><FilterOption id="805" count="47" label="Folate modulator"/><FilterOption id="38206" count="44" label="Biguanide antidiabetic product"/><FilterOption id="15187" count="44" label="Systemic dermatological antibacterial product"/><FilterOption id="747" count="43" label="HIV replication inhibitor"/><FilterOption id="750" count="40" label="DNA intercalator"/><FilterOption id="393" count="40" label="Immunostimulant"/><FilterOption id="7761" count="40" label="T-lymphocyte stimulator"/><FilterOption id="2659" count="32" label="Cardioprotectant"/><FilterOption id="610" count="28" label="Hematopoietic stimulator"/><FilterOption id="38215" count="28" label="Human insulin long acting product"/><FilterOption id="62254" count="27" label="Anticancer hormone antagonist"/><FilterOption id="1615" count="27" label="Neuroprotectant"/><FilterOption id="2954" count="27" label="Steroidal anti-inflammatory"/><FilterOption id="2941" count="26" label="Antidepressant"/><FilterOption id="3189" count="25" label="Corticosteroid agonist"/><FilterOption id="7760" count="25" label="T-lymphocyte inhibitor"/><FilterOption id="38211" count="24" label="Human insulin fast acting product"/><FilterOption id="312" count="24" label="Platelet aggregation inhibitor"/><FilterOption id="2667" count="23" label="Antiarteriosclerotic"/><FilterOption id="70" count="23" label="Anticonvulsant agent"/><FilterOption id="71" count="23" label="Antihypercholesterolemic agent"/><FilterOption id="382" count="23" label="TNF alpha synthesis inhibitor"/><FilterOption id="12378" count="20" label="Prophylactic vaccine"/><FilterOption id="1479" count="20" label="RNA synthesis modulator"/><FilterOption id="3" count="19" label="5-HT uptake inhibitor"/><FilterOption id="15148" count="18" label="Ocular antineovascularisation agent"/><FilterOption id="72" count="17" label="Antihyperlipidemic agent"/><FilterOption id="2947" count="17" label="Antiparkinsonian"/><FilterOption id="2943" count="17" label="Antipsychotic"/><FilterOption id="1538" count="17" label="Bacterial protein synthesis inhibitor"/><FilterOption id="664" count="17" label="Fibrosuppressant"/><FilterOption id="285" count="17" label="Norepinephrine uptake inhibitor"/><FilterOption id="2942" count="16" label="Anxiolytic"/><FilterOption id="1535" count="16" label="Beta lactam antibiotic"/><FilterOption id="73547" count="16" label="Carbapenem"/><FilterOption id="1532" count="16" label="Viral replication inhibitor"/><FilterOption id="32411" count="15" label="Hepatitis B virus replication inhibitor"/><FilterOption id="439" count="15" label="RNA synthesis inhibitor"/><FilterOption id="388" count="15" label="Vasodilator"/><FilterOption id="2970" count="14" label="Anti-emetic"/><FilterOption id="89" count="14" label="Bone resorption inhibitor"/><FilterOption id="463" count="14" label="Ribosome binding agent"/><FilterOption id="38205" count="14" label="Sulphonylurea antidiabetic product"/><FilterOption id="3984" count="13" label="Bacterial nucleic acid synthesis inhibitor"/><FilterOption id="3246" count="13" label="Insulin release stimulator"/><FilterOption id="1129" count="12" label="Non-steroid hormone receptor antagonist"/><FilterOption id="937" count="11" label="Androgen synthesis inhibitor"/><FilterOption id="38439" count="11" label="DPP IV inhibitor antidiabetic product"/><FilterOption id="1748" count="11" label="Fungicide"/><FilterOption id="284" count="11" label="Nootropic agent"/><FilterOption id="12596" count="11" label="Osteoclast inhibitor"/><FilterOption id="59620" count="11" label="Unspecified drug target"/><FilterOption id="1537" count="10" label="Cephalosporin"/><FilterOption id="614" count="10" label="Lipid uptake inhibitor"/><FilterOption id="62253" count="9" label="Anticancer hormone"/><FilterOption id="3313" count="9" label="Glucagon-like peptide 1 metabolism modulator"/><FilterOption id="2955" count="9" label="Non-steroidal anti-inflammatory"/><FilterOption id="15128" count="9" label="Ophthalmological agent"/><FilterOption id="449" count="8" label="Antiarrhythmic agent"/><FilterOption id="7018" count="8" label="Antihypertriglyceridemic agent"/><FilterOption id="3272" count="8" label="Growth hormone release inhibitor"/><FilterOption id="968" count="7" label="Coagulation stimulator"/><FilterOption id="12367" count="7" label="Inactivated viral vaccine"/><FilterOption id="695" count="7" label="Metastasis inhibitor"/><FilterOption id="12371" count="7" label="Subunit vaccine"/><FilterOption id="12364" count="6" label="Live attenuated viral vaccine"/><FilterOption id="1540" count="6" label="Macrolide antibiotic"/><FilterOption id="563" count="6" label="Microtubule modulator"/><FilterOption id="882" count="5" label="5-HETE modulator"/><FilterOption id="4007" count="5" label="Antidiarrhoeal"/><FilterOption id="5704" count="5" label="B-lymphocyte adhesion inhibitor"/><FilterOption id="5710" count="5" label="B-lymphocyte migration inhibitor"/><FilterOption id="5580" count="5" label="Chemotaxis inhibitor"/><FilterOption id="871" count="5" label="GABA modulator"/><FilterOption id="1332" count="5" label="Gastrointestinal system agent"/></Filter><Filter label="Biomarker Type" name="trialBiomarkerTypes" total="7"><FilterOption id="37" count="3747" label="Proteomic"/><FilterOption id="38" count="3651" label="Genomic"/><FilterOption id="31" count="2018" label="Physiological"/><FilterOption id="32" count="1802" label="Biochemical"/><FilterOption id="75" count="1294" label="Cellular"/><FilterOption id="39" count="812" label="Anthropomorphic"/><FilterOption id="40" count="765" label="Structural (imaging)"/></Filter><Filter label="Biomarker Role" name="trialBiomarkerRoles" total="4"><FilterOption id="695863716" count="4093" label="Therapeutic effect marker"/><FilterOption id="1571666123" count="1729" label="Disease marker"/><FilterOption id="730490367" count="1380" label="Toxic effect marker"/><FilterOption id="3242045531" count="29" label="Not determined"/></Filter><Filter label="Interventions" name="trialInterventions" total="100"><FilterOption id="3803" count="178" label="paclitaxel"/><FilterOption id="44383" count="153" label="carboplatin"/><FilterOption id="3199" count="129" label="gemcitabine"/><FilterOption id="8047" count="118" label="bevacizumab"/><FilterOption id="2953" count="118" label="docetaxel"/><FilterOption id="54804" count="112" label="nivolumab"/><FilterOption id="3792" count="112" label="oxaliplatin"/><FilterOption id="29831" count="106" label="sorafenib"/><FilterOption id="72699" count="97" label="atezolizumab"/><FilterOption id="12205" count="94" label="capecitabine"/><FilterOption id="6736" count="94" label="rituximab"/><FilterOption id="70667" count="92" label="pembrolizumab"/><FilterOption id="6050" count="86" label="metformin hydrochloride"/><FilterOption id="5369" count="84" label="ribavirin"/><FilterOption id="6386" count="78" label="trastuzumab"/><FilterOption id="7310" count="77" label="ritonavir"/><FilterOption id="23625" count="70" label="peginterferon alfa-2a"/><FilterOption id="13340" count="69" label="everolimus"/><FilterOption id="36630" count="64" label="ipilimumab"/><FilterOption id="3536" count="64" label="pemetrexed disodium"/><FilterOption id="11961" count="54" label="erlotinib"/><FilterOption id="2871" count="54" label="irinotecan"/><FilterOption id="27572" count="54" label="lenalidomide"/><FilterOption id="81193" count="51" label="durvalumab"/><FilterOption id="15954" count="50" label="bortezomib"/><FilterOption id="3072" count="49" label="etoposide phosphate"/><FilterOption id="10388" count="48" label="cetuximab"/><FilterOption id="29016" count="48" label="paclitaxel (albumin-bound nanoparticle, intravenous), Celgene"/><FilterOption id="16063" count="42" label="olaparib"/><FilterOption id="3313" count="41" label="fulvestrant"/><FilterOption id="2784" count="41" label="letrozole"/><FilterOption id="14163" count="40" label="adalimumab"/><FilterOption id="4510" count="39" label="tacrolimus"/><FilterOption id="13022" count="38" label="epirubicin"/><FilterOption id="54488" count="38" label="raltegravir"/><FilterOption id="12973" count="38" label="sunitinib"/><FilterOption id="14681" count="36" label="lopinavir + ritonavir"/><FilterOption id="45841" count="35" label="lenvatinib mesylate"/><FilterOption id="54452" count="35" label="rivoceranib mesylate"/><FilterOption id="2807" count="34" label="atorvastatin"/><FilterOption id="3669" count="34" label="mycophenolate mofetil"/><FilterOption id="28532" count="34" label="pertuzumab"/><FilterOption id="55275" count="33" label="secukinumab"/><FilterOption id="32981" count="32" label="darunavir"/><FilterOption id="32677" count="31" label="rivaroxaban"/><FilterOption id="47000" count="30" label="bendamustine"/><FilterOption id="55237" count="30" label="ibrutinib"/><FilterOption id="6259" count="30" label="tocilizumab (intravenous), Roche/Chugai"/><FilterOption id="6156" count="29" label="fludarabine"/><FilterOption id="53227" count="28" label="obinutuzumab"/><FilterOption id="4529" count="28" label="temozolomide"/><FilterOption id="14493" count="28" label="tenofovir disoproxil fumarate"/><FilterOption id="10309" count="27" label="abiraterone"/><FilterOption id="71886" count="27" label="ribavirin (oral tablet, HCV), Roche"/><FilterOption id="53200" count="26" label="daratumumab"/><FilterOption id="7934" count="26" label="doxorubicin (liposomal, STEALTH), Alza"/><FilterOption id="53981" count="26" label="enzalutamide"/><FilterOption id="3081" count="26" label="exemestane"/><FilterOption id="3474" count="26" label="lamivudine"/><FilterOption id="2836" count="25" label="clopidogrel"/><FilterOption id="61901" count="24" label="buparlisib"/><FilterOption id="59062" count="24" label="dolutegravir"/><FilterOption id="33591" count="24" label="lapatinib"/><FilterOption id="12646" count="24" label="panitumumab"/><FilterOption id="58741" count="23" label="daclatasvir"/><FilterOption id="51160" count="23" label="nintedanib"/><FilterOption id="96193" count="23" label="spartalizumab"/><FilterOption id="74726" count="23" label="upadacitinib"/><FilterOption id="15254" count="22" label="atazanavir"/><FilterOption id="58762" count="22" label="empagliflozin"/><FilterOption id="49219" count="22" label="tenofovir disoproxil fumarate + emtricitabine (fixed dose), Gilead Sciences"/><FilterOption id="37370" count="21" label="azacitidine"/><FilterOption id="56544" count="21" label="cobimetinib"/><FilterOption id="24343" count="21" label="dabigatran etexilate"/><FilterOption id="10172" count="21" label="efavirenz"/><FilterOption id="37613" count="21" label="maraviroc"/><FilterOption id="10271" count="21" label="palbociclib"/><FilterOption id="43738" count="21" label="pazopanib"/><FilterOption id="12420" count="21" label="rosuvastatin"/><FilterOption id="4200" count="21" label="sirolimus"/><FilterOption id="8165" count="21" label="tiotropium bromide"/><FilterOption id="45499" count="21" label="tofacitinib citrate (oral, inflammation), Pfizer"/><FilterOption id="45562" count="21" label="tremelimumab"/><FilterOption id="6408" count="21" label="vinorelbine"/><FilterOption id="52967" count="20" label="apixaban"/><FilterOption id="27696" count="20" label="pomalidomide"/><FilterOption id="44313" count="20" label="simvastatin"/><FilterOption id="55288" count="20" label="trametinib"/><FilterOption id="4567" count="19" label="etanercept"/><FilterOption id="4126" count="19" label="pioglitazone"/><FilterOption id="22395" count="19" label="ranibizumab"/><FilterOption id="65360" count="19" label="ribociclib"/><FilterOption id="36669" count="19" label="trastuzumab emtansine"/><FilterOption id="54449" count="18" label="afatinib"/><FilterOption id="83065" count="18" label="avelumab"/><FilterOption id="5907" count="18" label="duloxetine"/><FilterOption id="48181" count="18" label="lamivudine + abacavir, GlaxoSmithKline"/><FilterOption id="45902" count="18" label="ramucirumab"/><FilterOption id="6242" count="17" label="abacavir"/><FilterOption id="72538" count="17" label="abemaciclib"/></Filter><Filter label="Endpoint Index Primary" name="trialEndpointIndexPrimary" total="100"><FilterOption id="15293" count="129" label="Solid tumor - Assessment of Safety and Tolerability - Assessment of dose limiting toxicity"/><FilterOption id="8489" count="117" label="Lung tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="15287" count="117" label="Solid tumor - Assessment of adverse events"/><FilterOption id="9153" count="111" label="Lung tumor - Imaging/Radiological Assessments - Assessment by Response Evaluation Criteria in Solid Tumors (RECIST) Criteria"/><FilterOption id="1359" count="109" label="Non-insulin dependent diabetes - Assessment of Hemoglobin A1c (HbA1c) Levels - Change in HbA1c"/><FilterOption id="8713" count="108" label="Breast tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="3736" count="106" label="Hepatitis C virus infection - Assessment of Sustained Virologic Response (SVR)"/><FilterOption id="12048" count="106" label="Hepatobiliary system tumor - Assessment of Overall Survival (OS)"/><FilterOption id="6863" count="99" label="Hepatitis C virus infection - Assessment of Viral Load/Viral Kinetics"/><FilterOption id="9213" count="92" label="HIV infection - Assessment of Viral Load - Assessment of HIV RNA levels"/><FilterOption id="9155" count="83" label="Lung tumor - Assessment of Safety and Tolerability - Assessment of dose limiting toxicity"/><FilterOption id="8481" count="81" label="Lung tumor - Assessment of Overall Survival (OS)"/><FilterOption id="15285" count="77" label="Solid tumor - Assessment of Safety and Tolerability"/><FilterOption id="8505" count="74" label="Lung tumor - Assessment of Objective Response - Assessment of objective response rate(ORR)"/><FilterOption id="9008" count="71" label="Breast tumor - Assessment of Safety and Tolerability - Assessment of dose limiting toxicity"/><FilterOption id="12051" count="70" label="Hepatobiliary system tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="8719" count="69" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Overall/Objective Response Rate (ORR)"/><FilterOption id="8998" count="68" label="Breast tumor - Assessment of adverse events"/><FilterOption id="9247" count="63" label="HIV infection - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events"/><FilterOption id="12118" count="61" label="Hepatobiliary system tumor - Assessment of adverse events"/><FilterOption id="2622" count="59" label="Coronary artery disease - Assessment of Mortality/Death Rates - Cardiovascular mortality"/><FilterOption id="8513" count="59" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"/><FilterOption id="15312" count="59" label="Solid tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"/><FilterOption id="8514" count="58" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="15212" count="58" label="Solid tumor - Assessment of Response Rates (RR) - Assessment of objective response rate (ORR)"/><FilterOption id="8721" count="57" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="8436" count="57" label="Colorectal tumor - Assessment of Safety and Tolerability - Assessment of dose limiting toxicity"/><FilterOption id="8523" count="57" label="Lung tumor - Assessment of Disease Progression"/><FilterOption id="7569" count="57" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of Overall/Objective Response Rate (ORR)"/><FilterOption id="7547" count="55" label="Lymphoma - Assessment of Progression Free Survival (PFS)"/><FilterOption id="10830" count="55" label="Ovary tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="8163" count="52" label="Colorectal tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="12056" count="51" label="Hepatobiliary system tumor - Assessment of Response Rates (RR) - Assessment of objective/overall response rate (ORR)"/><FilterOption id="12115" count="49" label="Hepatobiliary system tumor - Assessment of Disease Progression - Assessment of time to disease progression (TTP)"/><FilterOption id="8187" count="47" label="Colorectal tumor - Assessment of Response Rates (RR) - Assessment of Objective/Overall Response Rate (ORR)"/><FilterOption id="7563" count="47" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="7908" count="45" label="Leukemia - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="7704" count="45" label="Lymphoma - Assessment of Safety and Tolerability - Assessment of dose limiting toxicity"/><FilterOption id="8430" count="43" label="Colorectal tumor - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events"/><FilterOption id="12127" count="43" label="Hepatobiliary system tumor - Assessment of Laboratory/Diagnostic Measures"/><FilterOption id="8639" count="43" label="Lung tumor - Assessment of Safety and Tolerability"/><FilterOption id="7680" count="43" label="Lymphoma - Assessment of adverse events"/><FilterOption id="15286" count="43" label="Solid tumor - Assessment of Safety and Tolerability - Assessment of serious adverse events"/><FilterOption id="8720" count="42" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"/><FilterOption id="12124" count="41" label="Hepatobiliary system tumor - Assessment of Mortality/Death Rates"/><FilterOption id="7360" count="41" label="Multiple myeloma - Assessment of Progression Free Survival (PFS)"/><FilterOption id="8670" count="40" label="Lung tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters - Assessment of maximum tolerated dose (MTD)"/><FilterOption id="1358" count="39" label="Non-insulin dependent diabetes - Assessment of Hemoglobin A1c (HbA1c) Levels"/><FilterOption id="8744" count="38" label="Breast tumor - Assessment of Disease Progression"/><FilterOption id="8996" count="38" label="Breast tumor - Assessment of Safety and Tolerability"/><FilterOption id="25874" count="37" label="Pain - Assessment of Intensity of Pain - Based on Visual analog scale[VAS]"/><FilterOption id="7049" count="37" label="Prostate tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="15309" count="37" label="Solid tumor - Assessment of Laboratory/Diagnostic Measures"/><FilterOption id="17220" count="36" label="Anemia - Hematological Assessments - Assessment of hemoglobin status"/><FilterOption id="12231" count="36" label="Hepatobiliary system tumor - Imaging/Radiological Assessments"/><FilterOption id="2" count="36" label="Hypertension - Assessment of Blood Pressure (BP) - BP control rate"/><FilterOption id="8640" count="36" label="Lung tumor - Assessment of Safety and Tolerability - Adverse events as graded by CTCAE/CTC"/><FilterOption id="10545" count="36" label="Renal cell carcinoma - Assessment of Progression Free Survival (PFS)"/><FilterOption id="2492" count="35" label="Coronary artery disease - Assessment of Cardiovascular Events - Acute/New Myocardial infarction (MI)/MI (Q-wave and non-Q wave)"/><FilterOption id="22595" count="35" label="End stage renal disease - Assessment of adverse events"/><FilterOption id="9212" count="35" label="HIV infection - Assessment of Viral Load"/><FilterOption id="7367" count="35" label="Multiple myeloma - Assessment of Response Rates (RR) - Assessment of Overall/Objective Response Rate (ORR)"/><FilterOption id="10243" count="35" label="Thrombosis - Assessment of Thrombotic/Thromboembolic Events - Assessment of venous thrombosis/thromboembolism"/><FilterOption id="8140" count="34" label="Leukemia - Protocol Specified Other Endpoints - Assessment of Clinical Efficacy"/><FilterOption id="9122" count="33" label="Breast tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"/><FilterOption id="12121" count="33" label="Hepatobiliary system tumor - Assessment of Safety and Tolerability - Assessment of dose limiting toxicity"/><FilterOption id="12117" count="33" label="Hepatobiliary system tumor - Assessment of Safety and Tolerability"/><FilterOption id="23916" count="33" label="Hypercholesterolemia - Assessment of Low-Density Lipoprotein (LDL)"/><FilterOption id="8078" count="33" label="Leukemia - Assessment of adverse events"/><FilterOption id="26827" count="33" label="Solid tumor - Imaging/Radiological Assessments - Assessment by Response Evaluation Criteria in Solid Tumors (RECIST) Criteria"/><FilterOption id="8714" count="32" label="Breast tumor - Assessment of Disease Free Survival (DFS)"/><FilterOption id="22545" count="32" label="End stage renal disease - Hematological Assessments - Assessment of hemoglobin levels"/><FilterOption id="3809" count="32" label="Hepatitis C virus infection - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events"/><FilterOption id="7879" count="32" label="Leukemia - Assessment of Overall Survival (OS)"/><FilterOption id="7045" count="32" label="Prostate tumor - Assessment of Overall Survival (OS)"/><FilterOption id="12114" count="31" label="Hepatobiliary system tumor - Assessment of Disease Progression"/><FilterOption id="8555" count="31" label="Lung tumor - Assessment of Mortality/Death Rates"/><FilterOption id="7564" count="31" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"/><FilterOption id="13771" count="31" label="Osteoporosis - Assessment of Bone - Assessment by Bone mineral density (BMD)"/><FilterOption id="26033" count="31" label="Pain - Assessment of adverse events"/><FilterOption id="2292" count="30" label="Alzheimers disease - Cognitive, Global and Functional Assessments - Alzheimer's disease assessment scale - cognition (ADAS-cog)"/><FilterOption id="23051" count="30" label="Lipid metabolism disorder - Assessment of Low-Density Lipoprotein (LDL)"/><FilterOption id="9218" count="29" label="HIV infection - Assessment of Immune Response"/><FilterOption id="7891" count="29" label="Leukemia - Assessment of Progression Free Survival (PFS)"/><FilterOption id="8090" count="29" label="Leukemia - Assessment of Safety and Tolerability - Assessment of dose limiting toxicity"/><FilterOption id="6940" count="29" label="Melanoma - Assessment of Response Rates (RR) - Assessment of overall/objective response rate"/><FilterOption id="2041" count="29" label="Multiple sclerosis - Assessment of adverse events"/><FilterOption id="37159" count="28" label="Breast tumor - Assessment of Laboratory/Diagnostic Measures"/><FilterOption id="24177" count="28" label="Stroke - Assessment of Mortality/Death Rates"/><FilterOption id="7026" count="27" label="Melanoma - Assessment of Safety and Tolerability - Assessment of toxicity profile"/><FilterOption id="3883" count="27" label="Rheumatoid arthritis - American College of Rheumatology (ACR) 20 Response"/><FilterOption id="15907" count="27" label="Ulcerative colitis - Ulcerative Colitis Assessed by Activity Indices - Assessment by Mayo clinic score (MCS)/ disease activity index (DAI)"/><FilterOption id="2619" count="26" label="Coronary artery disease - Assessment of Cardiovascular Events - Assessment of major adverse cardiac events (MACEs)"/><FilterOption id="7313" count="26" label="Head and neck tumor - Assessment of Safety and Tolerability - Assessment of dose limiting toxicity"/><FilterOption id="8641" count="26" label="Lung tumor - Assessment of Safety and Tolerability - Assessment of frequency and severity of adverse events"/><FilterOption id="2981" count="25" label="Acute coronary syndrome - Assessment of Mortality/Death Rates - Cardiovascular mortality"/><FilterOption id="2286" count="25" label="Alzheimers disease - Assessment of Adverse Events"/><FilterOption id="8997" count="25" label="Breast tumor - Assessment of Safety and Tolerability - Assessment of serious adverse events"/><FilterOption id="2515" count="25" label="Coronary artery disease - Assessment of Thrombotic/Thromboembolic Events - Fatal /Non-fatal stroke"/><FilterOption id="7312" count="25" label="Head and neck tumor - Assessment of adverse events"/></Filter><Filter label="Sponsors/Collaborators" name="trialCompanies" total="100"><FilterOption id="23137" count="523" label="Novartis AG"/><FilterOption id="19446" count="421" label="Roche Holding AG"/><FilterOption id="18767" count="370" label="Pfizer Inc"/><FilterOption id="28355" count="311" label="GlaxoSmithKline plc"/><FilterOption id="1009547" count="282" label="Sanofi SA"/><FilterOption id="17810" count="262" label="Eli Lilly &amp; Co"/><FilterOption id="15065" count="256" label="Bristol-Myers Squibb Co"/><FilterOption id="14190" count="253" label="AstraZeneca plc"/><FilterOption id="1039423" count="218" label="Hospital Clinic of Barcelona"/><FilterOption id="14455" count="201" label="Bayer AG"/><FilterOption id="26178" count="192" label="F Hoffmann-La Roche AG"/><FilterOption id="1067538" count="158" label="Janssen Research &amp; Development LLC"/><FilterOption id="14881" count="156" label="Boehringer Ingelheim International GmbH"/><FilterOption id="1144568" count="149" label="Novartis Pharma Services AG"/><FilterOption id="15331" count="131" label="Celgene Corp"/><FilterOption id="25599" count="124" label="Novartis Pharma AG"/><FilterOption id="14109" count="123" label="Amgen Inc"/><FilterOption id="1072507" count="119" label="AbbVie Inc"/><FilterOption id="1003065" count="115" label="Hospital Vall D'Hebron"/><FilterOption id="1059823" count="112" label="Merck Sharp &amp; Dohme Corp"/><FilterOption id="1091809" count="109" label="Janssen-Cilag International NV (BE)"/><FilterOption id="19453" count="105" label="Genentech Inc"/><FilterOption id="16450" count="105" label="Gilead Sciences Inc"/><FilterOption id="1013295" count="101" label="Astellas Pharma Inc"/><FilterOption id="30062" count="94" label="AstraZeneca AB"/><FilterOption id="1079783" count="81" label="FUNDACIÓ INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU"/><FilterOption id="1121088" count="81" label="Novartis Farmaceutica SA"/><FilterOption id="15133" count="74" label="Bristol-Myers Squibb International Corp"/><FilterOption id="29218" count="70" label="AbbVie Deutschland GmbH &amp; Co KG"/><FilterOption id="1003992" count="68" label="Universitat de Barcelona"/><FilterOption id="19214" count="66" label="Regeneron Pharmaceuticals Inc"/><FilterOption id="1038736" count="65" label="PETHEMA Foundation"/><FilterOption id="1039086" count="64" label="Germans Trias i Pujol Hospital"/><FilterOption id="20300" count="64" label="Takeda Pharmaceutical Co Ltd"/><FilterOption id="1017818" count="63" label="Instituto de Salud Carlos III"/><FilterOption id="1040940" count="61" label="Hospital Universitari de Bellvitge"/><FilterOption id="1003983" count="60" label="Bayer HealthCare AG"/><FilterOption id="1119200" count="60" label="Sanofi-Aventis Research and Development"/><FilterOption id="18614" count="58" label="Novo Nordisk A/S"/><FilterOption id="22546" count="53" label="Boehringer Ingelheim GmbH"/><FilterOption id="20452" count="53" label="UCB SA"/><FilterOption id="1005244" count="51" label="Biogen Inc"/><FilterOption id="1068202" count="51" label="Parc de Salut Mar"/><FilterOption id="18101" count="50" label="Merck KGaA"/><FilterOption id="13601" count="47" label="Abbott Laboratories"/><FilterOption id="15414" count="47" label="Chugai Pharmaceutical Co Ltd"/><FilterOption id="23119" count="47" label="European Organisation for Research and Treatment of Cancer (EORTC)"/><FilterOption id="19620" count="46" label="Eisai Inc"/><FilterOption id="1110770" count="46" label="Novartis Farma SpA"/><FilterOption id="22586" count="43" label="Boehringer Ingelheim Corp"/><FilterOption id="17839" count="43" label="Eli Lilly SA"/><FilterOption id="20519" count="43" label="National Cancer Institute"/><FilterOption id="17216" count="42" label="Incyte Corp"/><FilterOption id="24652" count="41" label="Shire plc"/><FilterOption id="1050515" count="41" label="ViiV Healthcare Ltd"/><FilterOption id="21991" count="40" label="Takeda Oncology"/><FilterOption id="1087775" count="37" label="Novartis Oncology"/><FilterOption id="1081359" count="36" label="Corporacion Parc Tauli"/><FilterOption id="18681" count="36" label="Ono Pharmaceutical Co Ltd"/><FilterOption id="1145220" count="35" label="GlaxoSmithKline Research &amp; Development Ltd"/><FilterOption id="18008" count="35" label="MedImmune LLC"/><FilterOption id="23780" count="34" label="Actelion Ltd"/><FilterOption id="20348" count="34" label="Teva Pharmaceutical Industries Ltd"/><FilterOption id="1020322" count="33" label="Daiichi Sankyo Inc"/><FilterOption id="25611" count="33" label="Universitat Autonoma de Barcelona"/><FilterOption id="1039087" count="32" label="Fundacio Lluita Contra La Sida"/><FilterOption id="1095980" count="32" label="NOVARTIS FARMACEUTICA, S.A. DE C.V."/><FilterOption id="1122528" count="32" label="SCS Boehringer Ingelheim Comm.V"/><FilterOption id="17332" count="31" label="Johnson &amp; Johnson"/><FilterOption id="1053612" count="30" label="Fundacion Clinic per a la Recerca Biomédica"/><FilterOption id="17259" count="30" label="Ipsen"/><FilterOption id="1003570" count="30" label="Janssen R&amp;D (Ireland)"/><FilterOption id="1042061" count="30" label="Spanish Breast Cancer Research Group"/><FilterOption id="1103352" count="29" label="Boehringer Ingelheim Espana Sa"/><FilterOption id="15121" count="29" label="Bristol-Myers Squibb Belgium SA"/><FilterOption id="27053" count="29" label="Glaxo Group Research Ltd"/><FilterOption id="16299" count="29" label="Sanofi Genzyme"/><FilterOption id="22563" count="28" label="Boehringer Ingelheim Ltd"/><FilterOption id="25902" count="27" label="Array BioPharma Inc"/><FilterOption id="1110884" count="27" label="Biogen Idec Research Ltd"/><FilterOption id="14913" count="26" label="Eisai Ltd"/><FilterOption id="19461" count="25" label="Hoffmann-La Roche Inc"/><FilterOption id="29481" count="25" label="Johnson &amp; Johnson Pharmaceutical Research &amp; Development LLC"/><FilterOption id="1004360" count="25" label="Sun Yat-Sen University"/><FilterOption id="22554" count="24" label="Boehringer Ingelheim BV"/><FilterOption id="27847" count="24" label="Boston Scientific Corp"/><FilterOption id="1055006" count="24" label="Ministry of Health, Spain"/><FilterOption id="16198" count="23" label="Forest Laboratories Inc"/><FilterOption id="19063" count="23" label="Pharmacyclics Inc"/><FilterOption id="25554" count="23" label="Seattle Genetics Inc"/><FilterOption id="1045513" count="23" label="Spanish Lung Cancer Group"/><FilterOption id="1037956" count="22" label="Astellas Pharma Global Development Inc"/><FilterOption id="1035512" count="22" label="EMD Serono Inc"/><FilterOption id="18077" count="22" label="Merck &amp; Co Inc"/><FilterOption id="22598" count="22" label="Unilfarma Lda"/><FilterOption id="28611" count="21" label="Actelion Pharmaceuticals Ltd"/><FilterOption id="24166" count="21" label="GlaxoSmithKline Biologicals"/><FilterOption id="13979" count="20" label="Alexion Pharmaceuticals Inc"/><FilterOption id="1059977" count="20" label="European Commission"/><FilterOption id="27108" count="20" label="Glaxo SA"/></Filter><Filter label="Last Changed Date By Day" name="trialDateChangeLastByDay" total="100"><FilterOption count="248" label="2019-01-24"/><FilterOption count="180" label="2019-01-25"/><FilterOption count="149" label="2019-01-26"/><FilterOption count="132" label="2018-10-15"/><FilterOption count="116" label="2018-10-14"/><FilterOption count="111" label="2018-10-13"/><FilterOption count="111" label="2019-03-07"/><FilterOption count="108" label="2018-10-12"/><FilterOption count="99" label="2019-06-27"/><FilterOption count="98" label="2019-06-28"/><FilterOption count="98" label="2019-07-03"/><FilterOption count="92" label="2019-06-20"/><FilterOption count="90" label="2019-06-07"/><FilterOption count="88" label="2019-07-01"/><FilterOption count="88" label="2019-07-02"/><FilterOption count="87" label="2019-06-26"/><FilterOption count="85" label="2019-06-14"/><FilterOption count="81" label="2019-06-21"/><FilterOption count="77" label="2019-06-25"/><FilterOption count="76" label="2019-06-12"/><FilterOption count="70" label="2019-06-06"/><FilterOption count="68" label="2019-06-17"/><FilterOption count="66" label="2019-06-19"/><FilterOption count="59" label="2013-12-02"/><FilterOption count="59" label="2019-06-13"/><FilterOption count="59" label="2019-06-18"/><FilterOption count="57" label="2018-10-16"/><FilterOption count="50" label="2019-05-31"/><FilterOption count="50" label="2019-06-10"/><FilterOption count="47" label="2018-07-07"/><FilterOption count="45" label="2019-05-17"/><FilterOption count="43" label="2018-06-09"/><FilterOption count="43" label="2019-05-24"/><FilterOption count="40" label="2019-06-11"/><FilterOption count="39" label="2019-05-23"/><FilterOption count="36" label="2019-05-22"/><FilterOption count="34" label="2018-06-23"/><FilterOption count="33" label="2019-05-27"/><FilterOption count="33" label="2019-06-03"/><FilterOption count="33" label="2019-06-04"/><FilterOption count="33" label="2019-06-24"/><FilterOption count="32" label="2019-02-07"/><FilterOption count="32" label="2019-06-22"/><FilterOption count="31" label="2019-03-20"/><FilterOption count="31" label="2019-05-15"/><FilterOption count="31" label="2019-05-30"/><FilterOption count="29" label="2019-06-05"/><FilterOption count="28" label="2019-04-05"/><FilterOption count="28" label="2019-04-17"/><FilterOption count="28" label="2019-05-10"/><FilterOption count="27" label="2018-11-16"/><FilterOption count="26" label="2018-11-27"/><FilterOption count="26" label="2018-12-12"/><FilterOption count="26" label="2019-05-07"/><FilterOption count="25" label="2018-11-22"/><FilterOption count="25" label="2018-12-05"/><FilterOption count="25" label="2018-12-14"/><FilterOption count="25" label="2019-04-11"/><FilterOption count="24" label="2018-04-28"/><FilterOption count="24" label="2018-06-30"/><FilterOption count="24" label="2019-02-04"/><FilterOption count="24" label="2019-03-21"/><FilterOption count="24" label="2019-04-15"/><FilterOption count="24" label="2019-05-13"/><FilterOption count="24" label="2019-05-21"/><FilterOption count="23" label="2018-05-26"/><FilterOption count="23" label="2018-07-14"/><FilterOption count="23" label="2018-11-28"/><FilterOption count="23" label="2018-12-06"/><FilterOption count="23" label="2019-06-08"/><FilterOption count="22" label="2018-11-13"/><FilterOption count="22" label="2018-11-17"/><FilterOption count="22" label="2018-11-29"/><FilterOption count="22" label="2019-02-21"/><FilterOption count="22" label="2019-04-22"/><FilterOption count="22" label="2019-04-23"/><FilterOption count="22" label="2019-05-02"/><FilterOption count="22" label="2019-06-29"/><FilterOption count="21" label="2018-05-19"/><FilterOption count="21" label="2018-12-18"/><FilterOption count="21" label="2018-12-20"/><FilterOption count="21" label="2019-03-29"/><FilterOption count="21" label="2019-05-14"/><FilterOption count="20" label="2018-11-20"/><FilterOption count="20" label="2018-12-10"/><FilterOption count="20" label="2018-12-13"/><FilterOption count="20" label="2019-04-25"/><FilterOption count="19" label="2017-08-10"/><FilterOption count="19" label="2018-01-23"/><FilterOption count="19" label="2018-11-23"/><FilterOption count="19" label="2019-02-20"/><FilterOption count="19" label="2019-05-09"/><FilterOption count="19" label="2019-06-15"/><FilterOption count="18" label="2018-01-24"/><FilterOption count="18" label="2018-05-29"/><FilterOption count="18" label="2018-12-11"/><FilterOption count="18" label="2019-03-01"/><FilterOption count="18" label="2019-04-24"/><FilterOption count="18" label="2019-05-16"/><FilterOption count="17" label="2019-02-22"/></Filter><Filter label="Trial Date End By Month" name="trialDateEndByMonth" total="100"><FilterOption count="179" label="201912"/><FilterOption count="103" label="202012"/><FilterOption count="78" label="201812"/><FilterOption count="78" label="202112"/><FilterOption count="75" label="202003"/><FilterOption count="74" label="201906"/><FilterOption count="70" label="201612"/><FilterOption count="70" label="202006"/><FilterOption count="69" label="201909"/><FilterOption count="68" label="201806"/><FilterOption count="66" label="201512"/><FilterOption count="60" label="201910"/><FilterOption count="58" label="201712"/><FilterOption count="53" label="201803"/><FilterOption count="53" label="202001"/><FilterOption count="51" label="201412"/><FilterOption count="50" label="201112"/><FilterOption count="50" label="201905"/><FilterOption count="50" label="201911"/><FilterOption count="50" label="202009"/><FilterOption count="49" label="201706"/><FilterOption count="49" label="201907"/><FilterOption count="49" label="202007"/><FilterOption count="49" label="202106"/><FilterOption count="48" label="202005"/><FilterOption count="47" label="201503"/><FilterOption count="47" label="201810"/><FilterOption count="46" label="201701"/><FilterOption count="46" label="201710"/><FilterOption count="46" label="201801"/><FilterOption count="46" label="201811"/><FilterOption count="46" label="201903"/><FilterOption count="46" label="202002"/><FilterOption count="45" label="201705"/><FilterOption count="45" label="201709"/><FilterOption count="45" label="201805"/><FilterOption count="45" label="201908"/><FilterOption count="45" label="202008"/><FilterOption count="44" label="201707"/><FilterOption count="44" label="201809"/><FilterOption count="44" label="201901"/><FilterOption count="44" label="202010"/><FilterOption count="43" label="202004"/><FilterOption count="43" label="202103"/><FilterOption count="42" label="201310"/><FilterOption count="42" label="201604"/><FilterOption count="42" label="201605"/><FilterOption count="42" label="201902"/><FilterOption count="42" label="202101"/><FilterOption count="42" label="202104"/><FilterOption count="41" label="201409"/><FilterOption count="41" label="201603"/><FilterOption count="41" label="202011"/><FilterOption count="40" label="201212"/><FilterOption count="40" label="201312"/><FilterOption count="40" label="201401"/><FilterOption count="40" label="201504"/><FilterOption count="40" label="201708"/><FilterOption count="40" label="201904"/><FilterOption count="39" label="201506"/><FilterOption count="39" label="201704"/><FilterOption count="38" label="201209"/><FilterOption count="38" label="201305"/><FilterOption count="38" label="201306"/><FilterOption count="38" label="201601"/><FilterOption count="38" label="201611"/><FilterOption count="37" label="201304"/><FilterOption count="37" label="201404"/><FilterOption count="37" label="201607"/><FilterOption count="37" label="201609"/><FilterOption count="37" label="201711"/><FilterOption count="37" label="202102"/><FilterOption count="36" label="201307"/><FilterOption count="36" label="201402"/><FilterOption count="36" label="201406"/><FilterOption count="36" label="201507"/><FilterOption count="36" label="201511"/><FilterOption count="36" label="201804"/><FilterOption count="36" label="201807"/><FilterOption count="36" label="202212"/><FilterOption count="35" label="201205"/><FilterOption count="35" label="201210"/><FilterOption count="35" label="201302"/><FilterOption count="35" label="201407"/><FilterOption count="35" label="201501"/><FilterOption count="35" label="201508"/><FilterOption count="35" label="201606"/><FilterOption count="35" label="202107"/><FilterOption count="35" label="202109"/><FilterOption count="34" label="202105"/><FilterOption count="34" label="202108"/><FilterOption count="33" label="201303"/><FilterOption count="33" label="201405"/><FilterOption count="33" label="201702"/><FilterOption count="33" label="201808"/><FilterOption count="32" label="201012"/><FilterOption count="32" label="201106"/><FilterOption count="32" label="201203"/><FilterOption count="32" label="201206"/><FilterOption count="32" label="201410"/></Filter><Filter label="Trial Date Start By Month" name="trialDateStartByMonth" total="100"><FilterOption count="73" label="201706"/><FilterOption count="70" label="201506"/><FilterOption count="70" label="201703"/><FilterOption count="68" label="201806"/><FilterOption count="65" label="201509"/><FilterOption count="65" label="201711"/><FilterOption count="64" label="201610"/><FilterOption count="63" label="201210"/><FilterOption count="63" label="201410"/><FilterOption count="63" label="201701"/><FilterOption count="63" label="201805"/><FilterOption count="62" label="201512"/><FilterOption count="62" label="201606"/><FilterOption count="62" label="201611"/><FilterOption count="62" label="201712"/><FilterOption count="61" label="201804"/><FilterOption count="60" label="201401"/><FilterOption count="60" label="201511"/><FilterOption count="59" label="201501"/><FilterOption count="59" label="201810"/><FilterOption count="58" label="201812"/><FilterOption count="57" label="201309"/><FilterOption count="57" label="201707"/><FilterOption count="56" label="201705"/><FilterOption count="55" label="201507"/><FilterOption count="55" label="201612"/><FilterOption count="54" label="201310"/><FilterOption count="54" label="201312"/><FilterOption count="53" label="201103"/><FilterOption count="53" label="201201"/><FilterOption count="53" label="201412"/><FilterOption count="53" label="201609"/><FilterOption count="52" label="201212"/><FilterOption count="52" label="201510"/><FilterOption count="51" label="201407"/><FilterOption count="51" label="201411"/><FilterOption count="50" label="201303"/><FilterOption count="50" label="201304"/><FilterOption count="50" label="201403"/><FilterOption count="50" label="201604"/><FilterOption count="50" label="201802"/><FilterOption count="49" label="201301"/><FilterOption count="49" label="201605"/><FilterOption count="49" label="201704"/><FilterOption count="48" label="201111"/><FilterOption count="48" label="201204"/><FilterOption count="48" label="201306"/><FilterOption count="48" label="201311"/><FilterOption count="48" label="201503"/><FilterOption count="48" label="201603"/><FilterOption count="48" label="201801"/><FilterOption count="47" label="200812"/><FilterOption count="47" label="201106"/><FilterOption count="47" label="201112"/><FilterOption count="47" label="201203"/><FilterOption count="47" label="201207"/><FilterOption count="47" label="201504"/><FilterOption count="47" label="201803"/><FilterOption count="46" label="201811"/><FilterOption count="46" label="201904"/><FilterOption count="45" label="201012"/><FilterOption count="45" label="201110"/><FilterOption count="45" label="201202"/><FilterOption count="45" label="201601"/><FilterOption count="45" label="201607"/><FilterOption count="45" label="201906"/><FilterOption count="44" label="200912"/><FilterOption count="44" label="201406"/><FilterOption count="44" label="201602"/><FilterOption count="44" label="201902"/><FilterOption count="43" label="201109"/><FilterOption count="43" label="201205"/><FilterOption count="43" label="201211"/><FilterOption count="43" label="201702"/><FilterOption count="43" label="201808"/><FilterOption count="42" label="201001"/><FilterOption count="42" label="201006"/><FilterOption count="42" label="201009"/><FilterOption count="42" label="201105"/><FilterOption count="42" label="201107"/><FilterOption count="42" label="201305"/><FilterOption count="42" label="201709"/><FilterOption count="42" label="201903"/><FilterOption count="41" label="200804"/><FilterOption count="41" label="200903"/><FilterOption count="41" label="201010"/><FilterOption count="41" label="201102"/><FilterOption count="41" label="201905"/><FilterOption count="40" label="200904"/><FilterOption count="40" label="200909"/><FilterOption count="40" label="201005"/><FilterOption count="40" label="201206"/><FilterOption count="40" label="201402"/><FilterOption count="40" label="201807"/><FilterOption count="39" label="200711"/><FilterOption count="39" label="201104"/><FilterOption count="39" label="201505"/><FilterOption count="39" label="201710"/><FilterOption count="38" label="200710"/><FilterOption count="38" label="201007"/></Filter><Filter label="Trial Phase" name="trialPhase" total="15"><FilterOption id="C3" count="2735" label="Phase 3 Clinical"/><FilterOption id="C2" count="1671" label="Phase 2 Clinical"/><FilterOption id="C4" count="843" label="Phase 4 Clinical"/><FilterOption id="PNA" count="620" label="Phase Not Applicable"/><FilterOption id="C1" count="393" label="Phase 1 Clinical"/><FilterOption id="C12" count="387" label="Phase 1/Phase 2 Clinical"/><FilterOption id="NS" count="325" label="Phase not specified"/><FilterOption id="C3B" count="225" label="Phase 3b Clinical"/><FilterOption id="C2B" count="192" label="Phase 2b Clinical"/><FilterOption id="C23" count="174" label="Phase 2/Phase 3 Clinical"/><FilterOption id="C1B" count="135" label="Phase 1b Clinical"/><FilterOption id="C2A" count="110" label="Phase 2a Clinical"/><FilterOption id="C3A" count="20" label="Phase 3a Clinical"/><FilterOption id="C0" count="16" label="Phase 0 Clinical"/><FilterOption id="C1A" count="8" label="Phase 1a Clinical"/></Filter><Filter label="Inclusion Criteria Index" name="trialInclusionCriteriaIndex" total="100"><FilterOption id="3976" count="338" label="Lung tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"/><FilterOption id="3977" count="337" label="Lung tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"/><FilterOption id="7864" count="312" label="Hepatobiliary system tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"/><FilterOption id="3900" count="312" label="Lung tumor - Subjects with Non Small Cell Lung Cancer (NSCLC)"/><FilterOption id="4840" count="304" label="Breast tumor - Subjects with Advanced/Metastatic Cancer"/><FilterOption id="3957" count="302" label="Lung tumor - Subjects Confirmed of Lung Cancer by Specific Modes - Subjects with cytologically/histologically confirmed diagnosis of lung cancer"/><FilterOption id="7865" count="300" label="Hepatobiliary system tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"/><FilterOption id="13159" count="280" label="Hepatobiliary system tumor - Liver Cancer Subjects with Specific Child-Pugh Score - Subjects with Child-Pugh class A liver function"/><FilterOption id="4880" count="279" label="Breast tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"/><FilterOption id="4879" count="278" label="Breast tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"/><FilterOption id="3936" count="276" label="Lung tumor - Subjects with Protocol Specified Stages of Lung Cancer(TNM staging) - Subjects with stage IV lung cancer"/><FilterOption id="32046" count="258" label="Hepatobiliary system tumor - Subjects with specific disease - Subjects with hepatocellular carcinoma"/><FilterOption id="13398" count="252" label="Hepatobiliary system tumor - Liver Cancer Subjects with Specific Barcelona Clinic Liver Cancer (BCLC) Staging - Subjects with BCLC stage B HCC"/><FilterOption id="7883" count="251" label="Hepatobiliary system tumor - Subjects with Normal/Acceptable Organ Function - Subjects with normal/acceptable hematological functions"/><FilterOption id="3940" count="243" label="Lung tumor - Subjects with Advanced/Metastatic Cancer"/><FilterOption id="584" count="243" label="Non-insulin dependent diabetes - Subjects with Diabetes Mellitus - Subjects with type 2 diabetes mellitus"/><FilterOption id="7884" count="231" label="Hepatobiliary system tumor - Subjects with Normal/Acceptable Organ Function - Subjects with normal/acceptable liver function"/><FilterOption id="13096" count="223" label="Solid tumor - Subjects with Advanced/Metastatic Cancer"/><FilterOption id="3938" count="215" label="Lung tumor - Subjects with Protocol Specified Stages of Lung Cancer(TNM staging) - Subjects with advanced stage lung cancer"/><FilterOption id="13399" count="211" label="Hepatobiliary system tumor - Liver Cancer Subjects with Specific Barcelona Clinic Liver Cancer (BCLC) Staging - Subjects with BCLC stage C HCC"/><FilterOption id="7891" count="209" label="Hepatobiliary system tumor - Subjects with Protocol Specified Participation Status - Subjects willing/able to provide informed consent/assent"/><FilterOption id="7830" count="207" label="Hepatobiliary system tumor - Subjects with Advanced/Metastatic Cancer"/><FilterOption id="7885" count="205" label="Hepatobiliary system tumor - Subjects with Protocol Specified Renal Function - Subjects with normal/acceptable renal function"/><FilterOption id="5418" count="203" label="HIV infection - Subjects with HIV Infection - Subjects with HIV-1 infection"/><FilterOption id="3914" count="201" label="Lung tumor - Subjects with Measurable Disease - Subjects with measurable disease as per RECIST criteria"/><FilterOption id="7850" count="190" label="Hepatobiliary system tumor - Subjects with Unresectable Hepato-biliary Cancer"/><FilterOption id="4483" count="189" label="Colorectal tumor - Subjects with Advanced/Metastatic Cancer"/><FilterOption id="5317" count="179" label="HIV infection - Subjects with Protocol Specified HIV Viral Load"/><FilterOption id="13129" count="176" label="Solid tumor - Subjects with Treatment Refractory Disease"/><FilterOption id="13160" count="175" label="Hepatobiliary system tumor - Liver Cancer Subjects with Specific Child-Pugh Score - Subjects with Child-Pugh class B liver function"/><FilterOption id="3537" count="173" label="Lymphoma - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"/><FilterOption id="3538" count="173" label="Lymphoma - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"/><FilterOption id="7859" count="171" label="Hepatobiliary system tumor - Subjects with Protocol Specified Life Expectancy - Subjects with life expectancy of three months or more"/><FilterOption id="13111" count="168" label="Solid tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"/><FilterOption id="13110" count="167" label="Solid tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"/><FilterOption id="4528" count="166" label="Colorectal tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"/><FilterOption id="4527" count="165" label="Colorectal tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"/><FilterOption id="4032" count="162" label="Lung tumor - Subjects with Protocol Specified Renal Function - Subjects with normal/acceptable renal function"/><FilterOption id="22417" count="160" label="Breast tumor - Subjects with Locally Advanced Cancer/Tumor"/><FilterOption id="4024" count="159" label="Lung tumor - Subjects with Normal/Acceptable Organ Function - Subjects with normal/acceptable liver function"/><FilterOption id="4074" count="158" label="Lung tumor - Subjects with Protocol Specified Compliance Status - Subjects able to comply with the study protocol procedures/ requirements"/><FilterOption id="4814" count="155" label="Breast tumor - Subjects with HER-2 Negative Breast Cancer"/><FilterOption id="22381" count="151" label="Lung tumor - Protocol Specified Other Inclusion Criteria - Protocol specified inclusion criteria for females"/><FilterOption id="901" count="151" label="Non-insulin dependent diabetes - Subjects with specific level of glycemic control - Subjects with Moderate Glycemic Control"/><FilterOption id="1751" count="150" label="Hepatitis C virus infection - Subjects with Chronic Hepatitis C Infection"/><FilterOption id="3935" count="143" label="Lung tumor - Subjects with Protocol Specified Stages of Lung Cancer(TNM staging) - Subjects with stage IIIB lung cancer"/><FilterOption id="4922" count="139" label="Breast tumor - Subjects with Progressive/Treatment Refractory Disease"/><FilterOption id="607" count="137" label="Non-insulin dependent diabetes - Subjects with specific level of glycemic control - Subjects with Poor/Inadequate Glycemic Control"/><FilterOption id="4857" count="132" label="Breast tumor - Subjects with Measurable Disease - Subjects with measurable disease as per RECIST criteria"/><FilterOption id="3933" count="132" label="Lung tumor - Subjects with Protocol Specified Stages of Lung Cancer(TNM staging) - Subjects with stage III lung cancer"/><FilterOption id="4073" count="130" label="Lung tumor - Protocol Specified Other Inclusion Criteria"/><FilterOption id="7091" count="129" label="Prostate tumor - Subjects with Advanced/Metastatic Cancer"/><FilterOption id="4894" count="127" label="Breast tumor - Subjects with History of Anti Cancer Therapy - Subjects with history of anti-cancer chemotherapy"/><FilterOption id="7853" count="127" label="Hepatobiliary system tumor - Subjects with Measurable Disease - Subjects with disease measurable by imaging techniques"/><FilterOption id="3539" count="127" label="Lymphoma - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 2"/><FilterOption id="3989" count="126" label="Lung tumor - Subjects with History of Anti Cancer Therapy - Subjects with history of anti-cancer chemotherapy"/><FilterOption id="4509" count="125" label="Colorectal tumor - Subjects with Histologically Confirmed Colorectal Cancer"/><FilterOption id="4813" count="123" label="Breast tumor - Subjects with HER-2 Positive Breast Cancer"/><FilterOption id="7881" count="120" label="Hepatobiliary system tumor - Subjects with Progressive/Treatment Refractory Disease"/><FilterOption id="5086" count="120" label="Leukemia - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"/><FilterOption id="3971" count="120" label="Lung tumor - Subjects with Protocol Specified Life Expectancy - Subjects with life expectancy of three months or more"/><FilterOption id="4569" count="119" label="Colorectal tumor - Subjects with Normal/Acceptable Organ Function - Subjects with normal/acceptable hematopoetic/marrow function"/><FilterOption id="7851" count="118" label="Hepatobiliary system tumor - Subjects with Measurable Disease"/><FilterOption id="5087" count="118" label="Leukemia - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"/><FilterOption id="3548" count="117" label="Lymphoma - Subjects Diagnosed Based on Histo-Pathological Examination"/><FilterOption id="4106" count="114" label="Lung tumor - Subjects with Protocol Specified Reproductive Status - Men with adequate contraception"/><FilterOption id="7893" count="113" label="Hepatobiliary system tumor - Subjects with Protocol Specified Compliance Status - Subjects able to comply with the study protocol procedures/ requirements"/><FilterOption id="7866" count="113" label="Hepatobiliary system tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 2"/><FilterOption id="4923" count="105" label="Breast tumor - Subjects with Relapsed/Recurrent Disease"/><FilterOption id="4467" count="105" label="Colorectal tumor - Subjects with Rectal Cancer"/><FilterOption id="4808" count="104" label="Breast tumor - Subjects with Hormone Receptor Positive Breast Cancer - Estrogen receptor positive (ER+) breast cancer"/><FilterOption id="4565" count="103" label="Colorectal tumor - Subjects with Protocol Specified Renal Function - Subjects with normal/acceptable renal function"/><FilterOption id="4817" count="102" label="Breast tumor - Postmenopausal Breast Cancer Women"/><FilterOption id="4877" count="102" label="Breast tumor - Subjects with Protocol Specified Life Expectancy"/><FilterOption id="3987" count="102" label="Lung tumor - Treatment Naive Subjects"/><FilterOption id="3997" count="101" label="Lung tumor - Subjects with Treatment Resistant Disease"/><FilterOption id="4468" count="100" label="Colorectal tumor - Subjects with Colon Cancer"/><FilterOption id="4564" count="100" label="Colorectal tumor - Subjects with Normal/Acceptable Organ Function - Subjects with normal/acceptable liver function"/><FilterOption id="4558" count="100" label="Colorectal tumor - Subjects with Treatment Resistant Disease"/><FilterOption id="5088" count="100" label="Leukemia - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 2"/><FilterOption id="3614" count="100" label="Lymphoma - Subjects with Progressive/Treatment Refractory Disease"/><FilterOption id="6663" count="97" label="Hepatitis C virus infection - Subjects Infected with HCV Genotype 1"/><FilterOption id="4041" count="96" label="Lung tumor - Subjects with Normal/Acceptable Organ Function - Subjects with normal/acceptable hematological functions"/><FilterOption id="3978" count="95" label="Lung tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 2"/><FilterOption id="3642" count="95" label="Lymphoma - Subjects with Normal/Acceptable Organ Function - Subjects with normal/acceptable hematological functions"/><FilterOption id="606" count="95" label="Non-insulin dependent diabetes - Subjects with specific level of glycemic control - Subjects with Good Glycemic Control"/><FilterOption id="3695" count="94" label="Prostate tumor - Subjects with Stage IV Prostate Cancer"/><FilterOption id="4856" count="93" label="Breast tumor - Subjects with Measurable Disease"/><FilterOption id="22262" count="93" label="Pain - Protocol Specified Other Inclusion Criteria"/><FilterOption id="13397" count="92" label="Hepatobiliary system tumor - Liver Cancer Subjects with Specific Barcelona Clinic Liver Cancer (BCLC) Staging - Subjects with BCLC stage A HCC"/><FilterOption id="32043" count="91" label="Lung tumor - Subjects with Protocol Specified Participation Status - Subjects able/willing to provide written informed consent"/><FilterOption id="4815" count="90" label="Breast tumor - Subjects with Triple Negative Breast Cancer"/><FilterOption id="4169" count="90" label="Melanoma - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"/><FilterOption id="4170" count="90" label="Melanoma - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"/><FilterOption id="792" count="90" label="Multiple sclerosis - Subjects with Relapsing Remitting Multiple Sclerosis (RRMS)"/><FilterOption id="4397" count="88" label="Head and neck tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"/><FilterOption id="13131" count="88" label="Solid tumor - Subjects with Normal/Acceptable Organ Function - Subjects with normal/acceptable hematological functions"/><FilterOption id="4398" count="87" label="Head and neck tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"/><FilterOption id="7908" count="87" label="Hepatobiliary system tumor - Subjects with Protocol Specified Laboratory Values"/><FilterOption id="4691" count="87" label="Multiple myeloma - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"/></Filter><Filter label="Trial Interventions Control Alone Name Display" name="trialInterventionsControlAloneNameDisplay" total="100"><FilterOption id="2953" count="47" label="docetaxel"/><FilterOption id="3803" count="34" label="paclitaxel"/><FilterOption id="29831" count="29" label="sorafenib"/><FilterOption id="3199" count="27" label="gemcitabine"/><FilterOption id="13928" count="24" label="enoxaparin sodium"/><FilterOption id="12205" count="21" label="capecitabine"/><FilterOption id="3313" count="19" label="fulvestrant"/><FilterOption id="7413" count="18" label="darbepoetin alfa"/><FilterOption id="44375" count="18" label="warfarin"/><FilterOption id="11961" count="17" label="erlotinib"/><FilterOption id="70667" count="15" label="pembrolizumab"/><FilterOption id="37370" count="14" label="azacitidine"/><FilterOption id="14163" count="13" label="adalimumab"/><FilterOption id="6736" count="13" label="rituximab"/><FilterOption id="4529" count="13" label="temozolomide"/><FilterOption id="8165" count="13" label="tiotropium bromide"/><FilterOption id="4577" count="13" label="topotecan"/><FilterOption id="44401" count="13" label="vancomycin"/><FilterOption id="11460" count="12" label="imatinib"/><FilterOption id="10252" count="12" label="insulin glargine"/><FilterOption id="2784" count="12" label="letrozole"/><FilterOption id="6050" count="12" label="metformin hydrochloride"/><FilterOption id="12973" count="11" label="sunitinib"/><FilterOption id="6408" count="11" label="vinorelbine"/><FilterOption id="2807" count="10" label="atorvastatin"/><FilterOption id="7934" count="9" label="doxorubicin (liposomal, STEALTH), Alza"/><FilterOption id="4567" count="9" label="etanercept"/><FilterOption id="3360" count="9" label="interferon beta-1a, Biogen"/><FilterOption id="22395" count="9" label="ranibizumab"/><FilterOption id="14493" count="9" label="tenofovir disoproxil fumarate"/><FilterOption id="14336" count="8" label="fluticasone propionate + salmeterol (asthma and COPD), GlaxoSmithKline"/><FilterOption id="3616" count="8" label="meropenem"/><FilterOption id="3536" count="8" label="pemetrexed disodium"/><FilterOption id="4510" count="8" label="tacrolimus"/><FilterOption id="53547" count="7" label="aflibercept (intravitreal, wet AMD, macular edema, diabetic retinopathy), Regeneron/Bayer"/><FilterOption id="3321" count="7" label="anastrozole"/><FilterOption id="3081" count="7" label="exemestane"/><FilterOption id="2871" count="7" label="irinotecan"/><FilterOption id="54804" count="7" label="nivolumab"/><FilterOption id="44312" count="7" label="salmeterol"/><FilterOption id="13239" count="6" label="decitabine"/><FilterOption id="53981" count="6" label="enzalutamide"/><FilterOption id="28773" count="6" label="eribulin mesylate"/><FilterOption id="13340" count="6" label="everolimus"/><FilterOption id="6140" count="6" label="formoterol"/><FilterOption id="3738" count="6" label="olanzapine"/><FilterOption id="12420" count="6" label="rosuvastatin"/><FilterOption id="72699" count="5" label="atezolizumab"/><FilterOption id="10388" count="5" label="cetuximab"/><FilterOption id="5999" count="5" label="ciclosporin, Novartis"/><FilterOption id="67892" count="5" label="epoetin alfa (Procrit/Eprex), Johnson &amp; Johnson"/><FilterOption id="3159" count="5" label="fluticasone propionate"/><FilterOption id="5267" count="5" label="leuprorelin acetate"/><FilterOption id="11036" count="5" label="linezolid"/><FilterOption id="12978" count="5" label="moxifloxacin"/><FilterOption id="13460" count="5" label="oseltamivir"/><FilterOption id="23625" count="5" label="peginterferon alfa-2a"/><FilterOption id="54624" count="5" label="regorafenib"/><FilterOption id="8713" count="5" label="sildenafil citrate"/><FilterOption id="44499" count="5" label="sitagliptin"/><FilterOption id="50038" count="5" label="tenofovir disoproxil fumarate + emtricitabine + efavirenz, Gilead/BMS/Merck &amp; Co"/><FilterOption id="10488" count="5" label="tolterodine"/><FilterOption id="42858" count="5" label="ustekinumab"/><FilterOption id="2773" count="5" label="valsartan"/><FilterOption id="6747" count="4" label="adefovir dipivoxil"/><FilterOption id="8047" count="4" label="bevacizumab"/><FilterOption id="44697" count="4" label="carbamazepine (extended-release), Novartis"/><FilterOption id="12135" count="4" label="celecoxib"/><FilterOption id="2836" count="4" label="clopidogrel"/><FilterOption id="55798" count="4" label="crizotinib"/><FilterOption id="53200" count="4" label="daratumumab"/><FilterOption id="2992" count="4" label="donepezil hydrochloride"/><FilterOption id="58762" count="4" label="empagliflozin"/><FilterOption id="44289" count="4" label="enalapril"/><FilterOption id="11367" count="4" label="ezetimibe"/><FilterOption id="17558" count="4" label="fluoxetine hydrochloride"/><FilterOption id="8710" count="4" label="glatiramer acetate"/><FilterOption id="32355" count="4" label="indacaterol"/><FilterOption id="6850" count="4" label="infliximab"/><FilterOption id="10411" count="4" label="insulin aspart"/><FilterOption id="36630" count="4" label="ipilimumab"/><FilterOption id="14681" count="4" label="lopinavir + ritonavir"/><FilterOption id="3735" count="4" label="octreotide acetate (long-acting formulation), Novartis"/><FilterOption id="43738" count="4" label="pazopanib"/><FilterOption id="9702" count="4" label="recombinant interferon beta-1a, Merck Serono"/><FilterOption id="44313" count="4" label="simvastatin"/><FilterOption id="49219" count="4" label="tenofovir disoproxil fumarate + emtricitabine (fixed dose), Gilead Sciences"/><FilterOption id="6242" count="3" label="abacavir"/><FilterOption id="2509" count="3" label="anagrelide"/><FilterOption id="7781" count="3" label="aripiprazole"/><FilterOption id="3311" count="3" label="bicalutamide"/><FilterOption id="44388" count="3" label="carbidopa + levodopa"/><FilterOption id="44383" count="3" label="carboplatin"/><FilterOption id="6955" count="3" label="cidofovir"/><FilterOption id="10172" count="3" label="efavirenz"/><FilterOption id="4728" count="3" label="emtricitabine"/><FilterOption id="7607" count="3" label="follitropin alfa"/><FilterOption id="11603" count="3" label="gefitinib"/><FilterOption id="8832" count="3" label="glimepiride"/><FilterOption id="55237" count="3" label="ibrutinib"/></Filter><Filter label="Trial Actions Primary Interventions Control" name="trialActionsPrimaryInterventionsControl" total="100"><FilterOption id="372" count="102" label="Thymidylate synthase inhibitor"/><FilterOption id="3808" count="74" label="Kit tyrosine kinase inhibitor"/><FilterOption id="3848" count="72" label="VEGF-2 receptor antagonist"/><FilterOption id="3846" count="70" label="VEGF-1 receptor antagonist"/><FilterOption id="3850" count="61" label="VEGF-3 receptor antagonist"/><FilterOption id="5085" count="60" label="B-lymphocyte antigen CD20 inhibitor"/><FilterOption id="1016" count="58" label="HIV-1 reverse transcriptase inhibitor"/><FilterOption id="1832" count="58" label="Nucleoside reverse transcriptase inhibitor"/><FilterOption id="48492" count="56" label="PDGF receptor beta antagonist"/><FilterOption id="142" count="55" label="Topoisomerase II inhibitor"/><FilterOption id="3816" count="52" label="RET tyrosine kinase receptor family inhibitor"/><FilterOption id="740" count="51" label="Epidermal growth factor receptor antagonist"/><FilterOption id="948" count="51" label="PDGF receptor antagonist"/><FilterOption id="138" count="50" label="DNA polymerase inhibitor"/><FilterOption id="374" count="50" label="Transferase inhibitor"/><FilterOption id="135" count="49" label="DHFR inhibitor"/><FilterOption id="3806" count="49" label="Flt3 tyrosine kinase inhibitor"/><FilterOption id="181" count="47" label="GAR transformylase inhibitor"/><FilterOption id="1722" count="45" label="VEGF receptor antagonist"/><FilterOption id="8805" count="44" label="AMP activated protein kinase stimulator"/><FilterOption id="4548" count="43" label="Raf B protein kinase inhibitor"/><FilterOption id="23014" count="42" label="Insulin ligand"/><FilterOption id="400" count="42" label="Insulin receptor agonist"/><FilterOption id="40" count="41" label="Beta 2 adrenoceptor agonist"/><FilterOption id="3756" count="40" label="Erbb2 tyrosine kinase receptor inhibitor"/><FilterOption id="204" count="40" label="HIV protease inhibitor"/><FilterOption id="12521" count="39" label="VEGF ligand inhibitor"/><FilterOption id="4550" count="38" label="Raf 1 protein kinase inhibitor"/><FilterOption id="141" count="38" label="Topoisomerase I inhibitor"/><FilterOption id="721" count="36" label="TNF binding agent"/><FilterOption id="768" count="35" label="HIV-1 protease inhibitor"/><FilterOption id="76" count="34" label="Aromatase inhibitor"/><FilterOption id="4542" count="34" label="Raf protein kinase inhibitor"/><FilterOption id="1741" count="31" label="Low molecular weight heparin"/><FilterOption id="4010" count="29" label="Calcineurin inhibitor"/><FilterOption id="7424" count="29" label="Cytochrome P450 3A4 inhibitor"/><FilterOption id="262" count="29" label="Muscarinic M3 receptor antagonist"/><FilterOption id="67136" count="29" label="Programmed cell death protein 1 inhibitor"/><FilterOption id="629" count="28" label="Inosine monophosphate dehydrogenase inhibitor"/><FilterOption id="381" count="28" label="TNF alpha ligand inhibitor"/><FilterOption id="111" count="27" label="Factor IIa antagonist"/><FilterOption id="286" count="26" label="Estrogen receptor antagonist"/><FilterOption id="113" count="26" label="Factor IX antagonist"/><FilterOption id="114" count="26" label="Factor VII antagonist"/><FilterOption id="119" count="26" label="Factor X antagonist"/><FilterOption id="10583" count="26" label="Vitamin K epoxide reductase inhibitor"/><FilterOption id="214" count="24" label="Interferon alpha 2 ligand"/><FilterOption id="48489" count="23" label="PDGF receptor alpha antagonist"/><FilterOption id="3754" count="22" label="EGFR family tyrosine kinase receptor inhibitor"/><FilterOption id="12162" count="22" label="Erythropoietin ligand"/><FilterOption id="4917" count="22" label="Proteasome inhibitor"/><FilterOption id="259" count="21" label="Muscarinic receptor antagonist"/><FilterOption id="1833" count="21" label="Non-nucleoside reverse transcriptase inhibitor"/><FilterOption id="11778" count="21" label="PurH purine biosynthesis protein inhibitor"/><FilterOption id="261" count="20" label="Muscarinic M1 receptor antagonist"/><FilterOption id="57003" count="20" label="Peptidoglycan recognition protein inhibitor"/><FilterOption id="6512" count="19" label="DNA methyltransferase inhibitor"/><FilterOption id="205" count="19" label="HMG CoA reductase inhibitor"/><FilterOption id="76469" count="18" label="26S proteasome complex inhibitor"/><FilterOption id="82444" count="17" label="DNA helicase inhibitor"/><FilterOption id="71851" count="17" label="HIV GAG POL polyprotein inhibitor"/><FilterOption id="12395" count="17" label="HIV GAG protein inhibitor"/><FilterOption id="7588" count="17" label="HIV-1 integrase inhibitor"/><FilterOption id="10240" count="17" label="mTOR inhibitor"/><FilterOption id="4913" count="17" label="P2Y12 purinoceptor antagonist"/><FilterOption id="3524" count="16" label="Abl tyrosine kinase inhibitor"/><FilterOption id="431" count="16" label="DNA gyrase inhibitor"/><FilterOption id="13571" count="15" label="Bcr protein inhibitor"/><FilterOption id="481" count="15" label="Interferon beta ligand"/><FilterOption id="66340" count="15" label="Penicillin binding protein inhibitor"/><FilterOption id="3154" count="14" label="CSF-1 antagonist"/><FilterOption id="2506" count="14" label="PARP modulator"/><FilterOption id="7025" count="14" label="Signal transduction inhibitor"/><FilterOption id="814" count="14" label="Tubulin modulator"/><FilterOption id="2585" count="13" label="Glucagon-like peptide 1 receptor agonist"/><FilterOption id="9320" count="13" label="Topoisomerase IV inhibitor"/><FilterOption id="64" count="12" label="Angiotensin II receptor antagonist"/><FilterOption id="76090" count="12" label="mTOR complex 1 inhibitor"/><FilterOption id="60" count="11" label="Androgen receptor antagonist"/><FilterOption id="7472" count="11" label="Cytochrome P450 17 inhibitor"/><FilterOption id="5537" count="11" label="Dipeptidyl peptidase IV inhibitor"/><FilterOption id="150" count="11" label="Dopamine D2 receptor antagonist"/><FilterOption id="3682" count="11" label="FGF1 receptor antagonist"/><FilterOption id="3688" count="11" label="FGF3 receptor antagonist"/><FilterOption id="511" count="11" label="TNF antagonist"/><FilterOption id="8222" count="11" label="Type II TNF receptor modulator"/><FilterOption id="13" count="10" label="5-HT 2 receptor antagonist"/><FilterOption id="18" count="10" label="ACE inhibitor"/><FilterOption id="7418" count="10" label="Cytochrome P450 3 inhibitor"/><FilterOption id="1092" count="10" label="GNRH receptor agonist"/><FilterOption id="14007" count="10" label="Programmed cell death ligand 1 inhibitor"/><FilterOption id="385" count="10" label="Protein tyrosine kinase inhibitor"/><FilterOption id="346" count="10" label="Ribonucleotide reductase inhibitor"/><FilterOption id="6515" count="9" label="Cytosine DNA methyltransferase inhibitor"/><FilterOption id="51708" count="9" label="DNA polymerase alpha inhibitor"/><FilterOption id="6830" count="9" label="DNA primase inhibitor"/><FilterOption id="516" count="9" label="Muscarinic M2 receptor antagonist"/><FilterOption id="12755" count="9" label="Niemann-Pick C1-like protein-1 inhibitor"/><FilterOption id="551" count="9" label="RNA DNA polymerase inhibitor"/><FilterOption id="37" count="8" label="Beta adrenoceptor agonist"/></Filter><Filter label="Trial Indications Adverse" name="trialIndicationsAdverse" total="100"><FilterOption id="102" count="1184" label="Diarrhea"/><FilterOption id="226" count="1116" label="Nausea"/><FilterOption id="829" count="968" label="Fatigue"/><FilterOption id="148" count="741" label="Headache"/><FilterOption id="110" count="701" label="Emesis"/><FilterOption id="1991" count="658" label="Neutropenia"/><FilterOption id="17" count="625" label="Anemia"/><FilterOption id="3038" count="464" label="Appetite loss"/><FilterOption id="3020" count="455" label="Skin rash"/><FilterOption id="324" count="439" label="Thrombocytopenia"/><FilterOption id="1833" count="409" label="Fever"/><FilterOption id="404" count="388" label="Constipation"/><FilterOption id="2274" count="387" label="Rhinopharyngitis"/><FilterOption id="178" count="336" label="Hypertension"/><FilterOption id="3062" count="302" label="Death"/><FilterOption id="516" count="285" label="Upper respiratory tract infection"/><FilterOption id="360" count="280" label="Pneumonia"/><FilterOption id="82" count="272" label="Cough"/><FilterOption id="3472" count="268" label="Abdominal pain"/><FilterOption id="746" count="266" label="Infectious disease"/><FilterOption id="2439" count="259" label="Arthralgia"/><FilterOption id="2400" count="243" label="Dyspnea"/><FilterOption id="3454" count="217" label="Dizziness"/><FilterOption id="680" count="213" label="Leukopenia"/><FilterOption id="402" count="212" label="Edema"/><FilterOption id="3221" count="208" label="Back pain"/><FilterOption id="1009" count="205" label="Urinary tract infection"/><FilterOption id="3795" count="203" label="Febrile neutropenia"/><FilterOption id="279" count="199" label="Pruritus"/><FilterOption id="1016" count="181" label="Stomatitis"/><FilterOption id="20" count="179" label="Pain"/><FilterOption id="13" count="174" label="Alopecia"/><FilterOption id="750" count="155" label="Insomnia"/><FilterOption id="552" count="148" label="Bleeding"/><FilterOption id="1039" count="147" label="Myalgia"/><FilterOption id="1821" count="144" label="Hyperglycemia"/><FilterOption id="129" count="140" label="Gastrointestinal disease"/><FilterOption id="445" count="109" label="Hypoglycemia"/><FilterOption id="1992" count="107" label="Lymphocytopenia"/><FilterOption id="181" count="106" label="Hypokalemia"/><FilterOption id="259" count="105" label="Peripheral neuropathy"/><FilterOption id="50" count="95" label="Bronchitis"/><FilterOption id="2576" count="94" label="Dysgeusia"/><FilterOption id="2955" count="92" label="Weight loss"/><FilterOption id="191" count="88" label="Influenza virus infection"/><FilterOption id="3073" count="86" label="Drowsiness"/><FilterOption id="1063" count="85" label="Xerostomia"/><FilterOption id="1078" count="82" label="Lung embolism"/><FilterOption id="432" count="81" label="Dyspepsia"/><FilterOption id="224" count="81" label="Myocardial infarction"/><FilterOption id="93" count="75" label="Depression"/><FilterOption id="114" count="73" label="Sepsis"/><FilterOption id="408" count="70" label="Hypotension"/><FilterOption id="3050" count="68" label="Chill"/><FilterOption id="2024" count="68" label="Erythema"/><FilterOption id="505" count="67" label="Hypersensitivity"/><FilterOption id="2434" count="67" label="Vertigo"/><FilterOption id="25" count="66" label="Anxiety disorder"/><FilterOption id="277" count="66" label="Proteinuria"/><FilterOption id="1835" count="64" label="Epistaxis"/><FilterOption id="182" count="63" label="Hypothyroidism"/><FilterOption id="69" count="58" label="Renal failure"/><FilterOption id="1263" count="56" label="Mucositis"/><FilterOption id="1280" count="55" label="Hypophosphatemia"/><FilterOption id="94" count="54" label="Dermatitis"/><FilterOption id="3868" count="52" label="Xerosis"/><FilterOption id="1256" count="51" label="Hyponatremia"/><FilterOption id="55" count="50" label="Cardiac failure"/><FilterOption id="1072" count="49" label="Colitis"/><FilterOption id="2954" count="49" label="Weight gain"/><FilterOption id="95" count="47" label="Dermatological disease"/><FilterOption id="678" count="47" label="Neuropathy"/><FilterOption id="358" count="46" label="Muscle spasm"/><FilterOption id="2440" count="46" label="Musculoskeletal pain"/><FilterOption id="172" count="45" label="Hyperbilirubinemia"/><FilterOption id="2195" count="44" label="Gastroenteritis"/><FilterOption id="668" count="44" label="Muscle weakness"/><FilterOption id="1542" count="43" label="Atrial fibrillation"/><FilterOption id="574" count="43" label="Deep vein thrombosis"/><FilterOption id="286" count="41" label="Renal disease"/><FilterOption id="325" count="40" label="Thromboembolism"/><FilterOption id="2529" count="38" label="Hot flashes"/><FilterOption id="250" count="38" label="Pancreatitis"/><FilterOption id="65" count="38" label="Stroke"/><FilterOption id="626" count="37" label="Heart disease"/><FilterOption id="2733" count="36" label="Hypomagnesemia"/><FilterOption id="201" count="36" label="Liver disease"/><FilterOption id="392" count="36" label="Varicella zoster virus infection"/><FilterOption id="1559" count="35" label="Congestive heart failure"/><FilterOption id="154" count="35" label="Hepatitis"/><FilterOption id="188" count="35" label="Inflammatory disease"/><FilterOption id="453" count="33" label="Pharyngitis"/><FilterOption id="57" count="32" label="Cardiovascular disease"/><FilterOption id="2469" count="32" label="Paresthesia"/><FilterOption id="174" count="31" label="Hypercholesterolemia"/><FilterOption id="509" count="31" label="Respiratory tract infection"/><FilterOption id="1061" count="31" label="Sinusitis"/><FilterOption id="2184" count="29" label="Gastrointestinal bleeding"/><FilterOption id="2145" count="29" label="Paronychia"/><FilterOption id="1876" count="29" label="Syncope"/></Filter></Filters><SearchResults><Trial Id="64569"><Indications><Indication>HIV infection</Indication></Indications><ActionsSecondaryInterventionsPrimary><Action>Antiviral</Action><Action>Dendritic cell vaccine</Action><Action>Genetically engineered autologous cell vaccine</Action><Action>Therapeutic vaccine</Action></ActionsSecondaryInterventionsPrimary><Technologies><Technology>Biological therapeutic</Technology><Technology>Cell therapy</Technology><Technology>Parenteral formulation unspecified</Technology></Technologies><CompaniesSponsor><Company>Hospital Clinic of Barcelona</Company></CompaniesSponsor><Countries><Country>Spain</Country></Countries><DateChangeLast>2018-08-23T00:00:00Z</DateChangeLast><DateEnd>2011-12-31T00:00:00Z</DateEnd><DateStart>2006-11-30T00:00:00Z</DateStart><Identifiers><Identifier>DCV-02/MANON07</Identifier><Identifier>NCT00402142</Identifier></Identifiers><InterventionsPrimaryDisplay><Intervention>autologous dendritic cell vaccine (HIV-1 infection), University of Barcelona alone</Intervention></InterventionsPrimaryDisplay><PatientCountEnrollment>60</PatientCountEnrollment><Phase>Phase 1/Phase 2 Clinical</Phase><RecruitmentStatus>Completed</RecruitmentStatus><Teaser>The purposes of the study were: To study the efficacy of a therapeutic HIV vaccine consisting of autologous myeloid dendritic cells pulsed ex vivo with high doses of inactivated autologous HIV-1, in HIV-1 infected patients in a very early stages of the disease (CD4 &gt; 450 x 10[6]/l). To analyze the HIV-1 humoral and cellular immune responses induced by this immune-based therapy.</Teaser><TrialCategories><Category>Cell therapy</Category><Category>Gene therapy</Category><Category>Vaccine</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Treatment</Term><Term>Randomized</Term><Term>Multiple Blind</Term><Term>Placebo Control</Term><Term>Single Group Assignment</Term></TermsDesign><TermsEndpoint><Term>Safety</Term><Term>Efficacy</Term><Term>Pharmacodynamics</Term></TermsEndpoint><EndpointIndex><EndpointIndex>HIV Vaccine - Assessment of Antibody Responses</EndpointIndex><EndpointIndex>HIV Vaccine - Assessment of CD8 Cell Responses</EndpointIndex><EndpointIndex>HIV Vaccine - Assessment of Immune Response</EndpointIndex><EndpointIndex>HIV Vaccine - Assessment of Immune Response - Assessment of cellular immunity</EndpointIndex><EndpointIndex>HIV Vaccine - Assessment of Viral Load</EndpointIndex><EndpointIndex>HIV Vaccine - Assessment of virological response</EndpointIndex><EndpointIndex>HIV infection - Assessment of Immune Response</EndpointIndex><EndpointIndex>HIV infection - Assessment of Safety and Tolerability</EndpointIndex><EndpointIndex>HIV infection - Assessment of Viral Load</EndpointIndex><EndpointIndex>HIV infection - Assessment of virological response</EndpointIndex></EndpointIndex><TermsPatientSelection><Term>Young Adults (18-44 yrs)</Term><Term>Middle-aged Adults (45-64 yrs)</Term><Term>Aged Adults (65-79 yrs)</Term><Term>Elderly Adults (80 and over)</Term></TermsPatientSelection><TitleDisplay>Dendritic Cell Vaccine in HIV-1 Infection</TitleDisplay><PatientSegmentTerms><PatientSegment>HIV Vaccine - Subjects with HIV Infection - Subjects with HIV-1 infection</PatientSegment><PatientSegment>HIV infection - Subjects on Prior/Concurrent Antiretroviral Therapy - Subjects on prior/concurrent HAART</PatientSegment><PatientSegment>HIV infection - Subjects with HIV Infection - Subjects with HIV-1 Infection</PatientSegment></PatientSegmentTerms><PrimaryCompletionDate type="Actual">2011-12-31T00:00:00Z</PrimaryCompletionDate><TrialDuration>61 Months</TrialDuration><NumberOfSites>1</NumberOfSites><ContactNames><Name>Felipe García, MD, PhD</Name></ContactNames></Trial><Trial Id="86451"><Indications><Indication>HIV-1 infection</Indication></Indications><ActionsPrimaryInterventionsPrimary><Action>HIV GAG protein modulator</Action><Action>HIV gp120 protein modulator</Action></ActionsPrimaryInterventionsPrimary><ActionsSecondaryInterventionsPrimary><Action>Antiviral</Action><Action>Prophylactic vaccine</Action><Action>Recombinant viral vector vaccine</Action><Action>Therapeutic vaccine</Action><Action>Unspecified virus based gene therapy</Action></ActionsSecondaryInterventionsPrimary><Technologies><Technology>Biological therapeutic</Technology><Technology>Parenteral formulation unspecified</Technology><Technology>Virus recombinant</Technology></Technologies><CompaniesSponsor><Company>Hospital Clinic of Barcelona</Company></CompaniesSponsor><Countries><Country>Spain</Country></Countries><DateChangeLast>2017-08-09T00:00:00Z</DateChangeLast><DateEnd>2013-05-31T00:00:00Z</DateEnd><DateStart>2011-09-30T00:00:00Z</DateStart><Identifiers><Identifier>2009-016578-34</Identifier><Identifier>NCT01571466</Identifier><Identifier>RISVAC03</Identifier><Identifier>RisVac 03</Identifier></Identifiers><InterventionsPrimaryDisplay><Intervention>MVA vaccine (HIV-1 infection), Esteve/IrsiCaixa Institute/Hospital Clinic Barcelona alone</Intervention><Intervention>disulfiram alone</Intervention></InterventionsPrimaryDisplay><PatientCountEnrollment>30</PatientCountEnrollment><Phase>Phase 1 Clinical</Phase><RecruitmentStatus>Completed</RecruitmentStatus><Teaser>The purpose of this phase I, double-blind study was to evaluate the safety and efficacy of the HIV-1 vaccine, MVA HIV-B in chronic HIV-1 infected patients successfully treated with Highly Active Anti-Retroviral Therapy (HAART).</Teaser><TrialCategories><Category>Gene therapy</Category><Category>Vaccine</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Prevention</Term><Term>Randomized</Term><Term>Multiple Blind</Term><Term>Placebo Control</Term><Term>Parallel Assignment</Term></TermsDesign><TermsEndpoint><Term>Safety</Term><Term>Efficacy</Term></TermsEndpoint><EndpointIndex><EndpointIndex>HIV Vaccine - Assessment of Antibody Responses</EndpointIndex><EndpointIndex>HIV Vaccine - Assessment of CD4 Cell Responses</EndpointIndex><EndpointIndex>HIV Vaccine - Assessment of CD8 Cell Responses</EndpointIndex><EndpointIndex>HIV Vaccine - Assessment of Immune Response - Assessment of cellular immunity</EndpointIndex><EndpointIndex>HIV Vaccine - Assessment of Laboratory/Diagnostic Measures</EndpointIndex><EndpointIndex>HIV Vaccine - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events</EndpointIndex><EndpointIndex>HIV Vaccine - Assessment of virological response - Virological breakthrough</EndpointIndex><EndpointIndex>HIV infection - Assessment of CD4 Cell Responses - Assessment of CD4 cell count/percentage</EndpointIndex><EndpointIndex>HIV infection - Assessment of CD8 Cell Responses - Assessment of CD8 cell count/percentage</EndpointIndex><EndpointIndex>HIV infection - Assessment of Immune Response</EndpointIndex><EndpointIndex>HIV infection - Assessment of Inflammatory &amp; Oxidative Stress Markers - Assessment of cytokines</EndpointIndex><EndpointIndex>HIV infection - Assessment of Safety and Tolerability</EndpointIndex><EndpointIndex>HIV infection - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events</EndpointIndex><EndpointIndex>HIV infection - Assessment of Viral Load - Assessment of HIV RNA levels</EndpointIndex></EndpointIndex><TermsPatientSelection><Term>Young Adults (18-44 yrs)</Term><Term>Middle-aged Adults (45-64 yrs)</Term><Term>Aged Adults (65-79 yrs)</Term><Term>Elderly Adults (80 and over)</Term></TermsPatientSelection><TitleDisplay>RISVAC03: A Study to Evaluate the Safety of the HIV-1 Vaccine MVA-B in Chronic HIV-1 Infected Patients Successfully Treated With HAART</TitleDisplay><PatientSegmentTerms><PatientSegment>HIV Vaccine - Subjects with HIV Infection - Subjects with HIV-1 infection</PatientSegment><PatientSegment>HIV infection - Subjects on Prior/Concurrent Antiretroviral Therapy - Subjects on prior/concurrent HAART</PatientSegment><PatientSegment>HIV infection - Subjects with HIV Infection - Subjects with HIV-1 Infection</PatientSegment></PatientSegmentTerms><BiomarkerNames><BiomarkerName>Cytokines </BiomarkerName><BiomarkerName> Human immunodeficiency virus RNA </BiomarkerName><BiomarkerName> T-Lymphocytes </BiomarkerName><BiomarkerName> T-cell surface glycoprotein CD4 </BiomarkerName><BiomarkerName> T-cell surface glycoprotein CD8 alpha chain</BiomarkerName></BiomarkerNames><PrimaryCompletionDate type="Actual">2013-05-31T00:00:00Z</PrimaryCompletionDate><TrialDuration>20 Months</TrialDuration><NumberOfSites>3</NumberOfSites><ContactNames><Name>Bonaventur Clotet</Name><Name>Felipe Garcia</Name><Name>Josep Gatell</Name><Name>Juan Quiros</Name></ContactNames></Trial><Trial Id="176830"><Indications><Indication>HIV infection</Indication></Indications><ActionsPrimaryInterventionsPrimary><Action>HIV GAG protein modulator</Action><Action>HIV gp120 protein modulator</Action></ActionsPrimaryInterventionsPrimary><ActionsSecondaryInterventionsPrimary><Action>Antiviral</Action><Action>Prophylactic vaccine</Action><Action>Recombinant viral vector vaccine</Action><Action>Therapeutic vaccine</Action><Action>Unspecified virus based gene therapy</Action></ActionsSecondaryInterventionsPrimary><Technologies><Technology>Biological therapeutic</Technology><Technology>Parenteral formulation unspecified</Technology><Technology>Virus recombinant</Technology></Technologies><CompaniesSponsor><Company>Hospital Clinic of Barcelona</Company></CompaniesSponsor><Countries><Country>Spain</Country></Countries><DateChangeLast>2017-07-15T00:00:00Z</DateChangeLast><DateEnd>2010-12-31T00:00:00Z</DateEnd><DateStart>2008-06-30T00:00:00Z</DateStart><Identifiers><Identifier>EUDRACT: 2007-002367-27</Identifier><Identifier>NCT00679497</Identifier><Identifier>R02</Identifier><Identifier>RISVAC02</Identifier><Identifier>RisVac02</Identifier></Identifiers><InterventionsPrimaryDisplay><Intervention>MVA vaccine (HIV-1 infection), Esteve/IrsiCaixa Institute/Hospital Clinic Barcelona alone</Intervention></InterventionsPrimaryDisplay><PatientCountEnrollment>30</PatientCountEnrollment><Phase>Phase 1 Clinical</Phase><RecruitmentStatus>Completed</RecruitmentStatus><Teaser>The purpose of this clinical trial was to study a modified pox viral vector considering: HIV subtype B accounted for the most frequent virus strain in Europe and North America, as well as in many parts of the world. This novel vaccinia construct expressing HIV subtype B gag, pol, env and nef antigens was to be studied in humans for the first time.</Teaser><TrialCategories><Category>Gene therapy</Category><Category>Vaccine</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Prevention</Term><Term>Randomized</Term><Term>Multiple Blind</Term><Term>Placebo Control</Term><Term>Parallel Assignment</Term></TermsDesign><TermsEndpoint><Term>Safety</Term><Term>Efficacy</Term></TermsEndpoint><EndpointIndex><EndpointIndex>HIV Vaccine - Assessment of Antibody Responses</EndpointIndex><EndpointIndex>HIV Vaccine - Assessment of Immune Response - Assessment of cellular immunity</EndpointIndex><EndpointIndex>HIV Vaccine - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events</EndpointIndex><EndpointIndex>HIV Vaccine - Assessment of Safety and Tolerability - Reactogenicity(local/systemic reactions)</EndpointIndex><EndpointIndex>HIV infection - Assessment of Immune Response - Assessment of anti-body titers/antibody responses</EndpointIndex><EndpointIndex>HIV infection - Assessment of Immune Response - Assessment of peripheral blood mononuclear cells (PBMC)</EndpointIndex><EndpointIndex>HIV infection - Assessment of Laboratory/Diagnostic Measures</EndpointIndex><EndpointIndex>HIV infection - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events</EndpointIndex></EndpointIndex><TermsPatientSelection><Term>Healthy volunteers accepted</Term><Term>Young Adults (18-44 yrs)</Term><Term>Middle-aged Adults (45-64 yrs)</Term></TermsPatientSelection><TitleDisplay>RisVac02: A Phase I Study of Modified Vaccinia Virus Ankara (MVA-B) in Healthy Volunteers at Low Risk of HIV Infection</TitleDisplay><PatientSegmentTerms><PatientSegment>HIV Vaccine - HIV Seronegative Subjects</PatientSegment><PatientSegment>HIV infection - Subjects at risk of developing disease</PatientSegment></PatientSegmentTerms><BiomarkerNames><BiomarkerName>Cytokines</BiomarkerName></BiomarkerNames><PrimaryCompletionDate type="Actual">2010-03-31T00:00:00Z</PrimaryCompletionDate><TrialDuration>30 Months</TrialDuration><NumberOfSites>2</NumberOfSites><ContactNames><Name>Josep M Gatell, MD</Name></ContactNames></Trial><Trial Id="153585"><Indications><Indication>HIV infection</Indication><Indication>Hepatitis C virus infection</Indication></Indications><ActionsPrimaryInterventionsPrimary><Action>Interferon alpha ligand modulator</Action></ActionsPrimaryInterventionsPrimary><ActionsSecondaryInterventionsPrimary><Action>Anticancer</Action><Action>Antiviral</Action><Action>RNA synthesis inhibitor</Action><Action>Systemic dermatological antiviral product</Action></ActionsSecondaryInterventionsPrimary><Technologies><Technology>Biological therapeutic</Technology><Technology>Capsule formulation</Technology><Technology>Formulation powder</Technology><Technology>Infusion</Technology><Technology>Intramuscular formulation</Technology><Technology>Intravenous formulation</Technology><Technology>Nucleoside synthesis</Technology><Technology>Oral formulation</Technology><Technology>Oral liquid formulation</Technology><Technology>Prodrug</Technology><Technology>Protein recombinant</Technology><Technology>Small molecule therapeutic</Technology><Technology>Solution</Technology><Technology>Subcutaneous formulation</Technology></Technologies><CompaniesSponsor><Company>Universitat de Barcelona</Company></CompaniesSponsor><Countries><Country>Spain</Country></Countries><DateChangeLast>2014-03-19T00:00:00Z</DateChangeLast><Identifiers><Identifier>BARCELONA/LAGUNO</Identifier><Identifier>P02080</Identifier></Identifiers><InterventionsPrimaryDisplay><Intervention>Variable regimens including interferon alfa-2b , peg-interferon alpha-2b , ribavirin</Intervention></InterventionsPrimaryDisplay><PatientCountEnrollment>95</PatientCountEnrollment><Phase>Phase not specified</Phase><RecruitmentStatus>Completed</RecruitmentStatus><Teaser>The purpose of this, randomized, single-center study was to evaluate the efficacy of peg interferon alfa-2b (PEG-INF) + ribavirin  (RBV) versus interferon alfa-2b (IFN) + ribavirin  (RBV) in hepatitis C virus-human immunodeficiency virus (HCV-HIV) co-infected patients [ 1473804 ].</Teaser><TrialCategories><Category>Biological</Category><Category>Small molecule</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Treatment</Term><Term>Randomized</Term><Term>Open Label</Term></TermsDesign><TermsEndpoint><Term>Efficacy</Term></TermsEndpoint><TitleDisplay>BARCELONA/LAGUNO: Clinical Trial of Peg-IFN Versus Inf in HCV-HIV Co-infected Patients</TitleDisplay><PatientSegmentTerms><PatientSegment>HIV infection - Subjects with comorbid conditions - Subjects with opportunistic/other infections</PatientSegment><PatientSegment>Hepatitis C virus infection - Subjects with Chronic Hepatitis C Infection</PatientSegment><PatientSegment>Hepatitis C virus infection - Subjects with comorbid conditions - Subjects with HIV infection</PatientSegment></PatientSegmentTerms><BiomarkerNames><BiomarkerName>T-cell surface glycoprotein CD4</BiomarkerName></BiomarkerNames><PrimaryCompletionDate/><NumberOfSites>0</NumberOfSites></Trial><Trial Id="370720"><Indications><Indication>HIV infection</Indication></Indications><CompaniesSponsor><Company>Hospital Clinic of Barcelona</Company></CompaniesSponsor><Countries><Country>Spain</Country></Countries><DateChangeLast>2019-02-23T00:00:00Z</DateChangeLast><DateEnd>2019-05-01T00:00:00Z</DateEnd><DateStart>2016-07-01T00:00:00Z</DateStart><Identifiers><Identifier>CLINIC HOSPITAL OF BARCELONA</Identifier><Identifier>NCT03846206</Identifier></Identifiers><InterventionsPrimaryDisplay><Intervention>mediterranean diet alone</Intervention></InterventionsPrimaryDisplay><PatientCountEnrollment>102</PatientCountEnrollment><Phase>Phase Not Applicable</Phase><RecruitmentStatus>No longer recruiting</RecruitmentStatus><Teaser>null</Teaser><TrialCategories><Category>Dietary supplement</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Treatment</Term><Term>Randomized</Term><Term>Open Label</Term><Term>No Control</Term><Term>Parallel Assignment</Term></TermsDesign><TermsEndpoint><Term>Efficacy</Term></TermsEndpoint><EndpointIndex><EndpointIndex>HIV infection - Assessment of CD4 Cell Responses</EndpointIndex><EndpointIndex>HIV infection - Assessment of CD8 Cell Responses</EndpointIndex><EndpointIndex>HIV infection - Assessment of Immune Response</EndpointIndex><EndpointIndex>HIV infection - Assessment of Inflammatory &amp; Oxidative Stress Markers</EndpointIndex><EndpointIndex>HIV infection - Assessment of Laboratory/Diagnostic Measures</EndpointIndex><EndpointIndex>HIV infection - Assessment of compliance/adherence</EndpointIndex><EndpointIndex>HIV infection - Assessment of lipid profiles</EndpointIndex><EndpointIndex>HIV infection - Pharmacogenetic/Pharmacogenomics Analysis</EndpointIndex></EndpointIndex><TermsPatientSelection><Term>Young Adults (18-44 yrs)</Term><Term>Middle-aged Adults (45-64 yrs)</Term><Term>Aged Adults (65-79 yrs)</Term><Term>Elderly Adults (80 and over)</Term></TermsPatientSelection><TitleDisplay>Mediterranean Diet and Bacterial Translocation and Immune-activation in Patients With HIV</TitleDisplay><PatientSegmentTerms><PatientSegment>HIV infection - Subjects on Prior/Concurrent Antiretroviral Therapy</PatientSegment><PatientSegment>HIV infection - Subjects with HIV Infection - Subjects with HIV-1 Infection</PatientSegment></PatientSegmentTerms><BiomarkerNames><BiomarkerName>ADP-ribosyl cyclase 1 </BiomarkerName><BiomarkerName> Cytotoxic T-Lymphocytes </BiomarkerName><BiomarkerName> D-dimer </BiomarkerName><BiomarkerName> Histocompatibility antigens class II </BiomarkerName><BiomarkerName> Interleukin-6 </BiomarkerName><BiomarkerName> Lipids </BiomarkerName><BiomarkerName> Lipopolysaccharide binding protein </BiomarkerName><BiomarkerName> Monocyte differentiation antigen CD14 </BiomarkerName><BiomarkerName> T-cell surface glycoprotein CD8 alpha chain </BiomarkerName><BiomarkerName> Tumor necrosis factor</BiomarkerName></BiomarkerNames><PrimaryCompletionDate type="Anticipated">2019-05-01T00:00:00Z</PrimaryCompletionDate><TrialDuration>34 Months</TrialDuration><NumberOfSites>1</NumberOfSites><ContactNames><Name>Felipe García, MD, PhD</Name></ContactNames></Trial><Trial Id="267627"><Indications><Indication>Acute liver failure</Indication><Indication>Chronic liver failure</Indication><Indication>Liver cirrhosis</Indication></Indications><ActionsSecondaryInterventionsPrimary><Action>Anti-inflammatory</Action></ActionsSecondaryInterventionsPrimary><Technologies><Technology>Biological therapeutic</Technology><Technology>Intravenous formulation</Technology><Technology>Stem cell therapy</Technology></Technologies><CompaniesCollaborator><Company>Clinica Universidad de Navarra</Company></CompaniesCollaborator><CompaniesSponsor><Company>Hospital Clinic of Barcelona</Company></CompaniesSponsor><Countries><Country>Spain</Country></Countries><DateChangeLast>2017-07-25T00:00:00Z</DateChangeLast><DateEnd>2020-02-29T00:00:00Z</DateEnd><DateStart>2016-02-29T00:00:00Z</DateStart><Identifiers><Identifier>2012-003900-11</Identifier><Identifier>Liveradvance</Identifier><Identifier>NCT02857010</Identifier></Identifiers><InterventionsPrimaryDisplay><Intervention>mesenchymal stem cell therapy (liver failure), Hospital Clinic of Barcelona/Clinica Universidad de Navarra alone</Intervention></InterventionsPrimaryDisplay><PatientCountEnrollment>30</PatientCountEnrollment><Phase>Phase 1 Clinical</Phase><RecruitmentStatus>Recruiting</RecruitmentStatus><Teaser>The aim of this double-blind, placebo randomized, controlled trial is to investigate the effects of allogenic bone marrow derived mesenchymal stem cells (MSCs) transplantation on liver and other organ functions and systemic inflammation in patients with acute-on-chronic liver failure (ACLF). Expected results: therapy with MSCs could have beneficial effects on the evolution of patients with ACLF (modulation of inflammatory response and improvement of liver and extra-hepatic organ function) what</Teaser><TrialCategories><Category>Cell therapy</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Treatment</Term><Term>Randomized</Term><Term>Multiple Blind</Term><Term>Placebo Control</Term><Term>Parallel Assignment</Term></TermsDesign><TermsEndpoint><Term>Safety</Term><Term>Efficacy</Term></TermsEndpoint><TermsPatientSelection><Term>Young Adults (18-44 yrs)</Term><Term>Middle-aged Adults (45-64 yrs)</Term><Term>Aged Adults (65-79 yrs)</Term></TermsPatientSelection><TitleDisplay>Liveradvance: Allogenic Bone Marrow Mesenchymal Stem Cell Therapy in Acute-on-chronic Liver Failure</TitleDisplay><BiomarkerNames><BiomarkerName>Ammonia </BiomarkerName><BiomarkerName> Bile acids and salts </BiomarkerName><BiomarkerName> Creatinine </BiomarkerName><BiomarkerName> Cytokines </BiomarkerName><BiomarkerName> Hepatic venous pressure gradient </BiomarkerName><BiomarkerName> Lactic Acid </BiomarkerName><BiomarkerName> Neutrophil gelatinase-associated lipocalin </BiomarkerName><BiomarkerName> Nitric oxide </BiomarkerName><BiomarkerName> Norepinephrine </BiomarkerName><BiomarkerName> Renin </BiomarkerName><BiomarkerName> Urea nitrogen </BiomarkerName><BiomarkerName> von Willebrand factor</BiomarkerName></BiomarkerNames><PrimaryCompletionDate type="Anticipated">2018-02-28T00:00:00Z</PrimaryCompletionDate><TrialDuration>48 Months</TrialDuration><NumberOfSites>1</NumberOfSites><ContactNames><Name>Javier Fernandez, MD PhD</Name><Name>Javier Fernandez, MD, PhD</Name><Name>PERE GINES, MD PhD</Name><Name>Pere Ginès, MD, PhD</Name></ContactNames></Trial><Trial Id="247707"><Indications><Indication>Crohns disease</Indication></Indications><ActionsSecondaryInterventionsPrimary><Action>Anti-inflammatory</Action></ActionsSecondaryInterventionsPrimary><Technologies><Technology>Biological therapeutic</Technology><Technology>Cell therapy</Technology><Technology>Parenteral formulation unspecified</Technology></Technologies><CompaniesSponsor><Company>Fundacion Clinic per a la Recerca Biomédica</Company></CompaniesSponsor><Countries><Country>Spain</Country></Countries><DateChangeLast>2019-02-19T00:00:00Z</DateChangeLast><DateEnd>2019-06-30T00:00:00Z</DateEnd><DateStart>2015-11-30T00:00:00Z</DateStart><Identifiers><Identifier>2014-001083-35</Identifier><Identifier>NCT02622763</Identifier><Identifier>TOLDEC-CD-INTRA</Identifier><Identifier>TolDecCDintra</Identifier></Identifiers><InterventionsPrimaryDisplay><Intervention>tolerogenic dendritic cell therapy (injectable, Crohns disease), Hospital Clinic of Barcelona/Fundacio Clinic alone</Intervention></InterventionsPrimaryDisplay><PatientCountEnrollment>20</PatientCountEnrollment><Phase>Phase 1 Clinical</Phase><RecruitmentStatus>Recruiting</RecruitmentStatus><Teaser>The main objective is to evaluate the safety and clinical response of intralesional injection of autologous peripheral blood differentiated adult dendritic cells expanded tolerogenic ( tolerogenic dendritic cell therapy ) in patients with refractory Crohn's disease treatment.</Teaser><TrialCategories><Category>Cell therapy</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Treatment</Term><Term>Randomized</Term><Term>Single Blind</Term><Term>Parallel Assignment</Term></TermsDesign><TermsEndpoint><Term>Safety</Term><Term>Efficacy</Term></TermsEndpoint><EndpointIndex><EndpointIndex>Crohns disease - Assessment of Clinical Response - Clinical response measured by crohn's disease activity index (CDAI) score by &gt; or = 100 points</EndpointIndex><EndpointIndex>Crohns disease - Assessment of Remission - Crohn's disease activity index (CDAI) score &lt; 150</EndpointIndex><EndpointIndex>Crohns disease - Assessment of Safety and Tolerability - Drug related adverse event</EndpointIndex><EndpointIndex>Crohns disease - Crohn's Disease Activity Assessed by Capsule Endoscopy/Endoscopy - Crohn's disease endoscopic index of severity (CDEIS) score</EndpointIndex><EndpointIndex>Crohns disease - Patient Reported Outcomes/Quality of Life Assessments - Assessment by Inflammatory Bowel Disease Questionnaire (IBDQ)</EndpointIndex></EndpointIndex><TermsPatientSelection><Term>Young Adults (18-44 yrs)</Term><Term>Middle-aged Adults (45-64 yrs)</Term><Term>Aged Adults (65-79 yrs)</Term></TermsPatientSelection><TitleDisplay>TolDecCDintra: Intralesional Tolerogenic Dendritic Cells in Crohn's Disease Treatment</TitleDisplay><PatientSegmentTerms><PatientSegment>Crohns disease - Subjects with Active Crohns Disease</PatientSegment><PatientSegment>Crohns disease - Subjects with Treatment Resistant Disease</PatientSegment></PatientSegmentTerms><PrimaryCompletionDate type="Anticipated">2019-06-30T00:00:00Z</PrimaryCompletionDate><TrialDuration>43 Months</TrialDuration><NumberOfSites>1</NumberOfSites><ContactNames><Name>Daniel Benitez, BS (Biology) PhD</Name><Name>Elena Ricart, MD PhD</Name><Name>Elena Ricart, MD, PhD</Name><Name>Sara Varea</Name><Name>Sara Varea, BS (Biology)</Name></ContactNames></Trial><Trial Id="221060"><Indications><Indication>Schizophrenia</Indication></Indications><CompaniesCollaborator><Company>Universitat de Barcelona</Company></CompaniesCollaborator><CompaniesSponsor><Company>Hospital Clinic of Barcelona</Company></CompaniesSponsor><Countries><Country>Spain</Country></Countries><DateChangeLast>2017-09-13T00:00:00Z</DateChangeLast><DateEnd>2016-03-31T00:00:00Z</DateEnd><DateStart>2012-01-31T00:00:00Z</DateStart><Identifiers><Identifier>NCT02341131</Identifier><Identifier>PI 11/01958</Identifier></Identifiers><InterventionsControlDisplay><Intervention>psychoeducation alone</Intervention></InterventionsControlDisplay><InterventionsPrimaryDisplay><Intervention>cognitive remediation therapy alone</Intervention></InterventionsPrimaryDisplay><PatientCountEnrollment>70</PatientCountEnrollment><Phase>Phase Not Applicable</Phase><RecruitmentStatus>Completed</RecruitmentStatus><Teaser>The main objective of this study was to analyze the role of a neurotrophic factor (brain-derived neurotrophic factor [BDNF]) as a putative biological marker of the cognitive recovery in schizophrenia following a Cognitive Remediation Therapy (CRT). Additionally, the role as outcome predictors of BDNF serum levels and the val66met polymorphism and data from functional and structural neuroimaging would be studied.</Teaser><TrialCategories><Category>Behavioral intervention</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Treatment</Term><Term>Randomized</Term><Term>Single Blind</Term><Term>Active Control</Term><Term>Parallel Assignment</Term></TermsDesign><TermsEndpoint><Term>Efficacy</Term></TermsEndpoint><EndpointIndex><EndpointIndex>Schizophrenia - Assessment of Laboratory/Diagnostic Measures</EndpointIndex><EndpointIndex>Schizophrenia - Assessment of Psychiatric Symptoms - Assessment of subjects by PANSS (Positive And Negative Syndrome Scale)</EndpointIndex><EndpointIndex>Schizophrenia - Assessment of Symptoms of Schizophrenia</EndpointIndex><EndpointIndex>Schizophrenia - Cognitive, Global and Functional Assessments</EndpointIndex><EndpointIndex>Schizophrenia - Pharmacogenetic/Pharmacogenomics Analysis</EndpointIndex><EndpointIndex>Schizophrenia - Protocol Specified Other Endpoints - Assessment of sociodemographic outcomes</EndpointIndex></EndpointIndex><TermsPatientSelection><Term>Healthy volunteers accepted</Term><Term>Young Adults (18-44 yrs)</Term><Term>Middle-aged Adults (45-64 yrs)</Term><Term>Aged Adults (65-79 yrs)</Term></TermsPatientSelection><TitleDisplay>Cognitive Remediation Therapy in Schizophrenia: Effects on BDNF Levels</TitleDisplay><PatientSegmentTerms><PatientSegment>Schizophrenia - Others - Healthy Subjects</PatientSegment><PatientSegment>Schizophrenia - Subjects with Neurocognitive Impairment</PatientSegment><PatientSegment>Schizophrenia - Subjects with gene variants - BDNF_HUMAN_rs6265(A)</PatientSegment><PatientSegment>Schizophrenia - Subjects with gene variants - BDNF_HUMAN_rs6265(G)</PatientSegment></PatientSegmentTerms><BiomarkerNames><BiomarkerName>Brain-derived neurotrophic factor</BiomarkerName></BiomarkerNames><PrimaryCompletionDate type="Actual">2015-12-31T00:00:00Z</PrimaryCompletionDate><TrialDuration>50 Months</TrialDuration><NumberOfSites>1</NumberOfSites><ContactNames><Name>Rafael Penadés, Ph.D.</Name></ContactNames></Trial><Trial Id="73490"><ActionsPrimaryInterventionsPrimary><Action>5-HT 2 receptor antagonist</Action><Action>Dopamine D2 receptor antagonist</Action></ActionsPrimaryInterventionsPrimary><ActionsSecondaryInterventionsPrimary><Action>Antipsychotic</Action></ActionsSecondaryInterventionsPrimary><Technologies><Technology>Film coating</Technology><Technology>Oral formulation</Technology><Technology>Orally disintegrating tablet</Technology><Technology>Small molecule therapeutic</Technology><Technology>Solution</Technology><Technology>Tablet formulation</Technology></Technologies><CompaniesCollaborator><Company>Fundacio Privada I Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau</Company><Company>Fundacion Clinic per a la Recerca Biomédica</Company><Company>Universitat de Barcelona</Company></CompaniesCollaborator><CompaniesSponsor><Company>Hospital Clinic of Barcelona</Company></CompaniesSponsor><Countries><Country>Spain</Country></Countries><DateChangeLast>2019-04-12T00:00:00Z</DateChangeLast><DateEnd>2011-12-31T00:00:00Z</DateEnd><DateStart>2011-02-28T00:00:00Z</DateStart><Identifiers><Identifier>2009-016519-40</Identifier><Identifier>APSEP</Identifier><Identifier>NCT01259973</Identifier><Identifier>TRA-065</Identifier><Identifier>TRA-065</Identifier></Identifiers><InterventionsPrimaryDisplay><Intervention>haloperidol alone</Intervention><Intervention>risperidone alone</Intervention></InterventionsPrimaryDisplay><PatientCountEnrollment>24</PatientCountEnrollment><Phase>Phase 1 Clinical</Phase><RecruitmentStatus>Recruiting</RecruitmentStatus><Teaser> on each scale used). Subjects would be hospitalized for 3 complete days (separated between them by 1 wash-out week after each treatment) from 8.00 h to 8.00 h of the following day at phase I unit of 'Hospital de Sant Pau i de la Santa Creu', in &lt;b&gt;Barcelona&lt;/b&gt;, in order to monitor the results obtained after each treatment. During their hospitalization, subjects would be given food and drink every 2-h.</Teaser><TrialCategories><Category>Small molecule</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Treatment</Term><Term>Randomized</Term><Term>Multiple Blind</Term><Term>Placebo Control</Term><Term>Crossover Assignment</Term></TermsDesign><TermsEndpoint><Term>Pharmacokinetics</Term><Term>Pharmacodynamics</Term></TermsEndpoint><EndpointIndex><EndpointIndex>Schizophrenia - Assessment of Hormone Levels - Assessment of prolactin levels</EndpointIndex><EndpointIndex>Schizophrenia - Assessment of Neuropsychological Function - Assessment of attention</EndpointIndex><EndpointIndex>Schizophrenia - Assessment of Pharmacokinetic/Pharmacodynamic Parameters</EndpointIndex><EndpointIndex>Schizophrenia - Assessment of Psychiatric Symptoms - Assessment of subjects by PANSS (Positive And Negative Syndrome Scale)</EndpointIndex><EndpointIndex>Schizophrenia - Assessment of Safety and Tolerability - Assessment of adverse events(AEs)/side effects</EndpointIndex><EndpointIndex>Schizophrenia - Assessment of Safety and Tolerability - Assessment of extra pyramidal symptoms</EndpointIndex><EndpointIndex>Schizophrenia - Assessment of Safety and Tolerability - Assessment of subjects by Barnes Akathisia Rating Scale (BARS)</EndpointIndex><EndpointIndex>Schizophrenia - Assessment of Safety and Tolerability - Assessment of subjects by Simpson Angus Scale (SAS)</EndpointIndex><EndpointIndex>Schizophrenia - Assessment of Sleep</EndpointIndex><EndpointIndex>Schizophrenia - Assessment of Symptoms of Schizophrenia - Assessment of aggressive symptoms</EndpointIndex><EndpointIndex>Schizophrenia - Assessment of Symptoms of Schizophrenia - Assessment of negative symptoms</EndpointIndex><EndpointIndex>Schizophrenia - Assessment of Symptoms of Schizophrenia - Assessment of positive symptoms</EndpointIndex><EndpointIndex>Schizophrenia - Assessment of Symptoms of Schizophrenia - Assessment of psychotic symptoms</EndpointIndex><EndpointIndex>Schizophrenia - Assessment of Symptoms of Schizophrenia - Assessment of subjects by BPRS (Brief Psychiatric Rating Scale)</EndpointIndex><EndpointIndex>Schizophrenia - Assessment of Symptoms of Schizophrenia - Assessment of subjects by SANS (Schedule for Assessment of Negative Symptoms)</EndpointIndex><EndpointIndex>Schizophrenia - Assessment of Vital Signs</EndpointIndex><EndpointIndex>Schizophrenia - Assessment of ocular function</EndpointIndex><EndpointIndex>Schizophrenia - Gene variants involved in outcome measures - CYP2D6_HUMAN_Duplication</EndpointIndex><EndpointIndex>Schizophrenia - Gene variants involved in outcome measures - CYP3A5_HUMAN_rs776746(A)</EndpointIndex><EndpointIndex>Schizophrenia - Gene variants involved in outcome measures - CYP3A5_HUMAN_rs776746(G)</EndpointIndex><EndpointIndex>Schizophrenia - Patient Reported Outcomes/Quality of Life Assessments - Assessment of subjects by VAS scale</EndpointIndex></EndpointIndex><TermsPatientSelection><Term>Healthy volunteers only</Term><Term>Young Adults (18-44 yrs)</Term></TermsPatientSelection><TitleDisplay>APSEP: Typical Versus Atypical Antipsychotics; Occupation of Striatal Receptors and the Appearance of Extrapyramidal Symptomatology, in Healthy Volunteers</TitleDisplay><PatientSegmentTerms><PatientSegment>Schizophrenia - Others - Healthy Subjects</PatientSegment><PatientSegment>Schizophrenia - Subjects with gene variants - CYP2D6_HUMAN_Mutation</PatientSegment></PatientSegmentTerms><BiomarkerNames><BiomarkerName>Cytochrome P450 2D6 </BiomarkerName><BiomarkerName> Cytochrome P450 3A5 </BiomarkerName><BiomarkerName> Prolactin</BiomarkerName></BiomarkerNames><PrimaryCompletionDate type="Anticipated">2011-11-30T00:00:00Z</PrimaryCompletionDate><TrialDuration>10 Months</TrialDuration><NumberOfSites>2</NumberOfSites><ContactNames><Name>Amalia Lafuente Flo, Pharmacology professor</Name><Name>Analía Azaro, Clinical Pharmacologist</Name><Name>Eva Ferrando Martorell, Pre-doc</Name><Name>Gemma Trias Lafuente, Psychologist</Name><Name>Ignasi Carrió Gasset, Head of Nuclear Med Service</Name><Name>Miquel Bernardo Arroyo, Head of Psychiatry</Name><Name>Rosa M Antonijoan, Clinical Pharmacologist</Name><Name>Sergi Mas Herrero, Pos-doc assistant professor</Name></ContactNames></Trial><Trial Id="242037"><Indications><Indication>Female infertility</Indication><Indication>Reproductive disorder</Indication></Indications><CompaniesSponsor><Company>IVI Barcelona</Company></CompaniesSponsor><Countries><Country>Spain</Country></Countries><DateChangeLast>2019-03-19T00:00:00Z</DateChangeLast><DateEnd>2016-01-31T00:00:00Z</DateEnd><DateStart>2015-05-31T00:00:00Z</DateStart><Identifiers><Identifier>1412-BCN-087-AB</Identifier><Identifier>2015-000290-12</Identifier><Identifier>NCT02567552</Identifier><Identifier>S0005RVK</Identifier></Identifiers><InterventionsControlDisplay><Intervention>progesterone (Prontogest) alone</Intervention></InterventionsControlDisplay><InterventionsPrimaryDisplay><Intervention>progesterone (Prolutex) alone</Intervention></InterventionsPrimaryDisplay><PatientCountEnrollment>24</PatientCountEnrollment><Phase>Phase 4 Clinical</Phase><RecruitmentStatus>Completed</RecruitmentStatus><Teaser>between 18 and 28 kg/m2 Endometrial thickness&gt; 7 mm the day of progesterone treatment initiation (day of follicular puncture) Follicular maturation with a single bolus of GnRH agonist Egg donors who undergo a cycle of ovarian stimulation in the IVI &lt;b&gt;Barcelona&lt;/b&gt; Center Egg donors selected in accordance with the requirements of Law 14/2006 of 26, May 2006 on Assisted Human Reproduction Techniques Informed consent has been signed and dated</Teaser><TrialCategories><Category>Small molecule</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Treatment</Term><Term>Randomized</Term><Term>Single Blind</Term><Term>Active Control</Term><Term>Parallel Assignment</Term></TermsDesign><TermsEndpoint><Term>Safety</Term><Term>Efficacy</Term></TermsEndpoint><TermsPatientSelection><Term>Healthy volunteers accepted</Term><Term>Female</Term><Term>Young Adults (18-44 yrs)</Term></TermsPatientSelection><TitleDisplay>Clinical Trial Comparing Endometrial Transformation With Subcutaneous Progesterone Versus Intramuscular Progesterone</TitleDisplay><BiomarkerNames><BiomarkerName>Endometrium </BiomarkerName><BiomarkerName> Estradiol </BiomarkerName><BiomarkerName> Luteinizing Hormone</BiomarkerName></BiomarkerNames><PrimaryCompletionDate type="Actual">2015-12-31T00:00:00Z</PrimaryCompletionDate><TrialDuration>8 Months</TrialDuration><NumberOfSites>1</NumberOfSites><ContactNames><Name>Agustín B Boluda</Name><Name>Medicina Reproductiva</Name></ContactNames></Trial></SearchResults></trialResultsOutput>